	   SnapGene      ¯GTTAGGCGTTTTGCGCTGCTTCGCGATGTACGGGCCAGATATACGCGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCTGGCTAGCgccaccatgTACCCATACGACGTACCTGATTATGCAACTTATCCTTATGATGTACCTGATTATGCTAGtTATCCTTATGATGTCCCAGACTACGCAAAGCTTGGTACCGAGCTCGGATCCACTAGTCCAGTGTGGTGGAATTCTGCAGTCAGCACAGTGGCGGCCGCTCGAGtctagaGGGCCCGATATCTCGACAATCAACCTCTGGATTACAAAATTTGTGAAAGATTGACTGGTATTCTTAACTATGTTGCTCCTTTTACGCTATGTGGATACGCTGCTTTAATGCCTTTGTATCATGCTATTGCTTCCCGTATGGCTTTCATTTTCTCCTCCTTGTATAAATCCTGGTTGCTGTCTCTTTATGAGGAGTTGTGGCCCGTTGTCAGGCAACGTGGCGTGGTGTGCACTGTGTTTGCTGACGCAACCCCCACTGGTTGGGGCATTGCCACCACCTGTCAGCTCCTTTCCGGGACTTTCGCTTTCCCCCTCCCTATTGCCACGGCGGAACTCATCGCCGCCTGCCTTGCCCGCTGCTGGACAGGGGCTCGGCTGTTGGGCACTGACAATTCCGTGGTGTTGTCGGGGAAGCTGACGTCCTTTCCATGGCTGCTCGCCTGTGTTGCCACCTGGATTCTGCGCGGGACGTCCTTCTGCTACGTCCCTTCGGCCCTCAATCCAGCGGACCTTCCTTCCCGCGGCCTGCTGCCGGCTCTGCGGCCTCTTCCGCGTCTTCGCCTTCGCCCTCAGACGAGTCGGATCTCCCTTTGGGCCGCCTCCCCGCCTGGAAACGGGGGAGGCTAACTGAAACACGGAAGGAGACAATACCGGAAGGAACCCGCGCTATGACGGCAATAAAAAGACAGAATAAAACGCACGGGTGTTGGGTCGTTTGTTCATAAACGCGGGGTTCGGTCCCAGGGCTGGCACTCTGTCGATACCCCACCGAGACCCCATTGGGGCCAATACGCCCGCGTTTCTTCCTTTTCCCCACCCCACCCCCCAAGTTCGGGTGAAGGCCCAGGGCTCGCAGCCAACGTCGGGGCGGCAGGCCCTGCCATAGCAGATCTGCGCAGCTGGGGCTCTAGGGGGTATCCCCACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGCATCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGGGGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTAATTCTGTGGAATGTGTGTCAGTTAGGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAACCAGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAACCATAGTCCCGCCCCTAACTCCGCCCATCCCGCCCCTAACTCCGCCCAGTTCCGCCCATTCTCCGCCCCATGGCTGACTAATTTTTTTTATTTATGCAGAGGCCGAGGCCGCCTCTGCCTCTGAGCTATTCCAGAAGTAGTGAGGAGGCTTTTTTGGAGGCCTAGGCTTTTGCAAAAAGCTCCCGGGAGCTTGTATATCCATTTTCGGATCTGATCAAGAGACAGGATGAGGATCGTTTCGCATGATTGAACAAGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGGTGGAGAGGCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTGCTCTGATGCCGCCGTGTTCCGGCTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGACCTGTCCGGTGCCCTGAATGAACTGCAGGACGAGGCAGCGCGGCTATCGTGGCTGGCCACGACGGGCGTTCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAGCGGGAAGGGACTGGCTGCTATTGGGCGAAGTGCCGGGGCAGGATCTCCTGTCATCTCACCTTGCTCCTGCCGAGAAAGTATCCATCATGGCTGATGCAATGCGGCGGCTGCATACGCTTGATCCGGCTACCTGCCCATTCGACCACCAAGCGAAACATCGCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGATCTGGACGAAGAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGCGCATGCCCGACGGCGAGGATCTCGTCGTGACCCATGGCGATGCCTGCTTGCCGAATATCATGGTGGAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTGGGTGTGGCGGACCGCTATCAGGACATAGCGTTGGCTACCCGTGATATTGCTGAAGAGCTTGGCGGCGAATGGGCTGACCGCTTCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCAGCGCATCGCCTTCTATCGCCTTCTTGACGAGTTCTTCTGAGCGGGACTCTGGGGTTCGCGAAATGACCGACCAAGCGACGCCCAACCTGCCATCACGAGATTTCGATTCCACCGCCGCCTTCTATGAAAGGTTGGGCTTCGGAATCGTTTTCCGGGACGCCGGCTGGATGATCCTCCAGCGCGGGGATCTCATGCTGGAGTTCTTCGCCCACCCCAACTTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCAATAGCATCACAAATTTCACAAATAAAGCATTTTTTTCACTGCATTCTAGTTGTGGTTTGTCCAAACTCATCAATGTATCTTATCATGTCTGTATACCGTCGACCTCTAGCTAGAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCAATGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGTCGACGGATCGGGAGATCTCCCGATCCCCTATGGTCGACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGTATCTGCTCCCTGCTTGTGTGTTGGAGGTCGCTGAGTAGTGCGCGAGCAAAATTTAAGCTACAACAAGGCAAGGCTTGACCGACAATTGCATGAAGAATCTGCTTAGG  5_                                       #      *                                                                                                                  "   "            )      !   -            '         	   !                                                      2                                                                                                            
                              $            !                     #   "                                                                                 *   &            (                                                !            "                                 '   1            !                                                 '      	               (         !      "            1   !            !      "         '      +         Y á9¡Êš›@“¸ÁÂf?�
8û8¼ÚGÉ}¹Ë á xâ bYËœ7@Ù	0Ÿ½HÊÇ¢r|Iý Z ÷ ð÷tÃìt¦“>
Ž9Û~#‘Ì  ÈN4:¢¯ƒA�”¹g¹Y
‘
í
,9üÕ‹]vÒºQ t û cò�³â°	¼	Ú	B
ÊIsþY 
|Ì”¯¿Ã
‚™áÎd’ÄÕú€ÈýŽÎ«2JZ ÎãôP�ùw8Aï	

"
>Êã4w«¾Ë­†]£¾}Ê¤ø â y!Zœ-øÉ
ì—£1 bÑ ø ¬_Áñuíò§”Ü?
µ
a�ÜQ÷ ¶0W3$ Œ MRèlÄï›°ê@Z•Ü	*j ´Õß5õu­ÍP.
™
:‡õ:Q¸3´ó’Í [ fø!Õ††ýªãÁ\#  ÉOV y•Ûé’
î
-|/G”ËÎ{N^”­TsÐ��[q»R ]‡º;°Ô˜hŠ±ùZ
Ï
:r%Où6…* œ {¿£¨áH ‚ºM¥íh	³	Å	G
O
j
ƒ
×
à
"n’ýŠ¯ÖŒ§Ž!Äw¬oŠ   “ T#5ú=P„B{œºH…	‹	¿	6
ä
k†<êõ¹ƒÓÞ d2ðžƒ	‰	®	±	½	
E
Í
2LO“#tZ ´5û	C
]fJ°œLÚÿ u ü +órã"ËæO©ü’6bc tî[›	Û	º¾óÅ,u¿ê—â2�×' n Í°Àxµý¦	0ÏðÂÅ�É±ÎífßÏÞÔ3„ž `•¨šâ_­eAƒ›ÖWþU“¬¾[»á ãuƒ½
XÑ“7ÃNKc°¡ }Ä
Á
Úû�”  ¯²Ðª

s
rËäJ¬"æ- % Ï:‘*Æ¹Ìl®dm”~¥ 7 ä�»Qdú{¡.9B`
#
xþhn‡J¤²³ õx«ð	õ	
?�Þç5¯¿^iq¿Ë4‰›ÉËÜ ù	 ¹ Å î AJûE”&ÓoÑÊÜÊ
ê
í,R¡/B„ïõ 1 B�¶¶ßý	c
¤^_ÒU“ > ã zÚ"Ùh[ùl	U
€2xcdT/   « p.7’¨
¬
¢@˜ÚFJi�.ž^�  ù Ì`Žø¿ðó·ö€—ß@
Þ
b„’8RÎ´·1ŒáU ­^v¨¬	>·™èà!-4% #YÂíòî‡‰•Ý|
�—Ïø_XåSRT �¶
 3æÝ&Œ¡Š¨Ÿôæh SÖ´©	çúš
+a e M � Õ N2~Ñ± A[€þ×é È þ %•m§»ÔÅ¸ 	á	cðO_Xœë–ÖÝôkU´A  3j‹¾[Š—µéÄ8 . {àõÿ6¬Äïôß	¬ˆ5ÿM=@¥ÍÛd×`V   C ~ ÅöQ�ö¡¹ô�+”µçô“8  µÖüQÎ
˜â;�Rv4<â2f  c w Ì  pFv®ë Q	/
~
š
ñ
$;ÍŠ˜ó%«B#€²âÎ /Çtù'�Û;f#‡þ\cò] \ ¼ ñ D›þKW‹Ñ	‡
£
G‡K«ZÐDt íg-æ\"Ö[J€9 ™ ÓþÖ	åžæ&	±
?µQäÂ  ²ÓP!z+;N
–ÙçêÕ
z}•Ì.ºEO’™®ž.²Y¢  s.«¼0HÏ?P•U‘2š�\¼Sl  , | ÊWZO ï
ª|ýVtÌr"  € Ê°ÏÜåû‹
“
Ó
ø
 "¸C_€ŽÑ5ãPÙ6‡Ój" ˆ»q‡™¨²ý®²öú€	+
�
Æ
Ð
ú
;éÒsvŒDGRÛâú‘ H£ß)Õ¼Õ		Ì	uäï@�¼é8ª)7Ap† ^<ÞiÁÅ			
ƒµõ$-È/4P‡3š ±ì ‹'
[
À&ýöÕ)  � –ã#–™©ÐâBµ]i	k
„
á
ý
#o€‹¿×¨Ç�,}�ä2ê'ŒÔ` ¡|Á‰®¡Ì�	H
P
Ø
&“œ°qì£ÅI{!  ä™´Àb,Nƒ´	Æ	Ý	:
‰QoÇÞè�ìwi¦Óxp%N‹§- vð'~O¤åIƒ»#\¦îÓ	n
Tþø¨aq‚¢"E„�Þå‡¥­_z¹g¡(G $†E…J†	Œ	7
v
y
5ZÒUl‡õw¤Á£ËÔß>0 ! Ú .‚AtòCŠ¢A»å
^(=ëölyðÇ'C‰è= ˜ Y¡‰�é>Qbˆ�I�	•	À	MzÖß¹7ºPõ' j ” ¤ ² 7Ue=6û’hK|�ÑÁÕ+	7	@	L	V	a	•
¸
š(UÔ'*„m à 3 €Às¥6’�
úÈ¡uÑHP�Ê ñ²Â¯	 

È
=â3¢Ôùa…Ð\½É1	 eÛ-
†Péü”[!  UŸz›¤°ìø„	Š	²	¾	Ä	F
Î
M¬éô rœ$NŽ5„‰ s1‚	ú	D
òÄtKNŽ¨ â´ü¥	^ÂÙÍTeÝÓM“º  $ cª
gkIh±Êc²!Û  ØnµÞ6Éü	b
§
^� "€¶õ«	2Îç³‹ ‰àäRžåg L Ô ý 2iŠ½·ÿ¨	bÕóýÖ7@d B b v ÄôoŽP	#Ì4òªóáL"*1“Úcá7 šìý,sä�Ðå	%	JPÿC Ò*ØäÿŠ
Ò
ª»©-O·˜Ë�-1Ø±¡ p§­ÀÔõ		¿ôÇãî3u‹CF»ü�(†o uãïNÏ´[\œ	Ò	Ü	ü
ÆëpvŒë+¡ƒy¸z i ‰ÑÀÕ)xïÆÊ< ±Áy5…«èóÏ[ ¼Ð�È4GOƒˆ bÝù	
¦
ñÃØj]dg Ÿ !1ënœ¶äþ§	1aÍI²àòßÕÙB�ä oâÎãZ¿	Ñ	©ÐN ÆÔ‚Ê
îB°…;y áaÜ›¾ã	Ð	`„ÿÌÓª×çòiZ»ñ¯œFã2 *WÚÛç˜™šTUVhiÎ	Ï	fæñ;<ÿ VWXY”¹ºÙÚ¬­®›­¿+,9CDE¼½âr � P+JXØaWjgBûœ=ÔÛç:\¾Æs 	–©è›®CX• Á®À-Â � Â ô GQÅ,KžX„¾
whÒCòLã4ÛÜ‘;]± I ¿ Ý ¹×äFòYü³¾.Ow�Ld{¿Ç S Y¹kvzÌ	p	�®ùÕt– O EÙ%bf
”€8Ä>èì#¢ ¨ × 	—é�p@Ï�:†¯ 4ªe
_
¯¸Û‚.Ã€ … 
7¥u~¤œ1	F	Â
ÝDïC¾–gë•Áü I+Å×	YüYU Â>ë r ‘ õ RvªÆL½ß«f	 
lÌE_iÓó„mñ÷ Ã Hn°ÎîÏY

S
¿
åD�­ä5®Ýú’™žœ  Ê -ˆ³ÑyŒ…MYÞ˜£ç^² ,c°¡¿Ÿ¬ºÃ		~	t
sx&KÅÜ#W<. J g Ò Þ Ð¥Çó#	§ŠJ/PŽÈ5 ƒ À mÖØå3ðýÊÍge¿MÀ & n p *k;ã	Zºöø|ª ( �’º+G…a»´m¯n•x‚ek¦ 4 ; ¶ ë >øBe±>q=M
$
)¼æžúZF¨�–— 8 F T _ `—¤ž¼Rà¢wÍ	ö1ˆK³Ö~  åZÆ|/:Calq	z	é	i!Ø¥=´‰¬¶Ùu oºû&{Z	 	K
žyÿo/¯uG žƒc¾	
g
Û
²·}ò
•9?GiRÊú P 'ÂF©ö	iß÷\Ÿa
IV�žÅ6¶é¸Šê¥� �=y¬Ç	ñ	@Jè6ÀQíß_rÀí,5Ì
$C£ ªÈöÚ&Çk;	å	eŽ°¤¼<jÌFñûœÝ
  W Š Kß]w˜­ÒîˆËë
-í¶Â{pzXö © ’pË
è
î d½0b‘k‡ º Æ ï B“ü•
ÔŽD²ÝéÂ›;°ð * Ø 5FÝ‡”'êIÍùq)
‡S¢AÐCâN…£] žàþ	`
À_ƒ¦ÓL/ 5CU··f
]
d
ù¬¶9Ä!~�” 2 � l�À°¥¹ôÜ—Œ¨× «´`ÈV i2³¥V
Ã
�*uo|ÿ0ý
 ? Úúvm	dD¿Êh † ä {ƒ#¦\�Þeì– Û8"ú2	G	Æ3Eðy¦—Uí:Âðgm ¡ ë¼2©
™ÛGtcýª/$—©_„Ñ� §…DØ 	£¦Ko!|Ã? q™·JGõ/�­
O–Zj±÷Æ(ë ¬ óŒ,Æ-8bg“A³ØZžVŸìø ö wÇMa8®‚ö?·¸>=
X
+�Ô7ŠÙ\" s ú Í	O�›ø“á÷	�˜à»	!
A
ÍëcvªÉ�ªX «çkÞ4Àñô¬O`ô9…~µÛ)2©âViò2$ ’ › S\†¹z¾ùàg	ß
ã
!mFj…“®ÊzSÏq¸‚nÝø ïZš	­	
+åéáN¯û"5KÙ&Ÿb _§w
¼
À
Á‚š6°ìÞbƒ¯� 6 ®œ±ºÏ ©Å-_ô	
r
qŒæ¸®p“šÿ,! 0 = Ÿ ¸ Ä í @IoÙúDg%µÒÐÛk	T
?ÙEw.ƒ
S.îŽ ]�÷ìï†ˆ–Þÿ
ƒ‘7–˜ß§,QS  $Z‰´¦ÓÕà	N^Ðæù™`Tè³ Ë z«Ãîóÿÿ}
á� —;
?¤æÖ_U .ÒåJÆ&Š†
¢
°
FÚ>Z"´8YÏ˜  ±ÿM¯÷
yüU‘�4â5Xi ¢»Ä			Ë	&
Å
t‚è,.?Žè©õ™#  À}˜­³â"˜äA‚m
%SP¾çÆÝ¢é‹H$f 'FM¦" -d @sŒ‘ñD¡”	u
·
4Y™'LT]Þ
'¢OBl=ç/  ß T¿r¤‘Ã	èû›Éª 0ÈsÌÉb¹ A K a Ó ™ÃüµôÏ	$	ª	3K!0Q6f h Ñ~¦×¨o‹Š,·� nâ4\ŸØN:x Ž O×Ùæ`SþËÒhÓØæðÿÀšÁ H N Á �ñyo	ñâø3²-€ „ Ö 3t£do0	E	îÎB�½fê q É +bu ¯¾Íx‹¼íÎ¹	}	R
€—ùlöV ' o jlÕ2â	ï`fõ÷ : E ÿ =–£n°p%Ly	Ÿ	J
(»åY×<}€•«µ &©Ç<¨Æä	Ú
d[žñPU£�»ì;FhÞµ+·ðéŒB  ) V ‰ 4’\‘Ü†“Hø‡†ì¼µÁMzjoy € kŒ¿T
ø¥ÇK–§ } ‚Å9fl ¦‹˜¶ê»,•²bn©°ö{–ƒÐ …¸æ7­�õ>à=Nº	<
*­É‰y[Ú¨hÜ©W / 5 < · ì ?ØùCfŸÚ,
‹M¯oØa‚®� 
\¥Òö Åþþß	¡

Ùà6=Ÿ:	>¦Î—P 
 |²á!?r�ðÊ	%
ö
RS½çû T>N4AGek˜  ` ˜q~£�Î	‰¶¸© G sœáðRcnx÷2žÒ×å,™9w 9 D atŸ¨®½ÆÌì1x	|	äîT¢º:g´¶ïèõ‹” U  ˆ ¥S…÷†ë÷¨õLz•Ï 	 ·×	[¤ €ýÙ+<¹	É	 
<SÙ9=n§3g­ „›ëp}…ï0bmw	{	êãÑäµî˜Š·v*  ¶ƒÇZÏÐ*;r	s	t	u	v	¶	·	¸	È	ê	ž
Ÿ
q™"#$%5678u¦Ðã'uv& æ }æ%ÂÈT^dÚR[(.;PÑDë	
rjš&‘w¼Õv>(wÚ  __eq)GÒEì	
L
Ÿ <k�Ñ‹Äôú?$¾¶ã d Ã¯z'&ÃCrvx pÉüS/<ì'|[	0
›
s%(}Î0½Ö¬w)H³( x Í ç ~ç&¶Ue»Û26VV\27QwR	¡	
ò
àp›’°ekx™�qÏÛ ò¦Èur‘dFí	M
h
È�:„ŒÅõû¿·û )@(� ¸Ü~lg@äó 0ú

Ü
9<ä–$ˆŠÿH@]SadËò  Ÿ`„ç`f…*?H¿Ó
³ ó=Òo{j%^ LlŒÒ	ˆ
àø ŸÆLð'‰/¹wÑŽ Q ½ ò EÃÿG#XÊ	÷	¤
J¨GÙb·ê‹<uÆy ] e (œªÄ�Hj]{ÃGW‚ˆ¬DsïE£¦iœ Ý°Mb(ªòs¤7à™Ä§[ë xMýK$­}’	˜	ò	p
ét)5\àç�6€*I %*D¤ �h.½^#~1mxî: qéT]T0íü(œ
×&ÏRcK­sÁi´Ío î>Êçz=È	\	1
AK7Á’¾×î`-	Äš y :V¼Wx4	I	S	^	3
€
²
�œ¥f$š¶=ò|ÆÐ è èð'÷ÿÜ'æ¢	æ	fq´@±½RG¯øüÞ «É€ÌÏÛQ×
3W%8ó
CVá±“l”kÍå»Ãr! Î Ô·fl7|‹]È3RlŸ¨çð'	<	Õ	úy†ÀW‚�ÜI  X àXÉ™ïs’ëeØ	ì
7/ž»FÆ|q{¸ü ó{,v®¾î	É–‘Ã¬üÍY£÷ ‹ L³ÔQ^Ì ˜
´
ÔîP…š¯·ö?YŸ/~³À" "x§<GOÓ—ÚèL‰G5
N
i
‚
Ö
{~‘.‰Í¦;�“Ã«Zp í*q4ˆ	Ì
\¹½1!e¾–1’›Ö‘am t/¬ï
WÐ@V’½à  9)zÝIým3lˆÈå ª “A‘«
é
¡+IQhA]œ-c]Tô’ ËX¾{
Ý
=¶å%‹Í^Tó Ç ”1–º³Ã}Wÿ  - } þûPEÞê
ð
«—þ‰u $œA<eÌ± » ð CýÕ[�V:eI[bsñ  + { :YÉ	NÎæúrÔ
!>¹BD
O™†Òk GÞ(ë†±Ýü
*
Œ
ù
´#ÑQÚ7á@Ô2'   &ˆ•a•Ë"+9
ˆn›Ý÷§`hp|�D�¥Òã1ä&†¤^Ó_1 — £ ± Ù 6X<�…ˆèag‡�JÐ@IÀÔ*	6	?	K	U	`	Ž	x
”
ôTvy£Ó&¸6kô&ˆ Ÿš£¯Úë÷ÿ	,
Ž
Ç
<áù¡ÇÓø`q„M0� # r×má©³û�	¤	a
ÁM�§HS±ÜÒ’ h‰¼�O	ñÔòŠˆþ)ãà?! M)ˆ³þ¬Óô	‰
Ñ
û
¶ê* í(twE0ºÅÉxû  0êmYø	
¥
¨MH	AcŒAÇ‚‡ )IàV—g½	Í	úB©åð:¸«*8BÅq R ¾ Ü ó FÄ D¸$¸ÖEË	e
vK­Úë�½vz"• § 6¤H*ŒÖ	^
XÜ·?Tê9…=û m©‡«ÞÂ
	e	
k%D^ÄXƒÝ­˜¢ð�› f m ‚ Ñ )�¤"	„¦‰ºÉI�j©4 3 ^ µ ê _÷AÅ=<ßY	è	� .õ0EtF§ˆØ Ž�Á‚j½Æ	:	Ih±¶ö|	`	H5E~úQ¤	 Þv¬íÌC±è(
ç
Ácáaš¢\W \
«³µó¿8‹Ö ù1²!)t¥n{Éìþï ò„CFô1afŒN¥s×#Å'¨÷ê  š [yNjÝ3š÷’¶W
â
 êuŒ6©ÈØ~p}(�1! ž ›¹$´Ñ¦Ä^j	™	ó	q
»
pÀØ*v-ë‚	RJþí+a äIªë%Ô~…
¯
þ
E‚]Ž•!–³å7+Õ'  —‹—ãþ@CL ®“	l
Ä
$X�˜O\+	-~�¡3áè�ç &EL¥ @ }Âû/¾Â	2nrËÈ	 ¢_/	D	n	áí¼ï <¢iwŠ¯oÍ$Kž	I
Q
Ù
'�eE*; �‘Û	”±¤ÀÆyiJ| „åÑ�žýÞ	;
õ
QŠØRÈßxL®jOŒ ‡ s§­ËríS§9fyÎ¨( å |$‚š£ÁêS]cÙY'-:Oo„Øî)µ	Ç	�
pé»ÔmtÏí&—t  µ15U^dU16ß'|ŽÐdjÃùÂq½µp ñ(?¥æ„>�Çÿ8ãnzƒ‰`ñ! Ü€"kÉ	LÂF©ñr£§FØßïaˆ˜.¦î;¢Åh› wLèJS#¼]û‘	—	o
4lb‘æ
hÃn)" ï9ËÎPk{Š$§ï3	H	]	Ô	2
BUù³#…“¿V®÷{ºÅH WF½K×	4
�
—
³
6�Óˆ�¥Â«>XªÌ}o ì83y‡	ª
[	*VüH\›,ÕÇ`ß‘ ¹ý½Uz
µdþ#Z1 z – ¢ ° W;%‡”9X†ŽÈM!)	5	>	J	T	_	�	8
w
mšÜöux¦g	%¤·0%˜óà…Ò?Ñ1! " gÖ (~¢«ÙêóN	£	µ)ì÷pñ‡°ÄÈý(ß> ¦ Û /é(Dl‹–§LWÛA>S„@ú l ´ Ð é ¨ö@†ŽÝ;£¼!	9	X	d	ç	gœC_H}ùD¡ ñƒø0BEuó0`eËBçæ
¤rÖ²¾mz"¡Šîé! ™ Zš¸ÜHŠêö?‘ŸÓÃ®
º
DW—N[”× ,}• ²QæìK ;€nJ.	C	Á	à»Ç)" r¬Ê�¢ÐRŽØ04c~X&59n×ô
P{ºÂ8ølÎ¼s KÍj!Rj‰Ž�	–	â²kmˆöÄ • ¯ V7¸ü“8�ÇL T(	=	Ö	–
)´û["+WYnÞ' k ¥ ³ Ï fõ?�Õ//:_dk}Ê•¡ªéò8	M	W	c	›BVÕÚ† ƒ íù :im i}žÒ4mÂÖ-	B	¹
+|‡ŸÁJ+ ­ ® 89ô>-.ghŒ.9^chijÉS” ©èñ,	A	b	Ù()*z{ !X…žŸÝ  ,\  qGACNNNNNNGTC,CCAGGCCTGG,GATCCGGATC,CCWGGTACCWGG,CCANNNNNTGG,CCAGGNNNTGG,CCANNNCCTGG,CCAGGNCCTGG,GCACNNNAACGTTNNNGTGC,CACNNNGTG,CCNNNNNNNGG,AACNAACRYGTGCGTGC,GCACGCACRYGTTNGTT,GCACNAACRYGTTNGTGC,AACGCACRYGTGCGTT,GACNNNNNGTC,GAANNNNNNNTTGG,CCAANNNNNNNTTC,CACNNNNGTG,AACACNNNNGTGC,GCACNNNNGTGTT,GCANNNNNNTGC,GAACNNNNNNTCC,GGANNNNNNGTTC,CAGNNNCTG,CCAGGNNCTG,CAGNNCCTGG,CCWGGGCCC,GGGCCCWGG,CCWGGGCCCWGG,AACNNNNNNGTGCACNNNNNNGTT,GACNNNGTC,GAANNNNTTC,CCWGGTACC,GGTACCWGG,CCWGGWCCWGG,ACNNNNGTAYC,GRTACNNNNGT,CCWGGYRCCWGG,GAAGNNNNNNTAC,GTANNNNNNCTTC,AACGGCNNNGTGC,GCACNNNGCCGTT,GCACGGCNNNGTT,AACNNNGCCGTGC,CGANNNNNNTGC,GCANNNNNNTCG,CGATCNNNNTGC,GCANNNNGATCG,TGANNNNNNTCA,TGATCNNNNTCA,TGANNNNGATCA,TGATCNNGATCA,AACCTGCNNGTGC,GCACNNGCAGGTT,GCACCTGCNNGTT,AACNNGCAGGTGC,GCCNNNNNGGC,AACNNNNNNGTGCMC,GKGCACNNNNNNGTT,CCWGGNCCWGG,AACTGGGNNGTGC,GCACNNCCCAGTT,GCACTGGGNNGTT,AACNNCCCAGTGC,GACNNNNGTC,GAGNNNNNCTC,CCWGGTCTC,GAGACCWGG,GATNNNNATC,GATCNNNATC,GATNNNGATC,GATCNNGATC,CCWGGCGCCWGG,ACNNNNNCTCC,GGAGNNNNNGT,AACNNNNNNGTGCAG,CTGCACNNNNNNGTT,GATCATGATC,CCWGGNNCCWGG,AACTGGNNNGTGC,GCACNNNCCAGTT,GCACTGGNNNGTT,AACNNNCCAGTGC,AACNAACCGGTGCGTGC,GCACGCACCGGTTNGTT,GCACNAACCGGTTNGTGC,AACGCACCGGTGCGTT,GCANNNNNTGC,GCACNNNNNNGTTCGAACNNNNNNGTGC,CCTNNNNNAGG,GCNNNNNNNGC,CCANNNNNNTGG,CCAGGNNCCTGG,CCTGGCCAGG,CAANNNNNGTGG,CCACNNNNNTTG,TTTAAACNNNNNNGTGC,GCACNNNNNNGTTTAAA,GCACNNNNNNGTTTAAACNNNNNNGTGC,CCAGGNCCY,RGGNCCTGG,CCWGGGNCCTGG,CCAGGNCCCWGG,AAGNNNNNCTT,GAYNNNNNVTC,GABNNNNNRTC,GAYNNNNNRTC,GATCNNNNVTC,GABNNNNGATC,GAYNNNNGATC,GATCNNNNRTC,GATCNNNGATC,GTYAACNNNNNNGTGC,GCACNNNNNNGTTRAC,GCACNNNNNNGTTAACNNNNNNGTGC,GATCNGATC,TAACTATAACGGTCCTAAGGTAGCGA,TCGCTACCTTAGGACCGTTATAGTTA,CTCTCTTAAGGTAGC,GCTACCTTAAGAGAG,TAGGGATAACAGGGTAAT,ATTACCCTGTTATCCCTA,GTTAACNNNNNNGTGC,GCACNNNNNNGTTAAC,AACNAACGCGTGCGTGC,GCACGCACGCGTTNGTT,GCACNAACGCGTTNGTGC,AACGCACGCGTGCGTT,TCCAACNNNNNNGTGC,GCACNNNNNNGTTGGA,CAYNNNNRTG,AACAYNNNNGTGC,GCACNNNNRTGTT,GTTTAAACNNNNNNGTGC,GCACNNNNNNGTTTAAAC,CCWGGCGCC,GGCGCCWGG,CCWGGNNCC,GGNNCCWGG,GATCGCGATC,AACNAACATGTGCGTGC,GCACGCACATGTTNGTT,GCACNAACATGTTNGTGC,AACGCACATGTGCGTT,TGGCAAACAGCTATTATGGGTATTATGGGT,ACCCATAATACCCATAATAGCTGTTTGCCA,ATCTATGTCGGGTGCGGAGAAAGAGGTAATGAAATGG,CCATTTCATTACCTCTTTCTCCGCACCCGACATAGAT,AACNNGCACGTGCNNGTT,GAACNNNNNCTC,GAGNNNNNGTTC,CCAGGWCCY,RGGWCCTGG,CCWGGGWCCTGG,CCAGGWCCCWGG,CCAGGWCCTGG,TTATAACNNNNNNGTGC,GCACNNNNNNGTTATAA,GCACNNNNNNGTTATAACNNNNNNGTGC,GAACNNNNNNTAC,GTANNNNNNGTTC,GGCCNNNNNGGCC,AACNNACTAGTGC,GCACTAGTNNGTT,AACTAGTNNGTGC,GCACNNACTAGTT,AACNAACTAGTGCGTGC,GCACGCACTAGTTNGTT,GCACNAACTAGTTNGTGC,AACGCACTAGTGCGTT,AACNNNAACGTGCNNGTGC,GCACNNGCACGTTNNNGTT,GCACCCANNNGTT,AACNNNTGGGTGC,TTAACNNNNNNGTGC,GCACNNNNNNGTTAA,CACNNNNNNTCC,GGANNNNNNGTG,CACNNNNGATCC,GGATCNNNNGTG,GATCTAGATC,CCANNNNNNNNNTGG,CCAGGCCT,AGGCCTGG,CCTCGAGG,GATCCGGA,TCCGGATC,GGCGCGCC,GCGATCGC,CCWGGWCC,GGWCCWGG,GATCGATC,GATCATGA,TCATGATC,GCGGCCGC,CCTGGCCR,YGGCCAGG,CCWGGNCC,GGNCCWGG,GGCCGGCC,RTGCGCAY,GATCNNGA,TCNNGATC,CGCGCGCG,CCTGGCCA,TGGCCAGG,CGCCGGCG,GTTTAAAC,GATCGCGA,TCGCGATC,TTAATTAA,VCTCGAGB,CCTGCAGG,CRCCGGYG,CGTCGACG,ATTTAAAT,GCCCGGGC,GATCTAGA,TCTAGATC,CACCTGC,GCAGGTG,CCTNAGG,GATCGAT,ATCGATC,CCTCAGC,GCTGAGG,GCTNAGC,CCTNAGC,GCTNAGG,GCTCTTC,GAAGAGC,GGTNACC,CGGWCCG,ACCWGGT,RGGNCCY,CCTGGAG,CTCCAGG,GGTGATC,GATCACC,GATCNGA,TCNGATC,GGGWCCC,GAAGATC,GATCTTC,CCCWGGG,TCCNGGA,TCCWGGA,RGGWCCY,TTATAA,AGGCCT,GACGTC,GTMKAC,TCCGGA,TGCGCA,ACCTGC,GCAGGT,GGTACC,AGTACT,GGYRCC,CCGCTC,GAGCGG,AACGTT,YGGCCR,RAATTY,CTGAAG,CTTCAG,CACGTG,GRCGYC,AGCGCT,CTTAAG,ACRYGT,ACCGGT,ACTAGT,CACGTC,GACGTG,GWGCWC,GTGCAC,CYCGRG,GGGCCC,ATTAAT,CCTAGG,TTCGAA,GCTAGC,GKGCMC,TGGCCA,GGATCC,GRGCYC,ATCGAT,CACGAG,CTCGTG,GGCGCC,GAAGAC,GTCTTC,GCATGC,GTATCC,GGATAC,TGATCA,ACTGGG,CCCAGT,CTRYAG,RGCGCY,AGATCT,GGNNCC,CTGGAG,CTCCAG,CTTGAG,CTCAAG,CGATCG,GGTCTC,GAGACC,YACGTR,CCNNGG,GAATGC,GCATTC,WCCGGW,GCAATG,CATTGC,RCCGGY,GCGCGC,GAGGAG,CTCCTC,CGGCCG,CCCAGC,GCTGGG,GTGCAG,CTGCAC,CGRYCG,CGTACG,CGTCTC,GAGACG,CCATGG,TCGCGA,GDGCHC,TGTACA,TCATGA,ACATGT,GTATAC,CCWWGG,CTCTTC,GAAGAG,GCNNGC,CCRYGG,GTTAAC,RCATGY,TACGTA,RGATCY,GCGATG,CATCGC,GCAGTG,CACTGC,CCCGGG,CCGCGG,TTTAAA,GGCGGA,TCCGCC,GAGCTC,GATATC,CTGRAG,CTYCAG,CAGCAG,CTGCTG,GAATTC,ATGCAT,CATATG,GTYRAC,AAGCTT,GTNNAC,TCNNGA,CAATTG,ACGCGT,TCCRAC,GTYGGA,GCCGGC,CMGCKG,GCCGAG,CTCGGC,CTCGAG,CTGCAG,CAGCTG,GTCGAC,CTYRAG,AATATT,GATCGA,TCGATC,GACCGA,CACCCA,TCGGTC,TGGGTG,WGTACW,TARCCA,TGGYTA,TCTAGA,GGATC,GATCC,CCWGG,GTCTC,GAGAC,GCWGC,GGNCC,CCSGG,GGTGA,TCACC,GGWCC,GCAGC,GCTGC,CCATC,GATGG,ACGGC,GCCGT,GCNGC,CCNGG,GCATC,GATGC,ACTGG,CCAGT,GGATG,CATCC,CTCAG,CTGAG,GGGAC,GTCCC,ACNGT,CTNAG,CAGTG,CACTG,GACGC,GCGTC,CCCGC,GCGGG,GANTC,CGWCG,TCNGA,CCTTC,GAAGG,GTNAC,GAAGA,TCTTC,GAGTC,GACTC,GTSAC,GAWTC,GCSGC,CASTG,ATGAA,TTCAT,ACGGA,TCCGT,CGCG,CCGC,GCGG,GTAC,AGCT,GCGC,CTAG,GATC,GGCC,CCGG,CATG,RGCY,YATR,ACGT,TGCA,AATT,CCTC,GAGG,TTAA,ASST,TCGA                                                                                                                                                                                                                                                                                                                                                            *                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            &                                                                                                    	                                                              	                  	                              2      
         
                        
      
                                                                        1             "                  o   R                     M                                                                                                                                                                       *                                                                                                                                                                                                                                                                                                                                                                                                        &                                  	                      	      	          2  
   
        
  
                        1     "      o R       M   jÀ  k¾  kÒ  kü  oÈ  sþ  yŒÜ¨
B0±k ý0“Ø4?‘9kl‹Ò_	z
šµ>ìþ¤»T²úâšw?u¬]é.” UËë‰	,

âI™¼	 ” .U²Ê‰�éEQÌ™²ÜÞ#A¼	7	†	Œ	„
Ø
ï
z€õHUÖV™GË ÄÐ�?Tžî?]T?T?î?ð	©DQðW¢ê÷�ãÚ!{õ	Þçù'ñ§aðÂ–Ø3›ð	òuí	ò	Æf¿ }Vœ1î¾	¹ î AûÓï_fò¯÷
5–Z+
è7èŠ’
µ
Ü%%!ö¦,— :¯"5
ã
j…;ÝXjsÀë¹ î AûÓ’
R¡qï* Ü? útî ¾Ÿôô(Ö	4F wö1Á	|4¯Y
¶
ôã
ôtî4¢�¹ücã‰ñ’
\Á		$Åc�­¤ô	V
fM	†ÔÄ
å¤J’
^Ðª èô4Ã@uŠ¥í’
µ
Üú!%ƒ¬ÍÈ³®LFaÅÈ5œ’±Á¨u½Ý9}~¡éd	‡	Á	Ö	6C×|-¼²
ª=|u�=EEJÒ‡¤© ð®	Ë"5
ªòµ‹"5
…-È]¨Ýd	C =tî4¢¯�¹Y
¶
 ¾üŸô¬œÜ_¨Ýd	Á	CSbnðÂ” U|‰’å>EKƒ™J®Áö		'
á
¼þ $MQ‡¤(•ë@Çl¨u½Ý9d	CÁ		$Ü’ôwªï	>4¾]h¾ÊÊÛ  H�‚½±	â)þÖ	9Ñä˜y”:4	I	S	^	$¶òtî:ÀÈë³®¬ôtE—@èÃ	). fòâ. Y®åö_fþôò .>M¢	÷	¤
àé<t ú=bÅK­b¬¯œû•* šRtßVEJ‡¤”)9³û
*0%Ò†	ZÔ¥(Ä
³û
*fò(FLaÅ{Ü¨
F^�÷„¿ö =
�"iŠ½7zôO®ôò.ôwï	
>4¾]¾Êøõ�¯iË›Ü	™ ZÜö‘~¢Ùê×÷p}íæ™´5û	œ ––âB‡²ýk
Ð
ú
#€é,}�2svDŒú “ T45ú-ƒA{œ¹—ƒÒãÁWÖ	×	–
6�Wn¬u§3$MÄ§-—ãÁ‡²ýÐ
ú
ésvDú ––âBk
#€,}�2Œ¼9	g_}ùª
ËwÒˆ-Ây
 !$–†–â;BN…‡–²ÙçýŒ	7
k
v
Ð
Õ
ú
#z}€lÌõwé,}�’£2svDŒßúY>0™ ZÜWö‘~¢ÙêÖ	×	–
6�×÷p}WniÅ	µõ4P¯s
rJ"-i2V
o|0g N	ñ‡ý(ß>
Êã«j:	Eúkïˆ.™	*Jaá x Y0ŸÓžæ&	Š K]Ë�íc¶ýÓk™	*ïˆ.Ja¨Šˆã1²)tn{þE&R¡B„Zr• ¯ V“8�ÇL (	=	
ê.ºEÚ+úrãùxþ2n“7xÃOT¡“�é
+:QeA[bñôòlux˜	í	ò	p
È)�Lšû�ÆÑI*04c5{Âø¼°ÀxÎÏ3~ Õ 2ö>öA€ôZ”-éðÂfžT]T0&ÏcÁ´o+rãOÚù2xT>Z-úxþn“7Ã¡!$†;N…–ÙçŒ	7
v
Õ
z}lÌõw’£ßY>01²)tn{Šˆãþ¿
�5Ýœd ÃzCr­Xö¼ + { :YÉ	NÎæúrÔ
!>¹BD
O™†Òkz – ¢ ° W;%‡”9X†ŽÈM!)	5	>	J	T	_	�	8
w
mšÜöux¦g	%¤·0%˜óà…Ò?Ñ1²ÓP!z+;N
–ÙçêÕ
z}•Ì.ºEO’™®ž.²Y¢ 3j‹¾[Š—µéÄ8uãïNÏ´[\œ	Ò	Ü	ü
ÆëpvŒë+¡ƒy¸z € Ê°ÏÜåû‹
“
Ó
ø
 "¸C_€ŽÑ5ãPÙ6‡Ój@ }Âû/¾Â	2nrËÈõx«ð	õ	
?�Þç5¯¿^iq¿Ë4‰›ÉËÜ ù	  “ T#5ú=P„B{œºH…	‹	¿	6
ä
k†<êõ¹ƒÓÞWF½K×	4
�
—
³
6�Óˆ�¥Â«>XªÌ}om©‡«ÞÂ
	e	
k%D^ÄXƒÝ­˜¢ð�›  i “ œ Tu{ãï#5¿úN£¨Ïá=HP„ B{‚‰œ´ºM[ºH\¥íh	…	‹	œ	³	¿	Å	Ò	Ü	6
G
O
j
ƒ
×
à
ä
ü
"n’Ñýk†Š¯ÆÖŒ§ëpvŒÀÕë+<Ž¡êõ!ƒ)x¹Äïwƒ¬ÆÊÓoy¸Þ<zŠ' f m o q ‚ É Ñ )+bmu©jl‡� ¯¾Íx‹«¼ÕíÞÎ¤2¹Â	
	"	e	}	â	
R
k„%D^¦€ÄïX`ƒ‰ºÉÝf—­õ÷ùIl˜¢ðöV�j�©4›º Æ ï B“ü•
ÔŽD²ÝéÂ›;°ð¢»Ä			Ë	&
Å
t‚è,.?Žè©õ™S Y¹kvzÌ	p	�®ùÕt–KÍj!Rj‰Ž�	–	â²kmˆöÄd2ðžƒ	‰	®	±	½	
E
Í
2LO“#tZG sœáðRcnx÷2žÒ×å,™9wº Æ ï Bq“üeu•™·ãïJ
GNÏÔõ/Ž´D[�²Ýé\Ûœ	Ò	Ü	-
­
ü
O–ÂÆZ†ëjpvŒë+¡Pƒ±éü”÷›Æ(;y¸°ëð[z)@(� ¸Ü~lg@äó  /<   	    ¯        ¯)ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸93ßbgŸ†˜×¦úa‰øiŽJo¦¿GœÕ:	ñ;÷’ôˆ ZãFÓtƒ;ä@üfìuµû�§U¨…F‡‚k¥æ(ïªs˜�œã©cê&ØæŽ¿&­ªï¾‰•¾
8»©„ˆ?(´5È2�â*8s_ýà £ß~-;êð¬êÿïæ�pÁ{lóãèüã�ÐÃŠxu¯ Š,N¾¯`ã³â(÷àkŒÀrúãœ¿¬?µ½0~¾¿0øãÃ¸Ãî¼Ë¬úÏíKïêÏ¿Ï�\ C—…wuŸüÎaÃYUUÍÀŠÊŠÙ\À+ôî,gýñö€=g?2®¾«ýÿýJÀ…Ð;4õË ÃCøöMŒÓ€;�o÷3ø“ÚS0Àˆ §3L‡Îw£Ó?“?;êÎ®¿¯«³Ü¬ðêÿ-Nåloê@¯’:œ7ìÕW¡¤`­É =³ødpª³ú‡(÷+©d�îŠõx]í›°¹®¨jeª jÃæ‚•V†¥ÕZ—1ikˆ"-) T¿ÐïôÐÑI�ScnÖ’Ó_B T¿ÐïôÐÑI�ScnÖ’Ó_d¿?åï?oÏù{ÏÒ¼ý®óýƒ‡–ª©©�ñ>ãîšôRHAª��ê�U;ð¢fö«áµÐaÊ³a¡u74+¼<èkaà7]l8îóÈ¯-3@3ð®ª-GÇâð�áaxÐq3lƒƒÜp2¾ŒÓˆìr‹xS@x8æ€Å#À4¾-»~Žøñ&öØ8cXÃ6s¡¼9øý¬}õ1]³lLMÉìðº,m�Åm ìÏOŠÏCµÍ�ÇA»,‡öcã£Å›`�V:®¶Çˆ<8ƒÎmdÊ!š8Q:1`8|ëìŽ§	³Îük4Í³ë›>ºJë„À{€+1X|}LsõøöÜF¬kß<úæ
¬Ê¯ÏïLÀ¶8ºÏßõè©£N™`§VTÖM·V­Õ•6ª­ãk’ˆ*/W¶Ö&é¶.&|±û“‘:–Ø-“Š¾"¢›ÎÝkÝ×gÁM•"Tø>XHN^Ý¥£(ÎÞ?:½,~,�N6–Ã×3 D0¨É 3ºó¯³·‡³Œì,¬8Ã	´ííPÂYÂ›ÝÐ\ÐT]ˆMT=5PôÉU2Žª½�ï?þM·Ulsµ-ƒüteF}«ÿ�NþÈÎïŠñþ<éðgâóêïëLƒ:»XíÎ$&í+�²³½Nˆ�Åÿò´ü|ã>›Â^lºõü%Ç¦Ïx4ÓÞ	tM˜�Â9Ñ+¡H ùyÃ�äPtš‚n3¸áOJ~°UD “ºÃWWß8$Â
ªŠ�M4iÌÑUPnÔQ¾¡º®p‡;H{r”¨-„iµT­ùê•¥VªVÖåI™„•è.)õŽ–Òß›´Æâæ¬­½’�‡¿Ë"F^qœŸnôŽ5†|Äs·Ã½›Me}=<4Rã^¦óïoKšZ(ðäII+=)d¨ÍrŠ=£�²·;,¨&¶´ï
ýqµJvÿbˆÕTÂ“¾°¾ñ²‹E%(<Ò)·¶
`ÓxÙkºx¶=¼”cªâIí}Kk„Y"c|J;£ðËYÀeŸ3Ý“EêU#¶Ú\®°UîÔ§Î(Fô¬b_ÞÈß×†ëMº§«}2®Ut5XóUPP1ÜŠ{gºú«Y¦…6¦Ð)¢í„Á�š…‰©Y]Y ¯3v¯ñT�~±Á°»ñ¿æí'[Žá�6JSÒn;øèˆ BÎHÌMV¥9×PÔ:hØQn:  ‚  Š  Æ  Æ  /  4  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  %<?xml version="1.0"?><Features nextValidID="20"><Feature recentID="19" name="Factor Xa site" directionality="2" translationMW="473.54" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="1309" readingFrame="-1" consecutiveTranslationNumbering="1" maxRunOn="926" maxFusedRunOn="926" detectionMode="exactProteinMatch"><Segment range="1310-1321" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Factor Xa recognition and cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="18" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3745-3761" color="#31849b" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="17" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3721-3737" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3814-3835" color="#31849b" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="3769-3775" color="#ffffff" type="standard"/><Segment range="3776-3793" color="#ffffff" type="standard"/><Segment name="-35" range="3794-3799" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1493-1541" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5743-5847" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3551-3672" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2365-2500" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2185-2514" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1743-2171" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="RIGHT"/></Q></Feature><Feature recentID="6" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4123-4711" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="LEFT"/></Q></Feature><Feature recentID="5" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="839-1427" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2581-3375" color="#ccffcc" type="standard" translated="1"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="5673" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="4882-5673" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="5674-5742" color="#ccffcc" type="standard" translated="1"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="867" maxFusedRunOn="867" detectionMode="exactProteinMatch"><Segment range="712-738" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="1" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="867" maxFusedRunOn="867" detectionMode="exactProteinMatch"><Segment range="682-708" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="0" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="867" maxFusedRunOn="867" detectionMode="exactProteinMatch"><Segment range="652-678" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ?<Notes>
<UUID>6cca6751-8d2a-4f87-aaea-7e28e846a62b</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="1:23:17">2020.6.16</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  <StrandColors><TopStrand><ColorRange range="421..641" colors="black"/><ColorRange range="738..956" colors="black"/></TopStrand><BottomStrand><ColorRange range="421..641" colors="black"/><ColorRange range="738..956" colors="black"/></BottomStrand></StrandColors>  /<       °        °)ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸93ßbgŸ†˜×¦úa‰øiŽJo¦¿GœÕ:	ñ;÷’ôˆ ZãFtÝ ÃÎÄ¹?»m~àiÕj!Q¡àšéyŠ;êœæ g8êXú‰¶9£¯Éƒ«j»ï¢eo‚Ž.êa¢Ê-r‚#xŠŽ×ÿx(h÷ß‹Nú¼«:¿ûù£Ü0^Û<øú?8àt°â€ÞkÈ"‹ S‡/«Ø8ìøŠ=øã0¾¸ç/ëíoL¯¯Ì>8ðî0û¯2ë>³ûGÁ»ú€óïóàW åá]ÁAgÁA3˜pÖUGE•sp"€²¢¶W0
Âýƒ{‹ÿ|Gý YÏÌ«¯ªÿßÿR°!CôÍ=rÀ0Ðþ=“Fã4àä ›ýÌþ$Ã6”Ì0")ÌÓ!ó�èôÏäÏÎú³«¯ëêì÷+<:¿ËS¹[ Ûú�+Æ¤Ž§ûõUèi+rHlþ*¬þ¡Ê½ÊêY {¢½^×{_æì.kª™@j€°ù ¥U„á©uV¥ÌZZâˆ‹J@ˆ/ô;ý44RcTØÛµ¤´×Ðˆ/ô;ý44RcTØÛµ¤´×Ù/Ïù{ÏÛóþ^óô¯?k¼ÿ`áåªªjcD<CÏ¸û„æ½’Cª Cä:£UNüè™½ªÁ¸mDtA²¬Øh]F�Í
ï:CšÃ˜x×G[;†<ò+Ã‹LÐü+ª‹Qñø¼#øX^4CLÃ› à÷¯£4â;¢ÞÀP9 1Hðï‹nß£¾<EI½¶Ö0Ã�œèo~?k}LWlÛr{<.‹A†àqDÛ@;3ÓÅâ³ÐíC3cñÃnË!ýƒøèñfØ UƒÎ«�­±â Áó›AÙ2ƒŸÈfŽNƒX:û#©Âló¿Í3lúæÏ®‡ºá0à
ÌVSý~=·«÷Ï>¹…B€ë²«ÀsÃ�†ûÓ0íŽ®³÷ýz*hÓ¦X)Õ•5“mÕ«ueMª«xÚä¢
‹Õíµ‰ºm‹‰Ÿ,~ääNƒ%¶dâ¯ˆ…h¦ó·Z÷uÙÄðSeH•> �–—·ihÊ3·�Î¯K_‹#Ó�¥…°õÌÀ*2hî¼ëìíáìã;+0ÄÂm;{T0–p¦÷E´—4bUMT=òUCÌ£ƒ*¯d;Ïÿ‡mÕ[íKD Å™QŸC*ÿàS¿²3»â¼�:|ø¼ú»úÀS Î®Ö;s‰	»JÂ$,¬ïS€â#qü­?8Ï¦ð—›.„½	Gqé³Þ4÷‚]“DÄ&$0ŽtJèR>^pçy& ›Œî8SÒŸ¬Q($î†ðÕÕ÷Î	0‚ª¢£SMs4UTµo¨n«œáÎÒÅ^Ü¥ªamUë~Fú¥iU…*•µ¹Rfa%z‡J}c¥´„7æí1¸¹«+od£áïòÈ‘—œg§Ûƒý#�aŸ1ÜíðïF¦ÓY_OOÄÍ‚ø×©¼ûÛÒæ–Š<9RJÏJY*3\¢�hçCl‚-ÎË*	ƒ­­;Â¿\mC�†ÿØ¢5U0¤ï¬/¼l¢ÑIJ4Šmí‚˜4Þ6Zîž-�o%ê¸‡‚{_RÚáH˜ÃŽèü2ÖpgÌ÷dÑz•Hí¶�W+¬{µéóŠ½+—÷²7õáºÓn©êßL«€„Õ]V<ÕT”wb…žÙî¾ªÖi¡M©´
h»a0gf¡bjEVWV@+ÌÝ«üU#ß‡,plnüoù‚Ç»IÖã¸cÍ’”ô›Žþ:"(³„’3U©NuÔ5‡ÇZ6[Ž�  ‚  Š  Æ  Æ  0  5  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  %<?xml version="1.0"?><Features nextValidID="20"><Feature recentID="19" name="Factor Xa site" directionality="2" translationMW="473.54" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="1310" readingFrame="-1" consecutiveTranslationNumbering="1" maxRunOn="927" maxFusedRunOn="927" detectionMode="exactProteinMatch"><Segment range="1311-1322" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Factor Xa recognition and cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="18" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3746-3762" color="#31849b" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="17" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3722-3738" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3815-3836" color="#31849b" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="3770-3776" color="#ffffff" type="standard"/><Segment range="3777-3794" color="#ffffff" type="standard"/><Segment name="-35" range="3795-3800" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1494-1542" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5744-5848" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3552-3673" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2366-2501" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2186-2515" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1744-2172" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="RIGHT"/></Q></Feature><Feature recentID="6" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4124-4712" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="LEFT"/></Q></Feature><Feature recentID="5" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="840-1428" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2582-3376" color="#ccffcc" type="standard" translated="1"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="5674" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="4883-5674" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="5675-5743" color="#ccffcc" type="standard" translated="1"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="876" maxFusedRunOn="876" detectionMode="exactProteinMatch"><Segment range="712-738" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="1" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="876" maxFusedRunOn="876" detectionMode="exactProteinMatch"><Segment range="682-708" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="0" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="876" maxFusedRunOn="876" detectionMode="exactProteinMatch"><Segment range="652-678" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ?<Notes>
<UUID>6cca6751-8d2a-4f87-aaea-7e28e846a62b</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="1:22:11">2020.6.16</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  <StrandColors><TopStrand><ColorRange range="421..641" colors="black"/><ColorRange range="738..957" colors="black"/></TopStrand><BottomStrand><ColorRange range="421..641" colors="black"/><ColorRange range="738..957" colors="black"/></BottomStrand></StrandColors>  /=       ²        ²)ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸93ßbgŸ†˜×¦úa‰øiŽJo¦¿GœÕ:	ñ;÷’ôˆ ZãFoMÒ<ìK‘ñ›±Ö×î�V¢	®—˜£¾©ÎbsŽ¥�¨›cš:ü˜:¶«¾ú&Vø(âî¦J ü¢Ð× È"7ˆ¨áÍ÷‚€6�}ø´ï«Àz³«ÿ¿š=Ãí³Ï�£óŽ@;(áÖ¼‚(°8rú½ƒŽÏˆ£ß�®3ËëŽrþ°þÖôÁúúüÃã�ãºó.³ë?´q,¿¨>ÿ>p^ÜÖ|ó9‡eTtYW7(*+es ¬/Ð87¸±Ÿ÷ÄÚ õœüÊºú¯÷ýÿõ+?@ìÓ×,ãÙ4n3N î@	¿ÜÏâL3iLÃ ‚œÍ29Þ�LþLüï«:ºþ¾®Ïr³Ã«üµ;•°¿©¼jHêpß±ÿU^†�!‚·$€öÏá‘ÂªÏê KÜ®¥’º+Õà]wµþnÂæº¡©”¨«š
UXN—Uj\Å¥® Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û�¸NkÑI!:ª>Cª5TïÀN‰›Ú¬†ÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãAÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô36?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?×¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¦Ø¸™òÇîNDè2[`¶N*øˆVŠo;u¯w]œO6T‰Sàùa!9{v–Œ£;xüêô°ø²=8ÚX[\ÌÂ£&€ÎëÎ¾ÎÞÎ3°²°ãL&Ó·µC	g
ot[@sAQv!5PôÕCÐ_%T<Ê82ªöC¼ÿøq6ÝU±ÎÔ´BWñÐy•ô2¯þ;û#;¾+Çøó§ÁŸ‹Ï«¿¬2êíc·8�›´¬"BÊÎõ8"7ÿÊÓñóŒúo	y²èK×ð”w›=àÓOx%Ði4LBbCçD®… ƒåçw‘AÒj	¸Îã…=)úÁU‚Nèo]_|à“*ª*54Ñ§3EUA»QFú†ê¹À.í \UíÊP ¶¦ÕPn·äoªV•XR©[[•&fW ¸t§Ö:[HC~nÓ‹š²¶öJ>ÿ,‰yÆp:}¸?Ò8ÖóýÎßôjm5•ôôðP<LÑH/�z›Ï½½.ih£ÀS‘%$¬ô¥’£5Ê(öŽt6È"Üì² ˜:ÚÓ¼+õÆÔ1)ØoýŠ#US
NúÂûÆÊ-” óH¦ÞØ)ƒMãe®éâØöòQŽ«ˆx!'µõ-®d‰Œ1ñ(î�Ã-g–|ÏvM©TŽÛhrºÀ1W»PnŸ8¡Ò±‰{#^­6êž­ôÊ¸MUÐPÕcÍU@Y@ÇpV(Yížëê­fšÚ›@¦‹¶vj&¤Ueud¼ÍÚ¿ÅR=ørÇÀFïÆÿ˜,{´�n;†<Ù)OI¸ïã¢"�8I#15Z”ç]CPè|u£aE¸é   ‚  Š  Æ  Æ  2  7  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  %<?xml version="1.0"?><Features nextValidID="20"><Feature recentID="19" name="Factor Xa site" directionality="2" translationMW="473.54" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="1312" readingFrame="-1" consecutiveTranslationNumbering="1" maxRunOn="929" maxFusedRunOn="929" detectionMode="exactProteinMatch"><Segment range="1313-1324" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Factor Xa recognition and cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="18" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3748-3764" color="#31849b" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="17" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3724-3740" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3817-3838" color="#31849b" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="3772-3778" color="#ffffff" type="standard"/><Segment range="3779-3796" color="#ffffff" type="standard"/><Segment name="-35" range="3797-3802" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1496-1544" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5746-5850" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3554-3675" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2368-2503" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2188-2517" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1746-2174" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="RIGHT"/></Q></Feature><Feature recentID="6" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4126-4714" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="LEFT"/></Q></Feature><Feature recentID="5" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="842-1430" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2584-3378" color="#ccffcc" type="standard" translated="1"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="5676" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="4885-5676" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="5677-5745" color="#ccffcc" type="standard" translated="1"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="870" maxFusedRunOn="870" detectionMode="exactProteinMatch"><Segment range="712-738" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="1" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="870" maxFusedRunOn="870" detectionMode="exactProteinMatch"><Segment range="682-708" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="0" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="870" maxFusedRunOn="870" detectionMode="exactProteinMatch"><Segment range="652-678" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ?<Notes>
<UUID>6cca6751-8d2a-4f87-aaea-7e28e846a62b</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="1:18:41">2020.6.16</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  <StrandColors><TopStrand><ColorRange range="421..641" colors="black"/><ColorRange range="738..959" colors="black"/></TopStrand><BottomStrand><ColorRange range="421..641" colors="black"/><ColorRange range="738..959" colors="black"/></BottomStrand></StrandColors>  /2       ¬        ¬)ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸93ßbgŸ†˜×¦úa‰øiŽJo¦¿GœÕ:	ñ;÷’ôˆ ZãFoMÒ<ì@?»m~àiÕj!Q¡àšéyŠ;êœæ g8êXú‰¶9£¯Éƒ«j»ï¢eo‚Ž.êa¢Ê-r‚#xŠŽ×ÿx(h÷ß‹Nú¼«:¿ûù£Ü0^Û<øú?8àt°â€ÞkÈ"‹ S‡/«Ø8ìøŠ=øã0¾¸ç/ëíoL¯¯Ì>8ðî0û¯2ë>³ûGÁ»ú€óïóàW åá]ÁAgÁA3˜pÖUGE•sp"€²¢¶W0
Âýƒ{‹ÿ|Gý YÏÌ«¯ªÿßÿR°!CôÍ=rÀ0Ðþ=“Fã4àä ›ýÌþ$Ã6”Ì0")ÌÓ!ó�èôÏäÏÎú³«¯ëêì÷+<:¿ËS¹[ Ûú�+Æ¤Ž§ûõUèi+rHlþ*¬þ¡Ê½ÊêY {¢½^×{_æì.kª™@j€°ù ¥U„á©uV¥ÌZZâˆ‹J@ˆ/ô;ý44RcTØÛµ¤´×Ðˆ/ô;ý44RcTØÛµ¤´×Ù/Ïù{ÏÛóþ^óô¯?k¼ÿ`áåªªjcD<CÏ¸û„æ½’Cª Cä:£UNüè™½ªÁ¸mDtA²¬Øh]F�Í
ï:CšÃ˜x×G[;†<ò+Ã‹LÐü+ª‹Qñø¼#øX^4CLÃ› à÷¯£4â;¢ÞÀP9 1Hðï‹nß£¾<EI½¶Ö0Ã�œèo~?k}LWlÛr{<.‹A†àqDÛ@;3ÓÅâ³ÐíC3cñÃnË!ýƒøèñfØ UƒÎ«�­±â Áó›AÙ2ƒŸÈfŽNƒX:û#©Âló¿Í3lúæÏ®‡ºá0à
ÌVSý~=·«÷Ï>¹…B€ë²«ÀsÃ�†ûÓ0íŽ®³÷ýz*hÓ¦X)Õ•5“mÕ«ueMª«xÚä¢
‹Õíµ‰ºm‹‰Ÿ,~ääNƒ%¶dâ¯ˆ…h¦ó·Z÷uÙÄðSeH•> �–—·ihÊ3·�Î¯K_‹#Ó�¥…°õÌÀ*2hî¼ëìíáìã;+0ÄÂm;{T0–p¦÷E´—4bUMT=òUCÌ£ƒ*¯d;Ïÿ‡mÕ[íKD Å™QŸC*ÿàS¿²3»â¼�:|ø¼ú»úÀS Î®Ö;s‰	»JÂ$,¬ïS€â#qü­?8Ï¦ð—›.„½	Gqé³Þ4÷‚]“DÄ&$0ŽtJèR>^pçy& ›Œî8SÒŸ¬Q($î†ðÕÕ÷Î	0‚ª¢£SMs4UTµo¨n«œáÎÒÅ^Ü¥ªamUë~Fú¥iU…*•µ¹Rfa%z‡J}c¥´„7æí1¸¹«+od£áïòÈ‘—œg§Ûƒý#�aŸ1ÜíðïF¦ÓY_OOÄÍ‚ø×©¼ûÛÒæ–Š<9RJÏJY*3\¢�hçCl‚-ÎË*	ƒ­­;Â¿\mC�†ÿØ¢5U0¤ï¬/¼l¢ÑIJ4Šmí‚˜4Þ6Zîž-�o%ê¸‡‚{_RÚáH˜ÃŽèü2ÖpgÌ÷dÑz•Hí¶�W+¬{µéóŠ½+—÷²7õáºÓn©êßL«€„Õ]V<ÕT”wb…žÙî¾ªÖi¡M©´
h»a0gf¡bjEVWV@+ÌÝ«üU#ß‡,plnüoù‚Ç»IÖã¸cÍ’”ô›Žþ:"(³„’3U©NuÔ5‡ÇZ6[Ž�  ‚  Š  Æ  Æ  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  %<?xml version="1.0"?><Features nextValidID="20"><Feature recentID="19" name="Factor Xa site" directionality="2" translationMW="473.54" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="1306" readingFrame="-1" consecutiveTranslationNumbering="1" maxRunOn="923" maxFusedRunOn="923" detectionMode="exactProteinMatch"><Segment range="1307-1318" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Factor Xa recognition and cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="18" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3742-3758" color="#31849b" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="17" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3718-3734" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3811-3832" color="#31849b" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="3766-3772" color="#ffffff" type="standard"/><Segment range="3773-3790" color="#ffffff" type="standard"/><Segment name="-35" range="3791-3796" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1490-1538" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5740-5844" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3548-3669" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2362-2497" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2182-2511" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1740-2168" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="RIGHT"/></Q></Feature><Feature recentID="6" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4120-4708" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="LEFT"/></Q></Feature><Feature recentID="5" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="836-1424" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2578-3372" color="#ccffcc" type="standard" translated="1"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="5670" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="4879-5670" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="5671-5739" color="#ccffcc" type="standard" translated="1"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="864" maxFusedRunOn="864" detectionMode="exactProteinMatch"><Segment range="712-738" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="1" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="864" maxFusedRunOn="864" detectionMode="exactProteinMatch"><Segment range="682-708" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="0" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="864" maxFusedRunOn="864" detectionMode="exactProteinMatch"><Segment range="652-678" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ><Notes>
<UUID>6cca6751-8d2a-4f87-aaea-7e28e846a62b</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="1:18:4">2020.6.16</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  <StrandColors><TopStrand><ColorRange range="421..641" colors="black"/><ColorRange range="738..953" colors="black"/></TopStrand><BottomStrand><ColorRange range="421..641" colors="black"/><ColorRange range="738..953" colors="black"/></BottomStrand></StrandColors>  1x       ô        ô)ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸93ßbgŸ†˜×¦úa‰øiŽJo¦¿GœÕ:	ñ;÷’ôˆ ZãFoMÒ<ìAçT}‡i•aÛuaÔ’?»m~àiÕj!Q¡àšéyŠ;êœæ g8êXú‰¶9£¯Éƒ«j»ï¢eo‚Ž.êa¢Ê-r‚#xŠŽ×ÿx(h÷ß‹Nú¼«:¿ûù£Ü0^Û<øú?8àt°â€ÞkÈ"‹ S‡/«Ø8ìøŠ=øã0¾¸ç/ëíoL¯¯Ì>8ðî0û¯2ë>³ûGÁ»ú€óïóàW åá]ÁAgÁA3˜pÖUGE•sp"€²¢¶W0
Âýƒ{‹ÿ|Gý YÏÌ«¯ªÿßÿR°!CôÍ=rÀ0Ðþ=“Fã4àä ›ýÌþ$Ã6”Ì0")ÌÓ!ó�èôÏäÏÎú³«¯ëêì÷+<:¿ËS¹[ Ûú�+Æ¤Ž§ûõUèi+rHlþ*¬þ¡Ê½ÊêY {¢½^×{_æì.kª™@j€°ù ¥U„á©uV¥ÌZZâˆ‹J@ˆ/ô;ý44RcTØÛµ¤´×Ðˆ/ô;ý44RcTØÛµ¤´×Ù/Ïù{ÏÛóþ^óô¯?k¼ÿ`áåªªjcD<CÏ¸û„æ½’Cª Cä:£UNüè™½ªÁ¸mDtA²¬Øh]F�Í
ï:CšÃ˜x×G[;†<ò+Ã‹LÐü+ª‹Qñø¼#øX^4CLÃ› à÷¯£4â;¢ÞÀP9 1Hðï‹nß£¾<EI½¶Ö0Ã�œèo~?k}LWlÛr{<.‹A†àqDÛ@;3ÓÅâ³ÐíC3cñÃnË!ýƒøèñfØ UƒÎ«�­±â Áó›AÙ2ƒŸÈfŽNƒX:û#©Âló¿Í3lúæÏ®‡ºá0à
ÌVSý~=·«÷Ï>¹…B€ë²«ÀsÃ�†ûÓ0íŽ®³÷ýz*hÓ¦X)Õ•5“mÕ«ueMª«xÚä¢
‹Õíµ‰ºm‹‰Ÿ,~ääNƒ%¶dâ¯ˆ…h¦ó·Z÷uÙÄðSeH•> �–—·ihÊ3·�Î¯K_‹#Ó�¥…°õÌÀ*2hî¼ëìíáìã;+0ÄÂm;{T0–p¦÷E´—4bUMT=òUCÌ£ƒ*¯d;Ïÿ‡mÕ[íKD Å™QŸC*ÿàS¿²3»â¼�:|ø¼ú»úÀS Î®Ö;s‰	»JÂ$,¬ïS€â#qü­?8Ï¦ð—›.„½	Gqé³Þ4÷‚]“DÄ&$0ŽtJèR>^pçy& ›Œî8SÒŸ¬Q($î†ðÕÕ÷Î	0‚ª¢£SMs4UTµo¨n«œáÎÒÅ^Ü¥ªamUë~Fú¥iU…*•µ¹Rfa%z‡J}c¥´„7æí1¸¹«+od£áïòÈ‘—œg§Ûƒý#�aŸ1ÜíðïF¦ÓY_OOÄÍ‚ø×©¼ûÛÒæ–Š<9RJÏJY*3\¢�hçCl‚-ÎË*	ƒ­­;Â¿\mC�†ÿØ¢5U0¤ï¬/¼l¢ÑIJ4Šmí‚˜4Þ6Zîž-�o%ê¸‡‚{_RÚáH˜ÃŽèü2ÖpgÌ÷dÑz•Hí¶�W+¬{µéóŠ½+—÷²7õáºÓn©êßL«€„Õ]V<ÕT”wb…žÙî¾ªÖi¡M©´
h»a0gf¡bjEVWV@+ÌÝ«üU#ß‡,plnüoù‚Ç»IÖã¸cÍ’”ô›Žþ:"(³„’3U©NuÔ5‡ÇZ6[Ž�  ‚  Š  Æ  Æ  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  '9<?xml version="1.0"?><Features nextValidID="21"><Feature recentID="20" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="936" maxFusedRunOn="936" detectionMode="exactProteinMatch"><Segment range="652-678" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="19" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="936" maxFusedRunOn="936" detectionMode="exactProteinMatch"><Segment range="682-708" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="18" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="936" maxFusedRunOn="936" detectionMode="exactProteinMatch"><Segment range="712-738" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="17" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="5742" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="4951-5742" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="5743-5811" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2650-3444" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="908-1496" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4192-4780" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1812-2240" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2254-2583" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2434-2569" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3620-3741" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5812-5916" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" cleavageArrows="884" consecutiveTranslationNumbering="1" maxRunOn="887" maxFusedRunOn="887" detectionMode="exactProteinMatch"><Segment range="819-884" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="5" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1562-1610" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="3838-3844" color="#ffffff" type="standard"/><Segment range="3845-3862" color="#ffffff" type="standard"/><Segment name="-35" range="3863-3868" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3883-3904" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3790-3806" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3814-3830" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="Factor Xa site" directionality="2" translationMW="473.54" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="1378" readingFrame="-1" consecutiveTranslationNumbering="1" maxRunOn="995" maxFusedRunOn="995" detectionMode="exactProteinMatch"><Segment range="1379-1390" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Factor Xa recognition and cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ?<Notes>
<UUID>e5ca1d62-3f2f-4426-943d-3d514d193223</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="3:28:28">2020.6.14</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  <StrandColors><TopStrand><ColorRange range="421..641" colors="black"/><ColorRange range="738..1025" colors="black"/></TopStrand><BottomStrand><ColorRange range="421..641" colors="black"/><ColorRange range="738..1025" colors="black"/></BottomStrand></StrandColors>  1n       ë        ë)ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸99ýœr~c^›é†'á¦9)¾˜býsTè'ÄìÞKÒ �k�½7H0ó±�Qö!¦Tm‡lyÔq‡RH@üfìuµû�§U¨…F‡‚k¥æ(ïªs˜�œã©cê&ØæŽ¿&­ªï¾‰•¾
8»©„ˆ?(´5È2�â*8s_ýà £ß~-;êð¬êÿïæ�pÁ{lóãèüã�ÐÃŠxu¯ Š,N¾¯`ã³â(÷àkŒÀrúãœ¿¬?µ½0~¾¿0øãÃ¸Ãî¼Ë¬úÏíKïêÏ¿Ï�\ C—…wuŸüÎaÃYUUÍÀŠÊŠÙ\À+ôî,gýñö€=g?2®¾«ýÿýJÀ…Ð;4õË ÃCøöMŒÓ€;�o÷3ø“ÚS0Àˆ §3L‡Îw£Ó?“?;êÎ®¿¯«³Ü¬ðêÿ-Nåloê@¯’:œ7ìÕW¡¤`­É =³ødpª³ú‡(÷+©d�îŠõx]í›°¹®¨jeª jÃæ‚•V†¥ÕZ—1ikˆ"-) T¿ÐïôÐÑI�ScnÖ’Ó_B T¿ÐïôÐÑI�ScnÖ’Ó_d¿?åï?oÏù{ÏÒ¼ý®óýƒ‡–ª©©�ñ>ãîšôRHAª��ê�U;ð¢fö«áµÐaÊ³a¡u74+¼<èkaà7]l8îóÈ¯-3@3ð®ª-GÇâð�áaxÐq3lƒƒÜp2¾ŒÓˆìr‹xS@x8æ€Å#À4¾-»~Žøñ&öØ8cXÃ6s¡¼9øý¬}õ1]³lLMÉìðº,m�Åm ìÏOŠÏCµÍ�ÇA»,‡öcã£Å›`�V:®¶Çˆ<8ƒÎmdÊ!š8Q:1`8|ëìŽ§	³Îük4Í³ë›>ºJë„À{€+1X|}LsõøöÜF¬kß<úæ
¬Ê¯ÏïLÀ¶8ºÏßõè©£N™`§VTÖM·V­Õ•6ª­ãk’ˆ*/W¶Ö&é¶.&|±û“‘:–Ø-“Š¾"¢›ÎÝkÝ×gÁM•"Tø>XHN^Ý¥£(ÎÞ?:½,~,�N6–Ã×3 D0¨É 3ºó¯³·‡³Œì,¬8Ã	´ííPÂYÂ›ÝÐ\ÐT]ˆMT=5PôÉU2Žª½�ï?þM·Ulsµ-ƒüteF}«ÿ�NþÈÎïŠñþ<éðgâóêïëLƒ:»XíÎ$&í+�²³½Nˆ�Åÿò´ü|ã>›Â^lºõü%Ç¦Ïx4ÓÞ	tM˜�Â9Ñ+¡H ùyÃ�äPtš‚n3¸áOJ~°UD “ºÃWWß8$Â
ªŠ�M4iÌÑUPnÔQ¾¡º®p‡;H{r”¨-„iµT­ùê•¥VªVÖåI™„•è.)õŽ–Òß›´Æâæ¬­½’�‡¿Ë"F^qœŸnôŽ5†|Äs·Ã½›Me}=<4Rã^¦óïoKšZ(ðäII+=)d¨ÍrŠ=£�²·;,¨&¶´ï
ýqµJvÿbˆÕTÂ“¾°¾ñ²‹E%(<Ò)·¶
`ÓxÙkºx¶=¼”cªâIí}Kk„Y"c|J;£ðËYÀeŸ3Ý“EêU#¶Ú\®°UîÔ§Î(Fô¬b_ÞÈß×†ëMº§«}2®Ut5XóUPP1ÜŠ{gºú«Y¦…6¦Ð)¢í„Á�š…‰©Y]Y ¯3v¯ñT�~±Á°»ñ¿æí'[Žá�6JSÒn;øèˆ BÎHÌMV¥9×PÔ:hØQn:  ½  ½  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  '9<?xml version="1.0"?><Features nextValidID="21"><Feature recentID="20" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="927" maxFusedRunOn="927" detectionMode="exactProteinMatch"><Segment range="643-669" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="19" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="927" maxFusedRunOn="927" detectionMode="exactProteinMatch"><Segment range="673-699" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="18" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="927" maxFusedRunOn="927" detectionMode="exactProteinMatch"><Segment range="703-729" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="17" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="5733" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="4942-5733" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="5734-5802" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2641-3435" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="899-1487" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4183-4771" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1803-2231" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2245-2574" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2425-2560" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3611-3732" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5803-5907" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" cleavageArrows="875" consecutiveTranslationNumbering="1" maxRunOn="878" maxFusedRunOn="878" detectionMode="exactProteinMatch"><Segment range="810-875" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="5" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1553-1601" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="3829-3835" color="#ffffff" type="standard"/><Segment range="3836-3853" color="#ffffff" type="standard"/><Segment name="-35" range="3854-3859" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3874-3895" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3781-3797" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3805-3821" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="Factor Xa site" directionality="2" translationMW="473.54" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="1369" readingFrame="-1" consecutiveTranslationNumbering="1" maxRunOn="986" maxFusedRunOn="986" detectionMode="exactProteinMatch"><Segment range="1370-1381" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Factor Xa recognition and cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ?<Notes>
<UUID>e5ca1d62-3f2f-4426-943d-3d514d193223</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="3:27:53">2020.6.14</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  <StrandColors><TopStrand><ColorRange range="421..641" colors="black"/><ColorRange range="729..1016" colors="black"/></TopStrand><BottomStrand><ColorRange range="421..641" colors="black"/><ColorRange range="729..1016" colors="black"/></BottomStrand></StrandColors>  1p       ò        ò)ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸99ýœr~c^›é†'á¦9)¾˜býsJzS Ÿ°oy/H‚®4fôÝ ÃÎÄuGØp†™Q¶±çPaÆI!ñ›±Ö×î�V¢	®—˜£¾©ÎbsŽ¥�¨›cš:ü˜:¶«¾ú&Vø(âî¦J ü¢Ð× È"7ˆ¨áÍ÷‚€6�}ø´ï«Àz³«ÿ¿š=Ãí³Ï�£óŽ@;(áÖ¼‚(°8rú½ƒŽÏˆ£ß�®3ËëŽrþ°þÖôÁúúüÃã�ãºó.³ë?´q,¿¨>ÿ>p^ÜÖ|ó9‡eTtYW7(*+es ¬/Ð87¸±Ÿ÷ÄÚ õœüÊºú¯÷ýÿõ+?@ìÓ×,ãÙ4n3N î@	¿ÜÏâL3iLÃ ‚œÍ29Þ�LþLüï«:ºþ¾®Ïr³Ã«üµ;•°¿©¼jHêpß±ÿU^†�!‚·$€öÏá‘ÂªÏê KÜ®¥’º+Õà]wµþnÂæº¡©”¨«š
UXN—Uj\Å¥® Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û�¸NkÑI!:ª>Cª5TïÀN‰›Ú¬†ÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãAÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô36?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?×¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¦Ø¸™òÇîNDè2[`¶N*øˆVŠo;u¯w]œO6T‰Sàùa!9{v–Œ£;xüêô°ø²=8ÚX[\ÌÂ£&€ÎëÎ¾ÎÞÎ3°²°ãL&Ó·µC	g
ot[@sAQv!5PôÕCÐ_%T<Ê82ªöC¼ÿøq6ÝU±ÎÔ´BWñÐy•ô2¯þ;û#;¾+Çøó§ÁŸ‹Ï«¿¬2êíc·8�›´¬"BÊÎõ8"7ÿÊÓñóŒúo	y²èK×ð”w›=àÓOx%Ði4LBbCçD®… ƒåçw‘AÒj	¸Îã…=)úÁU‚Nèo]_|à“*ª*54Ñ§3EUA»QFú†ê¹À.í \UíÊP ¶¦ÕPn·äoªV•XR©[[•&fW ¸t§Ö:[HC~nÓ‹š²¶öJ>ÿ,‰yÆp:}¸?Ò8ÖóýÎßôjm5•ôôðP<LÑH/�z›Ï½½.ih£ÀS‘%$¬ô¥’£5Ê(öŽt6È"Üì² ˜:ÚÓ¼+õÆÔ1)ØoýŠ#US
NúÂûÆÊ-” óH¦ÞØ)ƒMãe®éâØöòQŽ«ˆx!'µõ-®d‰Œ1ñ(î�Ã-g–|ÏvM©TŽÛhrºÀ1W»PnŸ8¡Ò±‰{#^­6êž­ôÊ¸MUÐPÕcÍU@Y@ÇpV(Yížëê­fšÚ›@¦‹¶vj&¤Ueud¼ÍÚ¿ÅR=ørÇÀFïÆÿ˜,{´�n;†<Ù)OI¸ïã¢"�8I#15Z”ç]CPè|u£aE¸é   ½  ½  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  '9<?xml version="1.0"?><Features nextValidID="21"><Feature recentID="20" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="738" maxFusedRunOn="738" detectionMode="exactProteinMatch"><Segment range="643-669" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="19" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="738" maxFusedRunOn="738" detectionMode="exactProteinMatch"><Segment range="673-699" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="18" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="738" maxFusedRunOn="738" detectionMode="exactProteinMatch"><Segment range="703-729" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="17" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="5740" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="4949-5740" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="5741-5809" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2648-3442" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="906-1494" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4190-4778" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1810-2238" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2252-2581" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2432-2567" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3618-3739" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5810-5914" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" cleavageArrows="882" consecutiveTranslationNumbering="1" maxRunOn="885" maxFusedRunOn="885" detectionMode="exactProteinMatch"><Segment range="817-882" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="5" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1560-1608" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="3836-3842" color="#ffffff" type="standard"/><Segment range="3843-3860" color="#ffffff" type="standard"/><Segment name="-35" range="3861-3866" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3881-3902" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3788-3804" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3812-3828" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="Factor Xa site" directionality="2" translationMW="473.54" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="1376" readingFrame="-1" consecutiveTranslationNumbering="1" maxRunOn="993" maxFusedRunOn="993" detectionMode="exactProteinMatch"><Segment range="1377-1388" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Factor Xa recognition and cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ?<Notes>
<UUID>e5ca1d62-3f2f-4426-943d-3d514d193223</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="3:27:41">2020.6.14</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  <StrandColors><TopStrand><ColorRange range="421..641" colors="black"/><ColorRange range="729..1023" colors="black"/></TopStrand><BottomStrand><ColorRange range="421..641" colors="black"/><ColorRange range="729..1023" colors="black"/></BottomStrand></StrandColors>  1q       õ        õ)ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸99ýœr~c^›é†'á¦9)¾˜býsJ•éN‚|NÁ½ä½"¸Ñ›Ótƒ;yÕaÂeFØvÇ�A‡u$„ÆnÇ[_¸uZˆThx&º^bŽú§9ˆÎ:–>¢mŽhëò`êÚ®ûè™[à£‹º˜A(ƒò‹C\ƒ ˆÞ"£‡5ÿÞ
 Ú=÷âÓ¾¯êÎ¯þþh÷¶Ï>>�Î8 ì8 7‡Zò¢ÀáËêö;>"�~¸Ì/®9ËúÃû[ÓëëóŽ<;Œ>ëÌºÏ¬þÑÄ°nþ <ûüøÀ9xWpPGYðP_Ìæ5•QÑe\Ü ,¨­•Ì°¿@àÞâÆßÿhÖsó*ëê¿ß÷ÿÔ¬Pý³O\°4?�dÑ¸Í8¹ &ÿs?‰0Í¥3‚
s4È|çz=3ù3ó¾¬êëúú»=ÊÏ¯òÔîVÀ6þ¤
ñ©#©Ã~ÇýUz@†
Ü’Û?†G
«?¨r�/rº–Hè¯W�uÞ×ù»šê†¦P ¬>h)Ua8j]U©s–¸�b"Ò�"KýÿM˜Õ66íi-5ô"KýÿM˜Õ66íi-5öKóþ^óöüÿ—¼ý+ÏÚï?Ø8yjªš˜Ñóî>á9¯E$„ê¨ù¨ÕS¿:&oj°nQl«6Q�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�Ó0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÌØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸L¸³‡ÇÔÇ?_�mÄjÆ½óÏ®aP :Álªððàa¾ôÌ»c�+¬ýÿ^Šš4é–
ueMdÛujÝYSjªÞ6¹(‚¢õ{mbn›bâgË¹9 Ém‚Ù8«â!Z)¼íÖ½Ývq<ÙR%O€#å„„åíÚZ2Œíãó«ÒÀWâÈôãial=s0C
Œš;¯:û;x{8ÎÂÊÃŒ10›NÞÕ%œ)½Ñm eÍEØ„ÕCÓUA|•Pó(àÊ«ÙóÿáÄÛuVÇ;RÑ1_ÇAæTgÐÊ¿øïìŒîø¯ãÎŸ~/>®þ°È3«µŽÜâBnÒ°‰+;Ôà8ˆÜ_ÿ+OÇÎ3é¼%æË¡/_ÂQÜzl÷ƒM=à—A¤Ñ1	‰#�º‚—œ9ÞEI¨&ã;Žô§ëTJ	;¡¼5u}ó‚L ª¨¨ÔÓFœÍUíEêªç ¸s´�qW·)@j‚ØF›UAºß‘¾©ZUaJ¥mnT™˜I^‚áÒŸXém!ù»Ln.jÊÛÙ(ø{ü²$eçÀ@éöàÿHãXgÌG÷;|;Ñ©´ÖWÓÓÁ@ñ3E ¾5êo>öô¹¥¢�ND”’³Ò–JŒ×(£Ú9ÐÛ ‹s²Ê‚`ëkNð¯×PÄ§a¿ö(�UL);ëï(´RRƒÍ"›{`¦7�–»§‹cÛÉF:®!à„ž×Ô¶¸E’&0ÇÄ£º?µœYó=Ù4^¥R;m UÊë Å^íAº|â„oJÆ%ýì�ýxn´Ûªz·Ó*à!5WACU�5UeÁX¡g¶{¯ªµšhSjmš.ØLÙ¨Xš‘U•Õ�
ó7jÿH÷áË¿þ`±îÒu¸îód¥=&ã¿ŽˆŠ,á$ŒÄÕjS�uC¡ñÖ�…ã¤   ½  ½  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  '9<?xml version="1.0"?><Features nextValidID="21"><Feature recentID="20" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="735" maxFusedRunOn="735" detectionMode="exactProteinMatch"><Segment range="643-669" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="19" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="735" maxFusedRunOn="735" detectionMode="exactProteinMatch"><Segment range="673-699" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="18" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="735" maxFusedRunOn="735" detectionMode="exactProteinMatch"><Segment range="703-729" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="17" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="5743" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="4952-5743" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="5744-5812" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2651-3445" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="909-1497" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4193-4781" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1813-2241" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2255-2584" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2435-2570" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3621-3742" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5813-5917" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" cleavageArrows="885" consecutiveTranslationNumbering="1" maxRunOn="888" maxFusedRunOn="888" detectionMode="exactProteinMatch"><Segment range="820-885" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="5" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1563-1611" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="3839-3845" color="#ffffff" type="standard"/><Segment range="3846-3863" color="#ffffff" type="standard"/><Segment name="-35" range="3864-3869" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3884-3905" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3791-3807" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3815-3831" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="Factor Xa site" directionality="2" translationMW="473.54" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="1379" readingFrame="-1" consecutiveTranslationNumbering="1" maxRunOn="996" maxFusedRunOn="996" detectionMode="exactProteinMatch"><Segment range="1380-1391" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Factor Xa recognition and cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ?<Notes>
<UUID>e5ca1d62-3f2f-4426-943d-3d514d193223</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="3:27:32">2020.6.14</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  <StrandColors><TopStrand><ColorRange range="421..641" colors="black"/><ColorRange range="729..1026" colors="black"/></TopStrand><BottomStrand><ColorRange range="421..641" colors="black"/><ColorRange range="729..1026" colors="black"/></BottomStrand></StrandColors>  1i       õ         õ)ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸99ýœr~c^›é†'á¦99¾˜býsJ•éN‚|NÁ½ä½"¸Ñ›Ótƒ;yÕaÂeFØvÇ�A‡u$„ÆnÇ[_¸uZˆThx&º^bŽú§9ˆÎ:–>¢mŽhëò`êÚ®ûè™[à£‹º˜A(ƒò‹C\ƒ ˆÞ"£‡5ÿÞ
 Ú=÷âÓ¾¯êÎ¯þþh÷¶Ï>>�Î8 ì8 7‡Zò¢ÀáËêö;>"�~¸Ì/®9ËúÃû[ÓëëóŽ<;Œ>ëÌºÏ¬þÑÄ°nþ <ûüøÀ9xWpPGYðP_Ìæ5•QÑe\Ü ,¨­•Ì°¿@àÞâÆßÿhÖsó*ëê¿ß÷ÿÔ¬Pý³O\°4?�dÑ¸Í8¹ &ÿs?‰0Í¥3‚
s4È|çz=3ù3ó¾¬êëúú»=ÊÏ¯òÔîVÀ6þ¤
ñ©#©Ã~ÇýUz@†
Ü’Û?†G
«?¨r�/rº–Hè¯W�uÞ×ù»šê†¦P ¬>h)Ua8j]U©s–¸�b"Ò�"KýÿM˜Õ66íi-5ô"KýÿM˜Õ66íi-5öKóþ^óöüÿ—¼ý+ÏÚï?Ø8yjªš˜Ñóî>á9¯E$„ê¨ù¨ÕS¿:&oj°nQl«6Q�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�Ó0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÌØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸L¸³‡ÇÔÇ?_�mÄjÆ½óÏ®aP :Álªððàa¾ôÌ»c�+¬ýÿ^Šš4é–
ueMdÛujÝYSjªÞ6¹(‚¢õ{mbn›bâgË¹9 Ém‚Ù8«â!Z)¼íÖ½Ývq<ÙR%O€#å„„åíÚZ2Œíãó«ÒÀWâÈôãial=s0C
Œš;¯:û;x{8ÎÂÊÃŒ10›NÞÕ%œ)½Ñm eÍEØ„ÕCÓUA|•Pó(àÊ«ÙóÿáÄÛuVÇ;RÑ1_ÇAæTgÐÊ¿øïìŒîø¯ãÎŸ~/>®þ°È3«µŽÜâBnÒ°‰+;Ôà8ˆÜ_ÿ+OÇÎ3é¼%æË¡/_ÂQÜzl÷ƒM=à—A¤Ñ1	‰#�º‚—œ9ÞEI¨&ã;Žô§ëTJ	;¡¼5u}ó‚L ª¨¨ÔÓFœÍUíEêªç ¸s´�qW·)@j‚ØF›UAºß‘¾©ZUaJ¥mnT™˜I^‚áÒŸXém!ù»Ln.jÊÛÙ(ø{ü²$eçÀ@éöàÿHãXgÌG÷;|;Ñ©´ÖWÓÓÁ@ñ3E ¾5êo>öô¹¥¢�ND”’³Ò–JŒ×(£Ú9ÐÛ ‹s²Ê‚`ëkNð¯×PÄ§a¿ö(�UL);ëï(´RRƒÍ"›{`¦7�–»§‹cÛÉF:®!à„ž×Ô¶¸E’&0ÇÄ£º?µœYó=Ù4^¥R;m UÊë Å^íAº|â„oJÆ%ýì�ýxn´Ûªz·Ó*à!5WACU�5UeÁX¡g¶{¯ªµšhSjmš.ØLÙ¨Xš‘U•Õ�
ó7jÿH÷áË¿þ`±îÒu¸îód¥=&ã¿ŽˆŠ,á$ŒÄÕjS�uC¡ñÖ�…ã¤   !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  '9<?xml version="1.0"?><Features nextValidID="21"><Feature recentID="20" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="735" maxFusedRunOn="735" detectionMode="exactProteinMatch"><Segment range="643-669" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="19" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="735" maxFusedRunOn="735" detectionMode="exactProteinMatch"><Segment range="673-699" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="18" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="735" maxFusedRunOn="735" detectionMode="exactProteinMatch"><Segment range="703-729" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="17" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="5743" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="4952-5743" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="5744-5812" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2651-3445" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="909-1497" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4193-4781" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1813-2241" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2255-2584" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2435-2570" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3621-3742" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5813-5917" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" cleavageArrows="885" consecutiveTranslationNumbering="1" maxRunOn="888" maxFusedRunOn="888" detectionMode="exactProteinMatch"><Segment range="820-885" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="5" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1563-1611" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="3839-3845" color="#ffffff" type="standard"/><Segment range="3846-3863" color="#ffffff" type="standard"/><Segment name="-35" range="3864-3869" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3884-3905" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3791-3807" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3815-3831" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="Factor Xa site" directionality="2" translationMW="473.54" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="1379" readingFrame="-1" consecutiveTranslationNumbering="1" maxRunOn="996" maxFusedRunOn="996" detectionMode="exactProteinMatch"><Segment range="1380-1391" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Factor Xa recognition and cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ?<Notes>
<UUID>e5ca1d62-3f2f-4426-943d-3d514d193223</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="3:27:20">2020.6.14</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  <StrandColors><TopStrand><ColorRange range="421..641" colors="black"/><ColorRange range="729..1026" colors="black"/></TopStrand><BottomStrand><ColorRange range="421..641" colors="black"/><ColorRange range="729..1026" colors="black"/></BottomStrand></StrandColors>  +      ú  ž         ž)ª3Ž³œFg2‡hi¡ä¦–ImiÀ-¤­“öf¯2�—§	X?>?\óö‡-e‡&+öIsÖ@z½¡ËXjp•ã÷ ÒvÔ‰¶cÔœÿæ‡-aÂVÏƒi�Òv¦êùè4�¹É¤¶Îiöc
 ÒvÖ dÂ¡íÀ½K½ÿhrÖ**ƒ}V×êõX²]{Ïö‡5`0�Èœ ¹™M¸92¥zS Ÿ°oy/H‚®4fôÝ ÃÎÄuGØp†™Q¶±çPaÆI!ñ›±Ö×î�V¢	®—˜£¾©ÎbsŽ¥�¨›cš:ü˜:¶«¾ú&Vø(âî¦J ü¢Ð× È"7ˆ¨áÍ÷‚€6�}ø´ï«Àz³«ÿ¿š=Ãí³Ï�£óŽ@;(áÖ¼‚(°8rú½ƒŽÏˆ£ß�®3ËëŽrþ°þÖôÁúúüÃã�ãºó.³ë?´q,¿¨>ÿ>p^ÜÖ|ó9‡eTtYW7(*+es ¬/Ð87¸±Ÿ÷ÄÚ õœüÊºú¯÷ýÿõ+?@ìÓ×,ãÙ4n3N î@	¿ÜÏâL3iLÃ ‚œÍ29Þ�LþLüï«:ºþ¾®Ïr³Ã«üµ;•°¿©¼jHêpß±ÿU^†�!‚·$€öÏá‘ÂªÏê KÜ®¥’º+Õà]wµþnÂæº¡©”¨«š
UXN—Uj\Å¥® Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û�¸NkÑI!:ª>Cª5TïÀN‰›Ú¬†ÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãAÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô36?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?×¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¦Ø¸™òÇîNDè2[`¶N*øˆVŠo;u¯w]œO6T‰Sàùa!9{v–Œ£;xüêô°ø²=8ÚX[\ÌÂ£&€ÎëÎ¾ÎÞÎ3°²°ãL&Ó·µC	g
ot[@sAQv!5PôÕCÐ_%T<Ê82ªöC¼ÿøq6ÝU±ÎÔ´BWñÐy•ô2¯þ;û#;¾+Çøó§ÁŸ‹Ï«¿¬2êíc·8�›´¬"BÊÎõ8"7ÿÊÓñóŒúo	y²èK×ð”w›=àÓOx%Ði4LBbCçD®… ƒåçw‘AÒj	¸Îã…=)úÁU‚Nèo]_|à“*ª*54Ñ§3EUA»QFú†ê¹À.í \UíÊP ¶¦ÕPn·äoªV•XR©[[•&fW ¸t§Ö:[HC~nÓ‹š²¶öJ>ÿ,‰yÆp:}¸?Ò8ÖóýÎßôjm5•ôôðP<LÑH/�z›Ï½½.ih£ÀS‘%$¬ô¥’£5Ê(öŽt6È"Üì² ˜:ÚÓ¼+õÆÔ1)ØoýŠ#US
NúÂûÆÊ-” óH¦ÞØ)ƒMãe®éâØöòQŽ«ˆx!'µõ-®d‰Œ1ñ(î�Ã-g–|ÏvM©TŽÛhrºÀ1W»PnŸ8¡Ò±‰{#^­6êž­ôÊ¸MUÐPÕcÍU@Y@ÇpV(Yížëê­fšÚ›@¦‹¶vj&¤Ueud¼ÍÚ¿ÅR=ørÇÀFïÆÿ˜,{´�n;†<Ù)OI¸ïã¢"�8I#15Z”ç]CPè|u£aE¸é   !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  !H<?xml version="1.0"?><Features nextValidID="18"><Feature recentID="17" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="5656" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="4865-5656" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="5657-5725" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2564-3358" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="822-1410" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4106-4694" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1726-2154" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2168-2497" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2348-2483" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3534-3655" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5726-5830" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" cleavageArrows="798" consecutiveTranslationNumbering="1" maxRunOn="801" maxFusedRunOn="801" detectionMode="exactProteinMatch"><Segment range="733-798" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="5" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1476-1524" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="3752-3758" color="#ffffff" type="standard"/><Segment range="3759-3776" color="#ffffff" type="standard"/><Segment name="-35" range="3777-3782" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3797-3818" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3704-3720" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3728-3744" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="Factor Xa site" directionality="2" translationMW="473.54" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="1292" readingFrame="-1" consecutiveTranslationNumbering="1" maxRunOn="909" maxFusedRunOn="909" detectionMode="exactProteinMatch"><Segment range="1293-1304" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Factor Xa recognition and cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ?<Notes>
<UUID>e5ca1d62-3f2f-4426-943d-3d514d193223</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="3:26:30">2020.6.14</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
   «<StrandColors><TopStrand><ColorRange range="421..939" colors="black"/></TopStrand><BottomStrand><ColorRange range="421..939" colors="black"/></BottomStrand></StrandColors>  @ý7zXZ  æÖ´F !   t/å£ádóÿ] Ë‡ØÎf‘ƒÊý{3Ôé·Ú(1v%f M*	mj÷)p80çÌ*iÚ	´NY]Qó“�úF7î&ƒÕ!Ò÷ÀnÏoH_¯vD)š�}µŒôK×ôjïÎSMF;ƒtÄíQw�Ý�m™«�aÜ‹V€«DÁµ«õ8†øUKpçÍ‘Qd{Ê fÃª„.ŸänÞÑÐñ\Ð£•ä�Q«ç\äù€3¶ÓÒªU?Ëä~K$›´ß‡ChŠ+ënÀHmrÆÆ89iQúLdn}¡Ó¼ÉCÈi©“íX—“¡¡‰ˆz?×§úeÒþºÄX›Ë•ê³¸PÔO×M$”XÐò£¦SVúQ°Þ&6&ž¤yd¨D'ZŒhÆJâdÂœôŽí{âzòñºÕ…ÔÀD�³»õnÑs]ÃhGÝÉ„©P›(»'OªäÑÿr!SÊ Ä¨Ü”ôa"_AÁºç¸†•’XY#,ë<q¥·nD–fØ£Ga{³Ù:<ºÌåm Û¥Šb>x8H	Ð“Å|H”J€}1¤^õ¢tVþ÷m¦ÒÂ»ª ¢ Á- bÉR_f ‡ÇW€ñ>àz•Ë.šÛà~6,IšœÕ¤%Kr)Œ�¿‡°�¾ð³}ã"eËÀÉ‚üÁZi Jn [òÐœÑÈÏšð$@•Íš·	í¤šõÚ~”»6qž	s	Íçe%pœä#…›N�±¤ÿ�!Q RõG© Q,qwkhœŸ¢`wÌÍ¬ìáo;n4Hoß<X+1!W.é„½p¿zØK_qúnB…Cp�X;F!·�ÄèL¸™[ûõá�!M„~8Ø°©Ã5°·qÌºíed«¡K»@üeÓ¹N@í^úÈDw+‚Ðçgû Òä¤UJ,ÁÿU>Ó=I‹~IßN<üLº47|?Ò¢™À|<nÃTüH²¾“Që©v^ÆQPvýYu9ùƒ¼KÐìvK¥xƒªßä™B1RÆ*�K`v!Â+�¿^$õN3·l«é™&"ù‹(nXÖì ý6³N³íþà®ã¬Š×Î„ÌwJÀìó|Þ¦³ô^^ŽV;iG9Ã”3®ƒ†£1«„†ù.‚.œû,âæW?¡±}Ÿ£<NTM’evcBr¦ÂR—ý!À=8Ç ?DoÔ…·ñâÖw¥ða_“Ö~â¦¤„0X©w	3D¢åû8eD)Ê¿ÞÒr3	ÅÕÁš†Gá³ë¦°9Úí>âGÕ÷·¸¤‹Ëòâ30]–Òœ.ì2³ÈJkzE›S8öÑGX:ÃO
ß©à³yåõ«Ýëæ !³ÂîBà
üÅÛ,b>²ðj ÿ\?+ÆæD1µ' \¸¾H÷½©7 =˜©víÜ\žñš]�aoP	ÀU6mä®%”ÿjŠ”@!¸]LþX¨R’TWoK"k	œ’g¯èê´�nBJAVvSn7ÒøÉ÷×.â“h9;îÊ5—ð§n•å¥ŠŒí}X�æj§}?à�h©¥&•}±ö´ð¼ävKÛ@b²àÿÏÜÕùËKØùÂ_d]ºd‘kö„QÈ‡«Ö9S#®ÔÜ:}©ÅRHÎ=(yÙA¢U=£I	­äÁŠG ûÊiìGž>I†,Qó–ZMÅCTQöë×�ÎYOXÖm%õ!*ÆÝñ'nXµ�ÁáÕiÓEŸ9…U!Qºo÷í—v,©Z Ì½dl§Áô�qñš,¥ŸdNòø°Œ�ÝB¶?"]Üy/ƒ’®4äs£]b�¢a} ö€Ö†¶¤¦\Ý\I|[ðÌßÓdÉêÌiëªfÞÚÞ¹`Gtã™}53ÒT×|0¢—wSã›*÷‰Ã^‡]´ÑÏ(É=xaži§?]ˆGÈbÊš‡=†VMá}À¯Ù üj…)È:õ«à#å7TAó‚ÝØc%Z/ÂD: ãŠ¼´6h“§¤ÓW|È4¯Oõnjšò8;± C¿÷ÚÀ€Ö— ùý8ã{_lŒ_¤ÌÌm`¦þÈ¤½^c=ä3¡UÒ¿�@ËCWÔ-TÜNcÒ.ÕDåEùìî]n¾íÁHÏÔxÂõ³Í–Ÿ¶I"LŠGá‰Ø¾¯£l�Ÿ5^‡U"]"áïVTŠèË>óÍÑé÷,3›ü~˜áðÁœÈÙRz½kê[¡tð¹HQ“!Û{�á£Û¢`Rj;âèî‡æ3jÏÜÔ’Ô×z¡Ïón¯“t=+^ç°Ç_Œå�q‹ÜyBÎÖ¿Gc¬‰!’†=pôÉ“;Çf–:�B%à¡ZÑsÓuRýw7Ð3¤< ®!LN!žó5ö2Mì,Hšç’â¥{
øî‹4¹¶öIÎu}Hqæ@°X0S´V­’t­ä±’Å¤ÂãV×»ûÝhjUÚ'oŒ;hDL»OÕ[nNÐ;6Š�"	Óãmk	}°ê‡×ÏBÜÅd®Ée›|9ÏO“û[§</ßÿÍãœº¶–ú�7ê—�‚˜å¢­‹±Ë?1”SâzÃœ¶[Öæ9]L×BŒí`¬Ä¥>|pêZ2ÙKÔÓÐÀP °‚jÁ¢¿_ç¶5fÒ¦êÜæv·1ù`"`'9]i  )OßM�ù'<�³6ÕpûvÊðúõº^^6”1ˆ~Zu ›V«}‹Ži?Ñx ¢|`$;B�Ç3«·*ÿî¹¶üyÎ¿¶�4 kVX$oXcžIFˆ€¾ùÍ¤Ìðþ™ÌÊ<¯(B]ð•k~ñ‹Šiš€mí‘mBtþ3G$Uè½ÅGQQì°®Ø†µ^á¦Ýí¢ôŠ	îvMè±óySù+b’Ÿk¼fÓÁg<1R6²6ùÒ²‰BG¬rwa÷ÜDjæ{GÞÆ9_±ëK.mÒ?æ©fÅÈ;Bu‰În£8ôŸmÝ+Ù÷G”»ìÚ¸³ôð¹-7£óª¶ikMyß&Ñd¦õÛ^ã$Ü–¿àÞÜtí¦åç†pXN«S¾@×¤Å†�J¦Ï¨œ]†”õëJAdÔ©b“L~9L|£ò¼1z‰üããf†¼Í,¯YÏÔæŒFjÚã±½$.Ì" ŒðY",ÞÅnõgÛ6Ç¨�Z]£ XŠ-EN.dåêHr¦w¶
ÛÑ_Ÿÿå©âl.â©Œ›‡‹B°´&AñÞ	`ÞÞk·ÎêusF{¿mò‚êãôybÿTDšGº @˜þ—U…Ñ¿Â²Vÿ<ØÜgà›¤i¦é«ÇÅüZM!{J{ukò�C`áãÐ'ŒbY Èºõó†1ãNÿ¢i÷êÇ5èBÕ·Xwy»uÙ,â4wÏgTîÃè$&µß1_kðf±#38Ù¿ÿ¤ËÛLÂ˜9sûá/Õkx™è¨ÁH¸E¬�\#}�EÐŽ/¯N–’HØ(Úg¾!Œ>¥@~Zz¼S;j	Âá+T#xov¸ å®<
Ì¦\êcEq[£	êÔu±Â§)oåÜ‡ÂüxðqW*%RÑÔnhHºz¿À­^%…Ëµç÷ÓBñÆ‘÷?-]ÑëÈÅ@ÐpcQ~Wyþ¼Î6ÈÖ¹:4I-”�<3à‚T|Pz¨3ÇÛ¥»î_õ¬ßHy¨Š€AÊ@ˆ‘žÍƒI”^ÔŠöL<60Ëf'²Ú¨ŽÔ}
'ªÕÍ Kù2Ÿ·] $ç0ª… tüˆÛŠ¼èvOðÒ/c]~†›=ùºZÆGR^åïŠ¯0ÞäR¸Hùy\<Âð×ïS–´´2…{ó)?¸ÙíE¨]�—¨1e‘ãõûˆrÒÎG×§ùÄÝ:âþx.‹X—v*ï?xX1MÅK™åÐ	ˆâXÓÿ¢C1DÓÛ"î%1�®×m™T™Æ“FJŒ*Š©âš¦u3*CC#CmFüÁïãæ“7Ûòõê´XmfN‰aR­xf�k˜æ¯”g½œn˜æsÒ¬ül!NþW�—Ã”C‚qˆáY®�´­ãÌ¯4ô7Š
¹ã§;u?wH)ëK½jË¶•x¼GçowºQú†Ä¹wï—NÏLf&-ÛÞäRAHz„(b“z$Ñ¯gÐ]‘L>ò qª¤å]·+>³ÂÇ¦ëk£hQ‘æat,suóÐ¥�Ñ7t¤áV-k²WÚßf­è	k-ëÞ}‹å›´�¾)–Æx+C)Ž÷,ùÿ>GÜYˆô1·íC0:ð_Á´^Õ{�-pas”óìõã”sVS	J×ÇÆòÔš›®ÅrBIY|â³ÊtwÙ–*¸©õôj@Æ^«W+ ðOmÕ¿�M½‹!Òx0"P©ÆòÂ§9�×DýqÒ:s ¹qfYsÊ•	ž,Ð[5Û�ÕØ¦ï@³áþÂJ©Ñ¶_dBQRÙƒ«ÜC³e_…à=ÎœðLÈ–¸áƒS´êÂÑµ=¬½«ŽQwëîí´¶ ‚dñžKórmwK˜!OèÚnMÅ`æþî«<‚Ù¯•ùöjƒ”¯•(AÉî†¨¯ASÏä’€�V¹3J¿JoÜ¹æ¢ú7‚+8<–ëË†~‡Õ7>û‘X¥±MaÝ¿††í¿“«xFbuWçÔÒ+¯û5Ñoþ“hÏFÍÃhML½ÆPþ—:‰m&f\xYÏù³*ôC-ŠZ„ V¿|==¹¢cjY†(°QþÙYÛ´<¢Ÿ½%™¡C/œ¿*œ	Š‚Âwyä4LE4   –8ÞEo]> ›ôÉ ¤�éû±Ägû    YZ  C�      C†®ZTR

SMP4      >ú!e  xÁIÏ®]zäóZíÝ>ÏÛìîkªûÊeK±Ë4
8–‡	J&C$�’!Ê,5c’!ZBÌAü H 1‹EŠ„€ ”²«ùš½ßæéîv­u�‡ü“ÿHÒ9c¬w!†îðæðþøøøùÛwoÞ?<¼ûâ‹ßÿò'_þà7çû¿ûý¿ÿýßþò·~_à«¿
àßHßÇŸÿ,}†¯“ÇÏÒøYú€Ÿ¥€6}@�–"~ö/ñÿÓÿø¥ÿúã/ÿŸ¿üÿ~ñÏ¿þËñ‹¯¿ûËÿóÛ_>?ýü›ç�?½Þ^Ï//·óu½mûž7­•"øcüïp?Ã_ƒù/€?
Å)…¨P PÈä!¤5’’„P€4R ¢ª 0blr¢† ”Õ²øêHB�B«RA“V¥*T$9cEŒ@@¥ª[IŠ¨ˆ�1FDHj­,Žª¤@ŒõF�eG¶9¨ˆ!(
!!¢  )PR QBTŒ

’ 	Q� ©¨AI¡ˆqÎY‹"0¬  aú¨¨¦VÏvkr5Ù,ÐjIW’Áb‹1.€[¡1t06} Q]6*¾¿ëŠœ…Ö—@h-¶46D j^¤Âz5¢ZÖ´&Âìû­OkER‚5s¯6¶V¶<_�½‰ÖTWÓZDÄ».)Ë¼U©NÄ¦ß A-  tt²í·œ…6ÐIuÕº¶ñ~ß÷a]S¢Šaz‚Åfg\Ã½”­ òV: [Ó{PÔçZ‹õ£SNû¥„Øñ"@T˜þRÍ²”0Ž.o/7ø6tbl&’€#•yµf²~üxA<l¦· P¤B|×V7¯—XFÓÂ ¤B˜~Èu-nx°åö2/�VSÕL™Í8Ê~úT³ëbc*(L_��ê7cë—óóEbÓy¡�RÒ;@­Ü}wß¹éu�ph‚W0}�  
0y nK-‡Ç¶_Îß^0�‡ZR„ A€¢‘¥nK¸ÿ¦<?ÿrAó¶—Z­FTŠ[š%^%m45 0¡’E‚6š�0d]µ»²\ŸW‡("�¤Èz[ìáÃÌ/¿˜ñ0³ªQ'©i¤Ôy½{÷nÀé»ïæîíØo
­B $`ˆê * `/ý�³Ûõ¶Â"w#êùºš:¼yèôÓÇ3Þï‰Íª“ôS�RëïŽ>Ÿ/7çîc¨†Âô7A�Í{†§Ûìbô€ÀÐP4L( (Ð}ßÌñèíåúª.4Mu&BT ’)‚ AL ty¥}óù·§OÀáÞbñL
¨HÕeê�ßóîöéé‚£éÁÈëüš›Ö†ãà×õú¬¡m�©B¨‘šç©÷·§ïž&3ôwíÐžo/çý!¶ª”ô„T3Uv‡ˆåúŠ€NŒ@Ó[�††€Lß!ZÊ¬Ã}�rþn-£ÚÎnËy[F�QM?AÁr�üáKàòé—Wî:hH]µÆ‡ˆËþº·}ìÕBA :ŸÔ}ñøÅ/¿©U ¦�€ì9{[?iqm§ë3B¬É¦Ÿ‚ `_f¼ýòÁŸ~ýrÛc›¡
¦Èû$ÃqÐËõ´û&:¨�¦÷ h*o÷ºéù»éâ>ëÛ­8u’ZÎóíîÃ#n¯ß\
†î¾ÙN×Õz1*¤P¸.[sü¡ç·OÏå~<ó·¯ß,wmÔj¨õvâ›Ï~øôóÿøðèËVAnµñ²½´]5ÐôÔ€5Ï9¼»Ÿ¦Ó§3úq�©p]¹}úÝ›Ñ˜jŒ:I
ÒP¶ëÕ¾4xþôëŠ‡C*˜~¤�N‹6�L~ýå§ýÍ›¾Y)JI(‰õz;Þ¿ëŸ.ß½²y<ŠÍbÔIj@ÐT]Öáx.ÓÇW„·�3»‚é+@ÑÝCÀ²œ¦ÁŒ^Èô æ¼uo¢™®¯›ïûV’QËlšÇÆ\æçb»Ø¨U2õ D¹çÅ†ö¶=soc„+dú¯@ˆê*yìcÞo×µñÞ:¥0u D±éb†>äyº…¡wQ	¦?!ºg-Ç»ù<å¾í¬V
ÓW �¥dÓ÷¾LÛMtÖdaz&‡¼Îè¾èÓÓ·ß~<è�é¿iPêVÛ»~Y?}ªe8zK‚éoƒ ¸\‹¼_??}‚; ™~
ÁêŽ­[–i7�ãp¨Ût�Lp�M(”*ekÇ·ü’Ñ4Öïš¢Ew	‡P÷å²ÕƒmG+ÛmZ­‹!dKPÔÌjºÞåõr[Ìp×…év×ö�¢dú1Ñ]³?¯—›¡q´Ðô�@AÕY%ÃR¦Kp!z£Âô„h)kÚa¿®¯ˆÎG5€9s�»^·ÝÄÖX PË¤Í±5ëõ)ÃþÎ;�§S±hšcoë<¯¦3F é?…ºgg»®è>]úâbëtÝ×›‰"}wÐ}~a\ãÔBÓß!ZtCsôz{…k„Ý@S
±k1]ÓÖmºe«aè\)Ûu3¶uÆVaêA@*—©ë>Œº=½^l3ŽcÈûôªö[Sp¿fsøÂèôóoÖúpì�ìåŽìûÎäzfñ>X“…éÏAA­3mì¼îóEm¾ª0½pÞVwßóúü¹=( ¹çU†cÌ§y…ë<D�"ª±iÍ¬3ic#ž¢éÇ P*÷9÷FÏ§)CÓ�¦£\.[¸ÿáûóíëo?áñ±Õ¼L?…¢,»z»æë¹ö¾	R#jÉjÚ–r)±¬ÑôŸ�­kÑöÑ‡ý:¿ø>ô®X£éHÕmnx¾ž®2½UM˜ömÍ‡‡Öó×¯æU j­áÐ Þæ³o�ÑÔƒÝëêÛe]?ë|@1 4o›ö�×ë7ë6´�#…BQ.S×|Þ‡××Ëd‡¾¯„hjA!¤Ôm†/íËËëwïÇVRíjtˆÊ¾–­'¢éï�‚ZÊf�Ç¼½ í[çaDÓƒBáVvÛ¿sºÌ/ªaìïƒYçõâ400 s™êp×úår[ÑÄÎƒ©&¸1jÍŒ7QŒ `©Ešc[·é¤yDì]–BÛ[»Íój‚ó�*L=(¨¥ÌÎ?8s^OsßtA`DÓßµT†&Ž{Þ®«´áxó¶œ°wGãu^Ïð-»¶‡Ÿæ'è¢�Mÿª+ÄœLõ²äÎz'V(¨Ërioï°¿|wZíÐ?´=×—K6Ñõ†"¢éo�BÉu.îî.®—ëëZŽ]Çj�¦°pÏæÐ™ºÝ.>¼W!Àºä† Û´�³{žû|ÛÔ»ÆT'¢©™ÙÄ±óY¯“"úXœÑô7A�Ö9/þ0
¦ÛëÂ£{0�]òKÍŒ1šþX¸¯f�^–ÓÆÐø@J:@uÛGgt_®›El,ŒªÝ–Ýß´ñzyyjÜpÜ›ìŠ‡®ù†»7�ß~s]ûqôªBazrgvqtöVnk­$–*µéœ¬å\i]´¶J@AÑ}6Ãñ-¶ëÓ¼Øcã¥
Ór×Õú£‘<�ó~”àFS
…Ûv“øömïN§oíÐTaú]P�‘«ëG›óúêÐtÞIrÐ½TvÃu»ôhŒ5%AîºÓœYórU]T•ô[Ðš«7Cã�Ë´­…5é¯ƒ‚šµ?BtÎ¯5¢o:)ûz]Ø„&TJú)(Ð’'ƒ»ã›ß}|	<ôÑšl˜ZP %o{8BÎÏç+×Y±%ýˆ¬»•±uK]n{èzkç:­‹£õð„T[JñmÛä²¯ª6DG#éß¹pˆ=æy½î1=i%ýÔ}/Ò�Îç¼ÌkgMGc%ýÇ`ÝU}èºo·,Ú6¡ŸkÞÖ]ÄzXê^hÃ©ë¼�Áy“ŽÐE:”mÞVgÅ5"ÕUÔõMKN×[dãƒUI?ûÆþ~48�æŠ>Fc` Ý}ã;Å²^EØG“þ.X°Ó÷«×ýF×Â©¤ÿZ÷‚ÐÅ¶”º¬haƒ�¢Öº‹»ï`/Ïu¢ëº`*ÊrÎFÑteŸ¶Û�ƒ7°’>ƒÖ¬bš®Ù%¯Ëf¼sIŸC]è(³ÞX£ˆ•4‚5+]ìÖ}�¤i£°p¾©­]ß-—íæMZI=(U°‹m»·ÛüÊ¦élTHúC�V¸Ãá¨õ|™àLðÞQmFÁ[ÖÛTˆqèa¦íBË.xK“þ5hÑ¼¢éÆºOË+›bj’"¨ØYv½ëóvÙV´¦�7*’�(vWiCë±ïâŒXJ¡šo†v]§ÙÓ:CgÒ ‚¹ÖÍúûÃ¢Ïçk†ïl¬@Ò	¢zÍ°t��óºãû®º\Ö²Ã™ 0©)U*�mÁ2_oÖ4Ýp¥Îû¬Å‹·t€¤GJ­Á‡Æ ¬e"Mß4UómÙÀÄX‘ô¬º£Ä&:›Ë~ÝUmï�Ëe›PLÛµr½™µÕ­I?�¡6®iÀ}Ï›ª+’~Õ5jºàlÍëÄjBo¶e]t·�IÕ½Ä¶­Û¶Wš@¯ ÖMªmbÈÜö­–ÆE:“~ÊÂìJ×9Ñy¿™¨&Du¥Ö" Ek­Ñ¥NRÛ¦Ëk�ÖÕÃ9¯�ô¬Ù\cY·UwëœªfÍ5vC‹¼]o6p"Ã^ÖÅ€�X ºu‡mF!§éâ„�óÕIï@r—Îµ~ß×+Œ“®�EÙö=c<|IµÖ"Îµ6TÙg]«·^D ÖâjŒÁx”¼×Ýš¦±"™ëža»h©y^¶*´Þx…¤„VÝ‘›hÕ}¿îtôF­I@T1«õ>vº×åRéûØú]ómÝ	ï\PØô$;¤5pY—­Xã‚©FÒWHŽšK®®�×éºzßI4t¤‘¡(	!Fe�ò”ÎcRõÕl@Ót¶b]&É†Þ@DÒ� ¢6“†h%ë²°"Ú¨ÆPDÒ÷@RÕdËØ†°–rF±°ACfl]‘×í†Pƒw4ˆ¤$•\e/Mw~_Ï¤‹M¬^ÉZ>¶=Poœ·®¡Hú(€jsµ.t%/Øb¼ƒDUw��‘f+Ób\×†E¦ÛŠ�‰@’Gr”b3¼tÞ‹äe‘¢¡õNê¾'NŒMB	á^knšƒiöívÝ ¬ XI ,(dß†\.û"¡±ðTSMÍÎ…hQ·¥ìtM³ÝòºVc»2÷ý&»³ƒ–¼l™lL � ’~„¨Q'ÕÁ°ffïšQ1mO¦8ß"ÛV·-#�dÝçÕi0|Y™+šaðº�NWÄÆ6$'P
S
ª²˜ÍÚØF[ë¾Àu À0ý
	ÖšUƒ�û>]«zã<¬�`ú1¤PëØÖŽ;ò2íƒišv—¼oM´Ö�@Mž{…õ}‡m›.•>Ú¶Š£¡Húo@µÖÕ:×ÇX·uQ[ç­€"IŸ�ªP³ZÓ^k^VWa],†I?%9¢²æàúÑ ,Ëæ²s^ TfTúè­ÙuÝªÖ‹ ’þ’# f7>ú �tMWQ×²ÑÑz±†€¤?I€¨B Ä`µÎK­hÄY�  B�ú*®sžu]¶"0¡º
PÒ09¨`Íp®é�¹Íšimˆ‚&ýC�P †Ü«)}ÖyY¬õÆ
)Š¤¿&Öì�í`kÕQc¬ $}…ÿò¿_CLñ¤$„ Š� AP(
…B!(L¢ „¤@PPŠ¨$ˆä(
Xq*b4°²úâU¡ˆ H!H£‘É�B¨€µ¨�b­q0BVS5{*0aj *BŠRT	BÅÂ8q*Ðb³+N¤ãœ4Âª›É¦xBÄˆD“ƒ¨ˆõ¢*$``i�!Xl±JBˆ
$ ‚ªZã�è®”ªbQmvâ¼‡ ïu-­	®šœµÀ¶ñÑæºoºøÖ¶{-»Ò;xI_‚BT˜H­Åªñ�±uß×Œ>6ëºîpm„9O‘¶UI� ªÝ‰›X·}nÙ˜ V˜:PÔã¼õàš¯/�Æ 
ÑtULëÊ>o;}Ú
�·¼[8k¬aúP@@‚ÂÔ€P£Q $j !¢‚âvZ�6Rs¹¸bÅYq©•™b]ðeÍ[ÉÞÙ Âôà^6„ñfº½n¦éº»;lçç~hÅ‹1„*EERR "9Jú 4	Óo�BT¸~�|™ŸÙXñý¡óó~Bíc‹SM¢`‡éî¹Nç]úÖÅìTÓoƒ  %¦GPÍ»r8¶®^N·Œ;;Ú·ÓÓîâÐ¥€éï‚åRöf|·ËëK5ƒoŽíååi¿Óô�Ã´\¾½¨½ï  ™Þƒ ¸/s÷ðx¨çÓëŠ·CÈ˜z¨K^j÷öX®ço¦|<)F	�è¾Ý~;-{8´Õ@Ó�@ B]ö5Œ÷‚ít–¾‹¶#A¥¤ï� J]}{x£ûéå¶2Ú»ã{7�>ÝJÓ�v§U'©!¤¨0ÝƒB)Y·æ>xs[Ÿ�ø!MïÀä°oKˆŸ·—ùå»çñ¡Ž•ÂÔ�Š¦ÿ 	¦Ï@)Ôt
ˆ¦ Aî¹ }3àv}Í±ï¢É€¨ )0"ÔJP$½…²rÉf¼7õõ2UÛšøÐ=˜r}^koW�Ñôc�ªËf>Ømz¹lú ±»N/§9¾¹óRL€y[0¼�åôò¼˜7wÞTÓ{ —i>ÜÝNß”kÛõ^¥ µœóýÛÏ<>}{¾={èž>m×¶=T·4µ  •óæÇ·Š×ç×¥m†¸d@ÔubûùÊoý‚áp0y˜Z ëmnÚw½¹<w1�õ‡»cx¾üúŒnŒ®€éÑ’‹zççå²H7övúnÚõ­¸‹þürZñÐWLÿ3HÅ¢åñhêëÓuïã($Èô{`rØêÔÝ;�ŸªL=HÕ}uÇCXo—Uš®K�é€ J™ØÖÛófF¸C÷&¯ß=OÛ±w–2õP–¼–øæÑ-ÏŸVûfŒ€S'é¯€Éa½åúî`–åyÞíã¡;ð|~ºá¡™¶zt�Ø?~Àëùã‹¼¿ÜaŠgê ª·e}|óúËï^ýÐÄñn(§×—uqmÓ¿íôééë	Cã ­SÆpßètº–ÐwV 2õ €Z5wmÐe:Û.60†Âôc¢uÛàz».˜¾�4…L=HƒºNu¸ÿ°ãã×OK÷xð7¡RR”¼­ûñÍ¡Ù>�Ÿûû®+Z¦¤A©ûûÃ¼žŸv<a3U)©Ñ}-8<º<Ÿ–I,ãÝ¡ÁóëuB3Æc»==]¨ÑŽo?N2Üuv'E½ažaî>âåÓ·úîp7nåÛëµ½¿s¦V5¯Å?ÞO|}RÓua‚©èºÿf´Óåôìš®+¬QsÞãc‹éö²4÷]CSÈô¤"Ïö~hë|9åö®‹
¨è6ÏføüÞ~÷íù»ÃÐc>=mk‹ÃÃ±«Ï?í¦óÃÛa¼�__Ô=¶Îl aX–5´ïûðÝÇ§�CsèÛûÀéô¼ùÇèL0ýPvµ‡!lûí¤¦m�ZSƒÑº\K|¼;¿>š×¦Å® …%o{÷øo—¯ôm­`ú�œ©þÎµ·ùŒ.‚šZP(™»´côÛrZ!ðÇû¸\Ÿ_çrì[«šzPîîÐ Ì·úÐiÈÂÔ�Õµ–n¹ÜNqF,4}¢Û¶óðÐÊürZÑºfôÃËú:›®�

š»&^§óÚØ„c¿æëÓ-7Íà
Óo€B­8FW—i.ÆD#šÞƒBQÖÜCÝËåŠ.4ŽF4ý� DKUÄ;lùvóhgŠ0õ PÔL�vÀ¾^®eŒ1T¦ƒ‚,Eq4fÉ³–¾qŽ"šÞƒÕmU7¼Þæ[¦÷ƒ�Ö§i·±ïß»_OzkŠ…¦Póªñ¡ŸôzšõnhašþÑº­M˜×s5mô´Y˜z¢%Wöó|Ñè}¬¾
Sà¼ó¾W¾~zU;ŽPjz
”Å1¯gŠ�¾X£©…¢,Õ�×e½Â5­
DÓ�@¡(×]îîº�>m¶;XW-4õ 9k¶æål»àZµ d¯K�cØ^_–<6ƒGÑô„°`+F³_ÎÓÕ7‡¡}½¼¬+ÚÐ?tÝéòô:‡&ÜÅ;“o×ó~ˆc!”Ê•î.¶Û|©h|oŠ…¦÷ P
3ã8ÊºßVbð0 {ÙÇëmšÅµfº8_O§¥‹£(L_�B)\ÅÜÅFÏ·Kt¡‡«M B4×Œ¡�¼Î¯5„¶¡Qjê@�ê–k8¶6OÓšÐxÑô» D¹®‹ºf»½Îæà[#›ˆ¦„°pËîÅ^Î³kl4 Q5O~<.çk†7ÝÃØ»ëé|s÷¾
…©ÑµLn|oýõãé$¸?{ÃÛõ4ÉÐFSi@r�V{÷e}y>³sã±koËå²íGÿ:·NÏºØYŠˆ¦�Bl¨¦mcÝæ+‚•þaûëùZ†cc…"šþMÂºåÙÜ÷QO·×-4�•lDÓ_!Ì²ˆº¸lçb3Ž"çëZl­d#šÞƒBÉu?¸r:Ïc;Z)—çZCl\õMï@‹®»�Q/—Ë¶÷ÇûPåõz^è»»&^¦ëëŒ®‰¦
4ý[  Ö¶‰m-ËuQ :»Ü^÷5û»ñxpëz=m­t0ÉAsÉhz¯Ëzc:g…¢é(Ð¢”®3.—y4N,AAÝÖÃCçÖËÇ57ÍPM_�‚‚²Û¾y^Oš;Ó‰I¿
4×-ûÇaÜ___2šæÐF»/ÓiéýÅ@4½º—Í]ôËö‰è|ôÕçôJÖ™ñ~´Ûåe]z;ZSÅHµk­þ®³e:ÛMoA�rÉ—!¾õnz9]ÍhFM=(Ð¢»ºûè1-§
ŒÍc£¼¼Üé»Ö€B�®uÁpÿ—écÝš¦÷hú
(÷½Øñà±OÏ“šf84®\§�Ûîïãàêy{Ê‚¦»k÷óyÓ6´A-°èÎ¶k¹oç\�‹4 Ô%çæXËmžò€ã±qûåú”·&<º#öyšÙ{Œhê@�­bÇF÷e™Ð»Fi%ý>ˆR–Òƒ˜íö\Ñ†qˆZ®ç™Õß†¨e¾L¹\« *÷Í÷½3ûödÐ4�(Rì-—ñ®uy:_ŒÜu^(¢©Z·�~<Æz�N FwèƒLó‹ò:ãTÒo€Íº3qÉ×óqç×|¾e„æ¾�¹¬/ÛÕÇæ¾i ××ÛJ‡ãÑÕår^úØ1
P—�qlÍóÉHÛ8oK@+knÛÎå¼¾ÂØÆ9 •YÑô–Ó~’2ÆT% €…¥†nÄR–ÛÞ¢ñVÒBë¦ÚÆŽX§I÷`ÚìÓZ´ª{2Ï·•±mîº°_®/€ëûÞ[¬ÓëÂèâ8FìÛiE�è¼WI 
XÍTØÜ”ëiª®mZ1" ÷¼«‡˜¯—ç-ºÖ;…¤è®»4Cãöe:;±­µFÍ»ë^.û«x8•ôXjÍÒ=ÒÞ¶OSuƒ¿sCÙ×Ë²Eu^�2�Ð‚¢2¶Še9ÍN0ýŠyûf«¾Æ(¨·y*^¼,¨{†‹£/u›sVÛô‡Øi¾�s}'N%ý«`ÝjÖ¶9j½-g¥õ¤“ÔƒÌ¥Hì;²Ü–Í _¬I#ˆªZblŒæ}‚ë<¬u/»ñCÐ2ïç`ll<œ¤w €ÌºiŽ½Ì§så<¬I(*•¶»ÊåvUµ¾ÕX%õ  cMÞ¶¥î­ôcÛ˜¹¼nËÐ†cÜ§©àÀ6@Äh@–*"cÝçiSøxlÁ²žr‰¾ëƒÉe½eÎ@k®&ôM+ëvÝ‹k|,Î¤ßuWxßzÑm]eiýŒÉyÚöàý0»nÓ­tŒ^|IÖÌ*MhBÖu[cBI#È„é[µy½è&ÞÞÛfåü¼ûÎë`AÝ³uqtà>ËàÚ•Û¼Tƒàcv&ýPÍŠb,ºç›
CÓ_·ù*ˆ¡+é'P]Mmãà7Y·¢iœX@RjÍ€¡!Ë:gV«Î—\ÂèúÎ°nËœ-[+N%}ŽjWÀ÷aÜíyºJñ&Š$µ T»JuÍÝZoçŒúÎê¶-“ŠoéÁ4B|Ì,³ËôÖ[I?�ÕÜ…£·ë¶Ü�³NÒ ²jÍ¥ëz‡yû¨ù¨ÞÃÐHú ÕU²½K¾èÕºØ�•¹Ì+Åš±�yÙ×@ÆäŒ¤?kÅ¹eÛÖâ­ñ££,Û¹Ôjmc,�¤÷`ÍD�¦5EóM1rhì\NµÀz±ÉIú·¡ÅìÆt^Â,{)Ö‹WcÒ j©PÛÄAÊœ_PChÓŸ�šÍæ¤õ�ÈÛ^vgœ‡�ªp�w¥NÓV¼íú½L‹Él  è|#¢y‚¬3jL¡Üe·®s™Ó®Õz•ôg «Ù¥´Þ;Á6ï›GoDÒ_ƒJµ}ëöº-iG¬Ûd
Ä1ÒHúÕWjmÜ±1Z×K•ê¼x€5h}·Ëº,kÃA]	¨;vç†àY¦¥"¶Cç±—iÚÍÖº'„1Õ»Î¡nyßMµÖÂHúMh±›˜¼U-SVFª1é�¢ÁÐ¯e^6ÐÛ ˆP$}TY„âì@£yÙ²"FzRPÌj$¬3e¹^%‡H¯4éû (u¯4.ô¨œnKõ^¼£…Ó�$T³Uq­œò¦µëÄ`ßöIècpº^K6Îç%ý6(PRÉZw†¦G¬Û¾Ð•è�€U—bel¬.û6!¨õp–4€$�jŠÀûÖ;äåb´Ä`DÉFÒ*Ar\ìÅæe¾Uã¬$# Q=ÀšMi\t–û~.RÆvÄ†é¶h¨1: , }ë:,z»J‘Í.B$ý» BÁª»Ac½)e[jãœ3”ô!9‚5ÃÙØÕ�ó~öÕ‰3N„’þ=�TBªYE|°­Ó-|0É	E$}‚
­…0±õ†yßWƒ:B(’þTP…šÅH+ÞÖºï{%l $cµèšÞj¹M‹k†®EÞ¦Îšˆ €’~
J-0›¨…ÓºCŒ7ÖõÅ¬^b�nyŠóN�B ¦?•
© °‹¶`ÞVF6ÖA¨€ÚØ;”}¾TGë-�B’U4¨Épf°­ìe¶œ´¢I„†(v‡¸Î;ÕåºmÎv½-e�g[�uÞ@ ¦? ThœB”¼Ofg¼  ’HŽ wÉÞ‡h$/ó^ªwVÄ¨Š¤Ÿ€	AÆÆÅó&'6P¤¡€ 3FÓí«¸Z×I³ñMsY§	›‡¢"�é§ ”j±p¦/¾h¨8°Š@ÒRI£Åì.4Îåº–¢ÆYc‰@¡¤BÁâD¬3îãó¿gþ1ð;¿‡µUB„¢A�¡!DE “ƒ ¤(Ò … Ð¨	¡ˆ
”&BA¨` ÂP@QR©ª$À¢ŠzP…¡B…B	(!5Òˆˆ1ŠêÀ*PB(´¬ªŠAXX5B²øâ©ŠPDE@‚J!„*ª�RàÄç Í€P ë�ó µ˜b¨†Fh 5„*P’5ÐXëM‘lT	c¨ÌJcšd™8q6ˆ¸t !
�
Èô}P5C¤5�Öù&™ÁoÓ¿„ÐPŠSOÓ=ULÑ6.›Ew¡7ÞHò @‚5›ÍúÐä<Ï²;Œ:£%¡"„�BR˜Þƒ`-Tº¦ëŒ™ó­”Þ9oÔ&
!…¤0}	
µfÀúØU™õbŠé“E# Ó�¤@,­Iï@	¡¦$UD¨¥,;»c„œ¯0„(p¢`r !aÑ}—ðÂ¼½N2ú�Ñô‚€P0Ý�BÝË&ýØSÏçµÆ‚¡+žéK�4$ ¦XÊ²´wCƒëéºà¾ï` SRh(uB
jÍsÓ¾¿³ù»oÏ¦¿ëƒ/Ât
*P¡ $Àt‚*€�¬ EEÒ@H!Á@ ºo{mïG™¦Ok{Û­–¦P°søê¿ýðŸÿSlîÑõ{5Ðô†BHÖHå~ÕpX§ËÇ]×8�¦LB) ( hzèr-þÍ=^^ŸvšÖ¡L?!Š}]¤;<Ýž^Ïþxç\‚‚SU@¬3ªE<a$ý!H-uoÞüÕw§Õ=öfR ¡”ô#¤QQOJ ZÖË¢ã»·]þøô
éEq÷9úfÅClâá~ÎóËÆ6J•ñ±ß·—Oó~àîú~]®7mÞµŽ¢dêAˆÝrwß™éòé†clMqê$909E=˜"@—)‡ÇÆ¯óë%÷>úâ(LoA’×kl¾|w˜ž~qêºïwÄ0ý¤‘œçÜ=~°ßž¾~]>»³«­JI?©XŠyxìùôú|qpÈô7@ u»HÿÅ÷ßáWÿòà³‡˜×
0ýO �½hüð~ÜŸ¾ù´ÆûÇb2H÷s®or\ñë¿œÇ»÷¨¤¤�  lg_¼¯O¿ü„·oŽÜ…JIˆn[ÆÝñÀÓù´»Ö¸æàÃz}Ù}£-¦„(óRÃØ»z»Ýj×xÑ
¦¤�.§ß?>à»o?ÚñÝƒT¥¤¤‘šçi¼û²9üúeëÞßE”’~BT·]ýñàëõEj ¥�\–ÓÚšÑj5ÐÔƒ ¤Ly}ÿåÛ¿ü‹__¼¿“€*’�uy±í‡õç¿üÕË›w�˜ìî À>U¼ýÁ;ó‹�?yýðØº<J¹agÅ¤Ô›9|øðÞ¿~÷ô±½?8ô­ÓÛt[¼�¾XhêAˆr+ÅîÂ~{žê¡íŠ@SB´è‚öØÈt;�¥ë¢)¦L[¹ùî{oíÏ_ÿb’þ8 ¤A-;qöÓ”¾‰húï@P°m×¦ÿâ‹¸~ýËÓ:†µÚ$5PC“ó«6Ÿ½íö_}ýõ|ìÑ?ž_}>ÙvŒß”|Þq×4¡L
ReÙxÿîùåi³ý±©ARAA^OåþŸÿüçßŸ½ñÈFÁôŸ‚4¨Ë“?|ñáô/þâWß,Þ¶º@”’~ BX÷erÝ{�éå›W;†ÆbòzZýØ¶Mÿ�·œÇC[æùÉúCcQiˆu�ìp°ÛõeÓØôE é@ˆrÝK{hüºÞVzÐ ö¼àpŒû|»hë¢ÈfHÍe©Ã]¬Óåu�Ýhe7ÐôWAˆb/›=Ü·z»N9v½@@¦Rê¾Çû‡azúøªf<Z€Àÿ_¼ìêº¦e¾ŸçÝ}›3ÆœkÎYU„Uvª0H °ƒ4£‰›†-ÄÄ†Mº6ìˆ&&¾á<ÏÃ†PU«ÖZcŽñï¾Í»yn¯‹ÒíŠáÃ³\¾þjy>Ï~ˆ	û^îŽÑEŠXþè}/áýÓùÇ·¯¿…¼ƒì
Ë¿B¬—áé>Þ*�á ](Ì@@l¯oþðáØ–Ï_½Éñ0Õ. ó/‚B î�4œðÕío¶}ða’‘m)o$Õ¦Ø¶å‚9$*(Ì1ì}“ó»´_/�âÓÙ)T,ÿ(°¾QÒ!é¾^«Å1˜VažA¡4+-œŸá¿½¬õœ¦Ø=…ùAˆÙºK<Ø÷7çáiîëËgàé ¡˜'P(†­ðùýI/—oÞÒð”:šÀò  ��êÎ‡ããí¥ÜÝ<Š‘ùG  �KÇóyÀëå²ºã…
Ë#(0î„;nß^7œ}ˆæP:Ë¦çSÚ·¸³ÎZ�Zþ(°f›…÷ÑßÖÛÕ†Ñ�æïƒ«è!¥±—åÖBŒ*–ÿˆ•ínÇ_Ûþõ_ýÆãs8,|ûü¨Sœ<¡P*kŸ§P×ÇêÇ!Q«0„X³­OOG)ËëVŸ‡è¥A,ô½ìóÓ	oŸ_—‡“lª ZEzöÜ÷Ç
ªÄ§iàeù)ÍÞUË_€Bá^o:}Š¸¾¾TS3R˜¿Mº—C’}ß×]SB€å(³ºÊ|>mõ¶í“;:)"–ÿ˜­{çÃ¸Ýn/j‡”Ì4ÔŠã�ä~¿lƒKbPZþB¬/eOïÎãýþy-Ó<;W–ÿ+((ÜáÏ)Öõz•”bê�bù(°¾õ}8¾wûíúhaŽƒ@Åò‚‚ÞªÙie[_êêBz:ûýò³G=œ£')Ì@¡˜•ÚÎç‰·ÛÛÝÅ”<š0O Ä°÷óO¶Þ^VŽC:„iÀõ~m'“@Åò— Ä¸mŸGÔÛËŽc½AAtîkœÞEÜ®/«¦Qœ‰åˆÚ:§yn¸®Õ‚(Ë¿Òywõø	áåó7÷ÓÉ›šåÿ²ôÃµn·•aL¡9µük À°³â0=Õò¸TNnµü#PÐ¤Ÿ‚Þ–{›0ŽP
 ¶Ž>ÌÇî–G‘”¢wTËlV7÷CÝoo&'?·ØÅòlV7=Ÿ\Ÿ{Ôq bè®tÇ Ôµ˜É *ùÀš5ISÄ¶Ý¯ê½Æ	½,­ÂG×Uò¿åt~¾•ËÛ›ÇÑ‹‰XþEP(¨\›�ç¹î·×Î!ÄisùZé»×g¶ÝmÐa 7 ¶·Ö‡áêåí¶1qb0«}s‡4O%,}©âtPÕü�a¶‹ãI­¬ttªbDC�qˆ©Ú¾&ïµKþÏ Z-EæóóRn×V†Cá@aþ>ÈÒ›ÂÑmÛ¥á Þµü ÄX·ÒÓ»qº-—oöö4ÌN]Ølon>'l÷ÛSRñÌ?‚YÙ€ø¬¡,÷­\Ëÿf•êã(¾pk-Á«ÓüÜm5wŽ£¬�—G?‡0@Dò/�9 ×Rdx>I»\‹ÍqˆwUË¿	‚j~g³é0¶=>?lJ7KuÅJÙà|±[-KÕ6«xµüË Y%,NÁs­0z/¢ù{°^z‹ir&u¿oCwó0eY»0ùè Ê<ÃlƒùéÔ±=¶?ôh’ÿÖÜ.ÎAKÝ·]‚D¨äï‚d)Ûï¼¬·o÷¦8‹�(½w¨8§ù_‚¨ÖvïO£ãöxA;ŽCìŽ’${AiH­·ºÖL$Ï04‚;D¯µÝ»ÑÆáY¹¯Ë­QƒIþo ¥»ªÍÇ}Ç}{xøSðXÛ¶v‡”DƒåD×ˆsLŽÛcsÍ4ŠŠæ_{¯|òâvn­+œwNòo�B6i…Ãq»o³ óôµ¶R+Äˆæ?Ñ]S":ïi¶îÃøq_¶ÍÔÇÑZ­fŒ>@Eò? ÆÎÌÃ[o¥ùà’ÂçŒ�¦’ÆÛê‚ÆA‚ï"ù×@CE5â¤VËHA£¨
$Ï`Ó*1¦ ðÑï¾¥hNóƒè¡9£÷ê ;¶Ýœ?Ž}¿mÎË˜’ik¬ÝpN!�<��Eº¤A]³Òv‘éD€.ºîÚ^vÛU$ÿH6q]“Ob¶5ÔT‘<�¤UÑBPéÛRª3/!ÍŠ©S”ÅÊ¶�üÏA‚½WÒ¥0¢®·»¯ãÐÚÑ!-8U@4í¦I‡®¶ôæÛ@oJ‘ü4XoFÓ„¾ï·BÃ„DU@,	ö&JŸ0t·—�ôè;ˆ��!yë{Ù­Eç Í¿›6‡A½J­K/^½W1¡õêÌÅèÐê¾öÃ�X+{aq P°œhlJH~IZSL©sï�Ð‘\ìê(’´Þ›JHˆUJi*Á‰ƒ$ÿk ˜$ÒújuŒ“k¶^whL³ßQPwª©ó*¤@òŸ�@öÙHïŽa\°–»nÎß• "„0˜pßKï½9Ðü¤¬¹Ÿ,Vn”æÔ«=Bò$H¡“Ö—¥H>š H>�0ºîÝÜ4E¶åjÍãÉi«uß›©¸ØDò$‹â4ûÆýV‚:M
À — ¬kœ#ê}½v†ä�ï
¨ˆ˜ÿH€�îÑcdÇº×Íy¼Q,ˆ˜Hþ„‰nP�fCÛï…¸�½ »J†0	¥ì÷ê-N>Tn½©‡W'0±ów@Â”ì¢]Gõ¾”­o%ŠW‚
H†ÚÍéÇÚú…Qƒ‚â BÌ& #Ð={Á
9Œ¾ðqmÞE7À›‡z¸z%ÿH¡Z$­÷Òœ;ŒÚËc]5úè{¥9u�FRòß�	M`½5ëaÜº/·]œ‹ê4¡ä_�Ù£ÓdHÑµÞ{™"ù‡ Ì@Qén‡z?yØ¶l$ëÕâ(’)sÕàã˜¼nõâ0�ó@©e-½�	ÍŠË¯þå¹“ RR 
¤�

M@ƒ€ˆ‰ 	‚4Å@!€dö `$³‡ˆPD µC� H©T BtOöUo¢fÖ{óì@"¤$ PÄDh‚.„	!@! !) @!)R)-°“ÑhÎy‹M›huFƒ@<ƒ¨ÒªÀõN¨À�*€ )F1À„BÐDè›SQí¡¹*®“¢*
P1L`Âü	¡
@aþ9]-…âÞîûZ]¢!»ëœë(Ö T'ªÌ?Š%˜„Ö«9ÆC ë}Aòˆ&Ì	ÌB� ó¯€h¡Šéà#¥öTß= ù(=Ý]!V+Kiê<¼Wæ6­¢>…È¾>´@\JP¸4šâM 1ÌRû²-Iƒ÷tÊü¬º	Çt0¶õ³TDŽãˆì7'*º˜ckßþ­÷Ï__–Ây˜}è sAŠ °²Œç(¸¼½‘Cü{}¹Õ9t¤Ø^÷ß�(×7qqˆÁ˜g`e)Ã|Ôu{,2�>š@énÇy²²ÜŠ|ô
eþ,ÕZz7Þo×�l‚„ù�•iš'´Ç1îÉ}‡·íõ­ú8âŒDëVÓ|Ë²<Ü0¤(ÝÁò¸÷†ñì‡²¼®ˆ.¥î,@!Çytû¾4çÉ4?�¸Ý?k¦äºS°—²â|:ðvû¼G?…Èæ#²îÅÒó!Þî—›øQ4¼ÖÇýÛÏM?¤$æ ÒÊZÝô.ÕÛòãG7¹î„ù ¶÷ÚÇï·|8ª� ¤q1{zÂ~ùöÚéÔ©æRQê‚éãiXo?Ùûñ4© s³‡’ óA£À›šïŽÉO (,ËÃ?}oªõõWoƒ¦8}šÏëË�ßöqŽ}~ÿ�Yÿæå«tx~çŠZWŠ�`>ƒ€X)¯aüxš–ËÏ^bô†ñçÓñÇ?ùË¼:wì0Àjgœ”ûýÖ]ŒÑ<…y!ìû²�OŸÞáåú3Ã¡2}úÞ„×—oãéçŸ\í‹’ÿ(0le×ç1µÛe+³ 2ÿ(ê¾áðly]Ä½½@Àü¤ë}	óó“^Þ~úF§õø�Czüä¯¾ÝÆiOçéò“—×·øt	æ¿B¬ÕÒ‡w–ËÏŠŽÃ â`y±²¯6½;àúv_Âó�ÔÌ?©ÒÚ}=½7ÿôë¯ïËq8‘0ÿ¤Û¥ÌÏ+í—ŸüøâÎ^Ÿf÷zùëË68‡�Ú# îKççÔ^/¯L‡ÁI˜¿B¬Ymã³ãºÜ¶„M`ù—a
öR¶éãYË7_Ý1C`˜g@«¥¦÷s[_Þ™^DÀü	„·mõç°\îÎÂ`ó¿éúXcú4‡Ÿ<~ò¦ó�`þW ­;L	íq�T)ÌP`Ü]ŸÓdû¾dˆº0!ìe«áð^ëåõÞ§pt�å?ô¶ë|ždÙ¿†óih–?ÁÖï+†�³\_¾^ãt
ÒÔ(yAaYïñôÝ§òöÍmO‡hUŒ’ÿÐÛ5âÓq*·Ÿ=Ïa>�“]¿)ëN�MH%ê^p8ŸÊíþÙñ¨þé8µûå§w9Ÿ4o^òŸ€Ù£”Çws½^~º·÷C¢˜ BŒ¥ÐGØý±ù˜¡ƒåßéØŠ>}qê·—m™ÎSÔ0	”ÒïqúÞ¬·o¾yøwÃ¨M�’'˜‚µnÃô)âõúUuFïº€ùK ·²Íïß{|ýr±ñÃ»t€bVþ<‡õívÇMH‘†îioEŸæA”`þ
¥á¡Ã!6>-yZèÂœA ¶”êŸGÝßVáâ§ƒ]>ßzœf¯›Àò�@!›YÇnõ~C‡ˆåO ÄPöŠã»¨×ûËŽÙÂqV»<^K˜ÒSXþ BÌ–º¹çêëËV¸ñiÆzy]êÉ|÷æ	„˜íÅâa
u»î2L>…å‚B´Úm>{Þ—·†§Ñ–¿B¥>äønÞÖÛÝæyr�ù÷@ˆÙ¾ÐŸO[}»½2¼O^º“ÞýtÄVîJb7aþ¤ôU‡w£n—ë…ó8ˆ8Xþs�b÷ÁqÚ×—ë¾ù§8=Íl—Û­ÃQH5PXÛªãÁë~¿B=ÒéÙÜr»\çøäÅ52ÿ(D«Mçg'—õºs‘¾
óAˆµº÷ð|äòøý0¥€±ü¿A¡ËC§÷‚õ¶nÆñ|˜Ãëõ«OÇ¤æ`ù#aãÖít^^ïO“P˜ÿJ·ÒÒñ z_aì"–ÿX­{Ÿ�º-Ÿ×ÂÈñô.áöíÛ½=�Áby!ìmkœßG\®Ÿ[N^ÍÄò@›t¦YÚu_û$ÉSÄòGP`,­ùé4Øãq)˜b±üJ‘ã“êV>û>�P±ü(”fkwçCÜÖ·[ÕÓè}W±üAAE÷zÒ´¶˜bôpÌßMZÑyµ>n›§›Ž‡A·ÏÄóìÅ™XþP`­·.çƒ+×Ûg„i´C,½”‡ó}|6Kiô"ÀÚÒÙÏëã¶öYÒ`* hkmÃ8÷º¾•5…êÔòo�vVÃ|ôäå¶«N�Ð| ìRŠŸÏØ^/WM!zP²Ggïz\)Ë%5�$·º»ù¨¸/×Ýa†Ó&°Öw¸÷cèßÜ/û0'/â˜ 
Ø¸·tÆµ>ÞãA4ÿ:(h(¦§ÃPÛõÞe˜|jöhÖz<žÇ¾_‹øƒŸÌ›e"ÿ.(`·ÖütŒ|¬ßl2§Þ$ÿPÐKmHÏin—ÛÚ¢®å_Q€à¦­´R‘‚7ÉÿìÕÌÏCDÝÖÍKŠâ X)[Ï~ÒûújL“¾)È¾±§áy¬v½”äï]—ü; íuÑù)�Ûë›`
Q|S]Ì\<ˆ«uYšT¼äÿë›íqze¹^µø�¢Qk‹‡Qû¾­ÉQdƒq˜’´uÛ× #’©äÿ «¶ÑŽs­ËËÍä8‘xl×�Š‘üÇ •²Ë0Ÿ¥_ïo*Ñ‡`¦’f{c‡1îû[]“„‘Î$ù#ØÐáÒtè¥ßîæÇ'—P·-õ0xG'ùû Ðü„iôÚ·[íÉMêà)Ìÿ„YéÕûá€Ýî�ÚGq©ÉßCw{ŸÎt¥l×Ñ)cè"ù?�¬û8Å^÷Ûr—çñÐ[{Ü{;avžŽ@Ó$h¶.+¦ðä}\î�ÏN¦á<�(ëýŠqÄ ñBÉÿÍš\š+j»uÔx@ò/ 6B:ÊXêãnæ|T� è†ptÑöroƒã�n¯·e™º›G×VÔæ‚* ’„¡9âZÙ¨§1Í¿‚f…ÝË<†bÛã/ê©ù×`Â^P4IÍÖeõÅ{/tùG h½=é «ë­X�Ac ù²iaÆA{¯gˆê Hþ»04W�$— ³R›Âyq„äÿRì½z�Ñ­Ú
'Î«�|A tí:¹XÑ+›KáP­–{%â8NÍmëcqpNsÑ\¡�!RËº¬Íùƒ«mÛÖ¢2Šz'É¿¢GÍíˆÃe/û�)8ß”’ß�èÉ­’N�Q¸•;Ô©&z É_‚½÷â4L
p)M Î9%¬Ûé‡¤m{A³÷€ä
‚BQƒ	)ù» AXï4©nõ±W—º
¬—Æ8MÞ¯ei:x	])¦êâ4·®uH¢s !ù7@ôÈ^)	�÷¶Æž\PGŠä_…&€UP|RkÛýá-ºL f½"ø!F³½nV�Fªª‰äw ‰Å.Z$¸1¶ºß––†y2Ùö½”	’JHþudO°
œiªØê[1	sò�}ÙïcŸÆ‰ÚÚRwxœ‚j±»æ]ô±£YÝ}ïœHþm˜˜7«â1iBkËf")%-¶]]‘ì�ºü=42ÍL�¾Ýè0Dõ Ì3Ø{‡$õÆb„‰8PÐüî»Sìx,Wø8�^ö}Û‹±)a½jK)9ßêKŒç	u-û±M¼AŒ H>ÀtäŽ"nž&ãýÚû .5¯@wÅœ›üVn¬æu€ó$X^§Àý¾
â9†j{-U½ïEÄ”hD÷¥Ç)ôRm£zsjj� hD€ƒ;Âd]6Çˆ¥<.Í�á)J]Ë²1à8Ž“µý•–¢F¥Âüó i»lÁÇ1™­�›«ª!P½A4¤Ù×í¡â½§W�ÝuÓ”(,¥Vˆ�üÌÒ­SÃàõœE—š
&’¿’VkLÓœ¬<%$ï]¤ì’=L¨"VÙ›üà­lKÑ>Ø¾¯ìn<JÃzÝÚaŸ‚s13‚J+4M:Ðú­Ô¦n' ó;qì¥BÃÝÞ�ªÇ!ŠÕmAtÓ8[·µP��Ýu§Q;+(Q
zƒ¨Nq Úúp-8/ŽB )¢u±1N®µíÞ!:G
)9€ €¬4§cì®–¾µâ�‹Maì"Hþ ží±oNæiÚ¾ïMœF§4ƒe¤kßTR8Ð¯[Ü!�þÁeuÕ¼N�ìB‘ü0kŽÞ‡¢f„BE$UcJ­õ²zK.*�’Ï Xm;ÂŽÒ÷ÇÕÓ<)zÝÂûƒÌ[mœˆP Qdí~s¯ëÛ&a:Í³ñ¾¾Ö1†y;nû%íÓ0�îýñÿþ?h.ôBASE      2è  xÁA  ƒ°YãxÔ þµ,9m1!&cf›1§(-TÂáBE,Ò¢ÑBE3V¤E£¥2'0+´–”lÛhÀ I5…¥!Ã,C×ÔFCÚp¸¶6šÇB“Td²Í²d2Õ—¸aªicf6Öe‚PŠ®ÍšÔˆm³	Ì–JÂCfY“9Bf2T‘Íi2‰á-MeM„(KW*À¦Î6³5¤-#’i6P�S™Œ¡"†²¡*2±ÉÚ&¨ŽE&ˆ-e*ÚZ‚L¤2µ©Ø6•›LQ ˜¶!¨C™lXV*l0…)Ð&YÁ6Sd6€&ƒÐ`[Î)“5¨¨�IÃËÛÔ™CHÐl£ ZFÛ¢,0ZÍ´
g´6ÂÙ¬ iµ‘4£f©‹6+©z…fäBPOS      î  xÁQŠA E±§ L×Í©tEþ¸-—nò÷ßŸoŸÏçûY¿ÏžçÝ3ýòãÎ†Ÿó<vöõåqÞ�íaÞ³õžv®³U»vívîŒ÷=9¯TÛUív®8½ki’B©£{ªºÏEœk»®Ž+r¤X¤åžr.`[Ýµê45a4qL èh@ÎdS ÇÐØÂÐÓ,`L°i#k#`0CÌhAk #ÀÑ€Ù€`€ÐZƒA3�ÀhÁ4­1 3Y@ƒ1¡¡AØ€%LdXˆ´Ab,ÄXk !Ð`(v�"5Ñ�ZJ‹¢Z!,s-±k2íÖYË4,hš¬ñÜ±ÐÒ€5Íþm·/ãCNF4      ¦  xÁQJÃ@†Ñ/NcÓè@% ÑñÕ¸�»F—â*|.ô%(­Rk‡„Ëd<§z‹`¯3N¦“*WUU(BÙ«‹¿Ê~Ð·ÇÝáy› =~†%	y#èiHx'¨©P‡“bÏ’o:›“Ð3ÜˆiHÐ™à ÙœžÎfôplFOgOô,ëñ›Î
¶#{ÁeÙÏ&’ds¸¬Å‘—ÍÈyD€ì”Ô ŽöÛ«íä�„Àå‰ûŸ°È[Ú¥×!6~q§† 	p¢Ö÷8ˆ�_î¢Om#Ük6«QÍñ7õˆ#ÜÛQ)î#ëiœî€š¾aq$}YÁ
V°‚¬`+XÁ
V°wþa7‡ýTEXT       Ïó   xÁMnÂ0Ðï(s€ÄšÇ6DÊÂI,
ù!
ÔU…e¡‹ªçï{ã�€>Ž	Þâ´ß�ˆÕÖ»¬©Ä!ÛUÎk¶Ta³ÁiŠÄ±„6.	×çƒ”ép{KéŠÒyRV¡ß7]ŸR¦ÃíElKÞ–HYóyl¡¬Â¢lX\á<å¤¬Â¢lØòVÚÏ4¡«W,¯Óq
kÝ.Ö|¿ïbó�Xïó©É…Õc8¶=l°Œº‰=ºÚÜ¿~pI³ 0ŒKš]Mbøú4šCLIP       	           Bh     B_®ZTR

SMP4      =ÕTd  xÁIÈömžäó¼†ÿxß÷3¼Ó÷}éê¡ª«MÓ©îDÄtºÓ‘;iÓBÄ¶"¡#FWj)HBr¡(d#º’ìEÁ¥ ƒ`C¦ªú†wzžçþÃ5üN�ƒÿÇÿ
¤ßƒd1FÇa§ãéx?Ï¯§þøêÍ—?ÿå»w_ÞÿÜÏÏ¿þKoß½ú—ÿÄŸüÕ_ÿÕ_Á�~Œ_ûåÀ?K>ü8ÍøÓ?N¿ ~œfüø»4áÇiÂ˜\zÄ�SÀÿ•"þÏÿ÷ÿþñßûGÀßûgÿð»¿ÿOþŸoÿÉ?øúëöÓï¾ùçŸÿé7_úúr½¼<?Ÿ¯ëù²ÝÎK)¹™Éá/âƒý¸ýð?GûŸQ{@í	£SŠ D#G#R( È  Dt@"$@"d¤(9È��ƒ‚`@Ð›ƒ7:©YkME8“#E3BD 4 "%)�h$
$�w„©Õ¦&‚r2R" É$#�ùFo¨]k& Bh J`c@) ”	€  ¡A‚œ<œÍæL¾šš5�T:BjÖ*Cßjk¦«^.6W[Í&õ}ï´ï7sÞ{Œdú5j-{óa‚ÏõÌÜ7ç<ÓoB„ÕºAq´¯[u}Î›7U¿3„!ÊŸ·¼õ˜¼÷+�C/ßª­®Fï½Òß€ V7Ìp¸Ö¥E�n4/µ²šç)ÌõÊ6ùˆ®É·ô‹¥¶“±özÉD¤÷„oé5DX�oC‡Z¶½©ôé·!²µÌá€ºÖes7�÷ëÏK¬rPmÒx:tõéÓ¶lýØOÁ•¼Ôìf»ÝVÅ0EQ.½ƒµ�1L¾åu)£§oLÐ¶Vúñp¨ëí93ô}Èô ºmÎ�^…uý|…¿�±n}1¦7@+¥ùùÍ«V^>ßºxié·!ZaÝ42o·\g4GK¿4JÓ°nûmŒ>xÓ¿ÐÒÚp÷®Ï/>­Ã«{ƒ,ý6 ÝÌÅ×GéãõÃÖã<Žµ¼ì·½ïïîÆîº?/èfvÕAÚuåá‹;àò“àþv3Ó/@j˜cwÛÏ7ôGZú§)€@ Ú­ºîÍ±{yþögÛùp÷®sëùú¼»úx÷èâþt»tãÐ• ²-kŽo¾×ãý7ß �¯ß=ŽíÓåC�;öÊ¥¿É×ºn˜_?¸ëç7Lw£j%-½�*Kýa@Yò­ï4dúkhÚË~œO·µMÃ´„*¥_† ·cÃøêt(ç§O‹Ãiž°,ŸKŽ¾IIHo Ð´×z8ö®¾\¶mt|“ÒŸ…@k[vqŽaÛ?•8ÄÎ\cúkP
(µÄÃãëxþöÃ‚0ïâñúôñ‰óÃX-“–þC`Ûsë§x½žŸòx:¨B€
ZålÖÅÞ‚¢QŽDÛnhSdcúO 9¶›ax<àòüü™Ý<V	€Õ5÷GÛö\Zœ½W ¥_‚H´ôADY‰7¯q{ÿ|»ÆÙW3HëRðÇÞ}�§o~†»W¯cÍ&ÈnÜ�cmŸ_ÖC72AéoB•kˆÓ¡Ûö—Õº®#HK?€Hk¹wr¡]Ë†1D™KX•ïOý~þðR§Ã\!0	é/@d­+ú#¼ò‹ê!  9ærÇ¯Þ þôŸƒW÷oh¥	J?‚ ØZÊñþ.Øõ»g§;úLZú@·¢îáaÂË‡oÞãîÈ¢Ép¾;xûîzæasÜ‘»Í¯îüËóù³'U9°YÆ1Ú¾ßjðSg¡2 °o9žÞMöÝóû_�z¬ ÓoAdq«pï°îûŽnÞ@™ÆnuÛsu£Z äNo¾Âöáëñt”¡1½ƒÈZ6Ã�–_Z™†ié¿‡ ´å¢ðå»®¼ÿÓ÷ãáñÍÑoùz+­ë‡f¢¥·�|­KmÓ«Wç�?sîtrl�–þUˆ ò&÷ÐáÓóGÙaêU ¦7i¶åz˜3nŸ—[&Ó;ˆ,~u<t\÷¼3Ñiéˆ¬Yì�ÎÛš·àbt-ýD ¥æ8}ñj\ž¿ûô„y2\|KD¥VL_¾ŽxzÿôÞß:¿_ó§åÚB3ÑÒ_‡HYÉæÆÇ×´ï?[œéié?‚Z6½³õ¼·8º®oéD¿ßÏ@.+CçÔ¶]qp½9Xúß!‚U+ÆÓCÌŸ>}¸ÞwÌ¾¦ß€H«[‰<õ¾ž×-»±wÓïÃjFèbk—vÎ
±Ÿ‚¯ûznn
Á7o‚ÕKåéñûó§÷ÏšOÇÓq­ûyÛ0t”¯éoC¤ÙÚê0‡ýz½½¸ØŒéÙÚ¥átÿ \>?Áß�‡
*¢óSŒk=t>F3¦ß‡l‡Ã8¢ä}…áÒ!²•NcØ¶Oeç0x–þ$Ä¦¶wýã�^>=ŸKwêãŽ¦t€T|?Ömi†)|Ì¶®ÅuêÁ¥¯`¶»â»n[÷èÇÉë¾ƒs¼¥wifó8h_ö¥ô±WhL¿hW«Ãüö—¯_>^ºq<Á®yÍÀ!º`LÖ2‚ï¦jÛÍš†À ŸÞA0ªÖ-úÑÇª›å^Î{9*µj<¾q8ûiÅé0¡¤µæñpÿåéãÇ5ÇÙo0‚éç!‚h»ÐMÝX÷í\ÝØ�rp´4@)¢´5wG|:ØOÝÔâN¦ïCd-gµ»ã›CX_ž÷8M£÷jÎÒ¿†ÖßÆaŽh×¼.ƒ�A¾Ñ¥?	©VCwœcÆÓå¹ŽÓ ìôJÿ„ ²b¥Sš½ìWhûPÛC´èl¹šó§ãÊËÓ­L÷á¾Ð¶mÍƒ��…L"Ú^ªîçm½~Ê0ô…"ÀÔCR±’ãp7îöüyyió	y‘é5Ë°:Œ£G[—½rð!48—þ]ÈêæjBuûºQ;tÓ;ÈênÎ5¨íµ2ô] }:ÂZ&b?8Ù^¶z@L©¸<Úm_€è;Ñ¥ÿRË® Ÿ„·*]�˜Þ@P³LïºÎ±ÖÍ,Ó¡ºÌÇ†µ-VûÞ!øôCH®òà°—\*bèD¦EG£$(M"k]áã8HË²d�&¶²×8ô§€¶_÷Œ‡1°î9·=;G£]ú�¬íj]7�}Þ–uõ�ï\0Ggé7!¡µ5ä©æ›6õÑ{O€iD
ÊÈŒýýÖËçíeš�wÕ;‚éÏÀ¬Õf.ô®±¶LöC|áŠê4�¾S]¯†0ø ç+˜ÞÁ¬ r}FÉB�àÒï£YÍû©Âr•Gç�7¦FÊlw¹ï&[;×†É=¨ÛU3ƒcGÉ€‘FX] iŠ'Ôç¼eïÝ ÒÖjs¾cÈº
æûàÌêºz#££�.ÝCLÕ—ÎÍ-ç²yôýhX�K]ßy4í«)ûâÁôG�IÅg7†²=µÆÐEÓïB¤Ù.iŠGç´ì›1ô�÷@�9¸0ZS.­y0fçÒª-wèIXUƒc„(SqM¡ë›ßs.ž}W[nKu5FuÍ9SÉÁÕº„:O‡�unò=8gÖZîØy+»•Þw�·-¯‹yŒNS„@ƒ¬„±�ûr-ÕuŒž®‘Rê!²ÖÂèûÈµ‚Œ.:9g¨~wêÝL+K]‰1öNÍPÑUg^éµVú7´µ"zöÓW�*ä1ùÎ–­ìÞy‡@±Æfˆ=bÑB!8çÀt„¬e/7Änñ›íˆžœ7˜,‡†>¶º—RšŒ½Zk[Ù£W@Ó†ê7”©F-ûV­èˆàÖJ°èú˜-—‚ÐMu³
x�ˆNL?‚`‚¬Vx?4kõæŠ„ GHÕíÁõCWµï}ç' W-…æÍA# dV®ïá[±R AÇô
!ªí~ïb7uß²wÑuN¦	&66µ,Žqê¸Ö—f!¢
 å-ýqH"¬W1t¦Õ®Mž³&×E9³•òæ@ç¨ôÀ( 4+è8F�ZJAìIB(1õ�˜‚(×Ôj|¿¡"x€ª›åO‡ÙïëùùŠÉ"˜‚cc…K¿‰2Éè¡]èúiäº¯¥†ÎGó’µš½º8fä«Ì�é©V3»n0§[[9xç Zw†8v®-Û¥Ñ…Î98’ ôëHAlÖJÅàC½UŸ{×A0:¦/ ˜h@Ëðè»è¶|Îdç\,ŽfµUßÃ—zst>4# ¦ïC ÉÔ²Y�Ñµ—ËV;ïc ‚#1ý‚Q€*£u>¢–m1'2æ,ý>3× V‹ÜH¢lÔ}ã‚J×èZúË��’š*ªC<L§EO×³C<"È�.ŠPÀô‹�(× &	Ž¶3†a/ûfD½k®!68Y][p§à¹®ç½q°®8HÖ "³P}ÓŸ‚)–AÎ½íëyuñ0ùyÙ7`ó„²o7ó<:Q D(ýH€`€SÝœ§Àµ<Õ<ð@¸ZKkŽŽ`ú¢X™ÄÐÁ×P‚BP@®Ý}ˆ �e�A!R¾Õ›¯�!’Ñ$ÑT}e�´¯†x´íVÈ±ï‡ÐÊ¶ž1 +&X
L?�ó¯üƒS¥@�F  Ò �‚ AS„  %@„	JDit"ÐH" Á’L€‹êé`µdW«$çåšØFç�Ž µÝe„&8ç<á R  	�df’1ø ®úŠâëM.ô±™ÕÒª�¢'(‚AB ÐÒR�D ˆ £³Ôƒ(ˆ4R"H#a¤”zÐH‚¬Y³æ1!ˆY%xõ€7©Š>™þKÖŠË]�{[ªèƒ‚)ýyˆRu»GbA.¥EÏÎ¹æZú
¢ÌJ'ïª[UåÆÑnÝ—öý‰~_jöôèKWIµ,97ÞnÛZ,œ…(¥_„S¡oal²|³ÒQå¼¬Õ…!LƒÚËukÎ÷ƒ‡¯®¥_‚À–Õ4‡·§m­CGW½YzjÙßM!—s)n½ùˆæ×Æñ4wµ>¯ë-øÙðçó^‡=áié¯@€ÚÚ,ÜÝ�þúòRkß…B@-WßÏ÷�åëŽv=Í›¥#¶¶™ucpþeßZp�"ÓïCdS‘Ç0åe£s¾k DÔ\|G®Ëycï†Bg–&ˆ@ÛÂ<,×ËÒ0…ûéˆëõùLÄãá.¸åi}æ©�;”þæLvÛu|ó%ñüÓ�Ÿî_Ý»Z¥ V„ãñ¸m—çe9öÞWGK¿ADYÁ×Ãõù'ï¿ÃaÅÄ—€mÃãc)OOÏ}<¸`‚Ò_†@«ëæç‡®_.×­ëîßÝ¿¼ÿöÓó5NãôÐ÷ž.›õwÓ_… ØÂ6ÞOSÞ???çóýÏÏ/›Ó<ì˜þD°I:�»–óçÎU¦B¤Ù–Ù�zWÏ·²ûÉ™hi†R@Î%<¼;Þ.ß~|ýãƒùåéRû¹ß¤ô7!€­^ª¾èãËûÏ·ÏÓç»ÎÚÓËÜ±7”huÝ]ÿØOùùvÆ:ß-ý VÓñí]xÿùã¹øûž01ýÀ–¦ùî‹p{úös›¦ã8½ò·ç÷wƒ¯lLï ‚ÈÊãð0b¿Ü–0LÕ‹–þ3@±-ÜÇ>.·ËSÓlõ
w8ÝåÛóuñ¾w÷cÞžŸv7MÖLPzAD}vzušqûðùr;Ž¡mÞÄô}4+Åw÷øt^kâýÃ¡^^žÎ~¸?Þ¿îËõåŠrœávÒÒoAÍ/±;Ž®,kQ:¹ÊôËi-·Þ/åRã‚¯L_B ÙÚÊôêp\/^LÃ\ZúKh¥™ú‡È—ëuõãTÀôÛÀ–3†Ã£/Ÿ¶›;ö�Üvÿpxt——ßçÁPú=´º4×ÏwÊ/ëÂ¡óbcúe´ºU?ßw!_oMsè«9Zú1°";÷pl|y:[˜»`¤‰PÞËðøzÚò‡[}u U_�éw!‚È­áao×ëz…ïÇÓ�_>__rçNóÝÃ¦§—ut‡©A T×=N÷S\Ö/:Ä¾š£¥Z]Œý¡oërsýÐ»Foé�,…‰q+·¥ÆC''Zú#4[º‡S¿?Ÿ?ýxº÷—ËÙ‡1˜‘–þ°­›õ§“[–�Ÿû~‡ ºÞ|÷ppçÏŸ>£ÞÇL�i†ZçcÜ·�«NÃàié—!² g¯—v‘ïGÁ§ Õ8¶Û’yŠFZú-´º®þ0=æýúywat^¢¥_‡H³lÖ�‚ËË­i;•éoAªežæ.û§lCO�Æô[A•s§×�ÕçO``hi†@«‹µãa
Ë¾Þp=( *¶ÃaB^–u:6¦@¤Y©=O�k9/Õ:Ì'Ÿ·Þëpœá3hi‚d'ÍùvÛ[?v¡Ñ[ú"Í¶üÚ%ïÙ<ýá!ß>ÔÊi¬¥1ýDZ[eýqív-5ÜER´ô"[[�Ý¡ž÷Œ1†�IKÿD¥Ö0¾~˜?|øøTïV6¦wiòÝàýv««ë|  •¥ùÃ8c{ÉÆ8dW™þ;ˆl¥Z˜^°ž_Ö‡9Z%-Mi¥­~zs?Ô—Ÿ67�!K´ô}ˆlíŠ8?Œ5_žÏ•Ý¡
ÞÒ[ˆ”Õ³ùùõ«Œóç÷{èæûÑmöô|½ŒÓD#eÛÞÂÃñ••—§vk�£¥×Aä–ýÝpwÍ¯»ún�ØÒ!eZèïœne1†Î(G¡íVÃäÇz[ÖeÁ^€ëùåŠ0ôØé-ýDZ¶…Ó«ƒnŸ_ÖÎîÆn¯!ý"knòs[=oµë¦L
"ëÖšŽS»Ýê•ÇÞ‹`uÍ¾FàzÝ}œ\/c:@¤µµqœÆ�Ïå’1tŠÕ§ß�”Ñ|?Ï¶æsF×ïkú"l¯­ïŽ§ÀO×ºî¾6KGˆ´\…ñáà®/OOUÇáÔO{½žC‚7K"«sã]ï—år±>ö�i†H«{ípï§=_×‚1tbúã�•|¸÷Ý–Ÿš±�Ñ¼Ò	f;œf€e?[‹]8�#êòÒøCwšÜºÝ¶Úq@�O?€@fuót(ûùz½…ièw¦wiÚkéûÃêzYÁ©öXÒ ²f«qœûîR–jað]‹J_BªÖœ›GWòu³úx×Eí·ó–G×æ›�¡ÐõCÀmß<ÇÎ;1ý×�²Èã0úmß7†1t‚Oÿ
TwX8„à–íZÄ®ó”£Ú„nèÐòË­qŽ1u°Òªïïf_žö‹ŽShLjuWìú¹�-÷òÞQTûnž#^ÖµÖ£géoÀˆ–…�íœ×¥Æ0ùîrm‹s1Â§_�,ËíÇp4¼,,zÅôïA¶S>ÌC¯|ÛjÕ…¦¬nbŠ÷mÝãz:1ý!¤V7Y¡º/{naœCçÚËeË•qŠ‡Xn·¼w®ï#Ì¹t„T@×ùC‹]áœóÁ¥ÿ"Ä¶C.v=ÛyYÍº®Í7B›mº›îï/ûËåÜÐw.d”:˜kD[+c÷jšô²Ü¬†Q"$A)B)Àv9õ}§-ïÅ£ó�NL(ƒeš…±–írÝÜá0¼{¹l
a±Ñ£Õ­ù.º.oç²µ.ŽãlÙ¯–û)úØ@Õ²¸Úw±Y»…09çEZ!¨Õ½Æ~>Œ(ËR6úÉG3ç•zHÎYÝ[ëú±ó‹=—-OÝØ¹XlÛ
0plÎ ¥ïA€ˆb{‡qŠe½–ÜfN$Ó °¶íôá~<.ùz~Ê˜bt©ÔA`;§aèl¿Ýr‰Îû h` Ùfá@¯¼l­„¡?¯ÛµîsŒ^ži„Èš8M}hË-7ï‚Q`úTköê}4ÕµXpDlÎd¶±únj¥ä•æûè½Èô?Ah,q7ø~8°•ËÞ¬‹�wrÞèÒïÂÔvW1vÈÚs:F¦BµízÆ›ËV²3˜þSu¥rŠ^­že$;:€é`PÕÓ¬œ—5w\$Éô
‚ÁZ6ýä¦-_—Šqp}ÞèD
0Úýîcœ»º¯·Šè»@+ÈÕdS?¹Pêº5saê£/mÛ21Ï“Øoµ²“÷t ˜~BõÅÕÐ9ï1zïÍ¹ôW!˜*ÝCn{nr‘à-ý ’ÌjŽƒêy×‚‚Á�.ý
D S+;C»€ºîÕ�>ø`ð•–~2Jmcè›•RÙ:'8È13Ëôœûle£z‡à¦¿Á`j¥¶b-Ú2kì:#hté5„Öj1ÆÞ»b‹¯}%C èÒ¯B”ÁjFtóÐµ²íµ�—£à@—~‚‰B	{tÃ(^-«yÏžtrLÍªy�„]q)ô!4çèÒ#M,¡x†âk±›oÑ…¾Ñ	`úUd¨aƒºî Ëë*ÍÇš@€éW 4ÐÈâ[õaT+us{_†„`0:S¡W×MÕö¥5ëázÓ¿*¾ßõ¬¥n¨1zçEåZúó0Q [+a
pmoÁ<‚ÔjvµsC´–W"Fï½ÄÁt‚��M-Gs1z·—Ý,vz»´³É{tŠ $L_@FÑ-{pÈ¶ÆNÎ�Õmð]?L[]–¢!öæá%Še TÛ0ø1cµ«wAÁË7:Aé¯@)­ßw(u­›uãÁù²-­:Æ¾ô;�Pü¬ëˆu]o=Ã<4ä-ËwÃP–­¶Ø¹t"›Jhè‚÷ÒØÅ£qÙ—cßG3§F¦GH¡Êà:¸Z¸â(ç ÖJ@è¼¯m¯ˆ‘�  Ö²3ßGƒÖV=º¾³¥ÝZÎ‚w¤“É Á98óˆnî½Ýö¼¶.C¿ZÙ|öðÎ+ÈZ3Dv�ÎÆÞÑÊ¾ã0Æ¶Ö«5g}^ÎI00ýHAÖZîBÜ÷RJ4ï:˜F@ÅUvv•ke‚é/@0´V:DßÁgZi�ÞŠ Ó_…`�‰d+¥ ŸØ.MÞa œ@#¤êLãæ6ùà�€9KA$Å*(=@””ÁûÉÚ¾=çàºyˆm_óæ]?öcsëÍ€Á`c#ÓA� �-»-º±ZÛ3sœâàÉZ,[ë<-0=@¢É™·Ú¼ë\nUÁ±ƒkªt½s" È`=hugˆ1bÓÅGvH�Vw#úÑp»í¥óÁÍ9¯—ÿø÷Qÿ<ðŸâ¥•`’ ˆ4:K"�€ ÔC¤¥š((õ A€ŠFs"DƒR€H	`®²i ‘¢`¤ €D 4WA¥” BD�i”"(@�h`£ ÉAL¢3R �„Ñ@“K4R)@[
 �Fg®ÂDÈ)�Lj0 '»f­�®69À‚(ˆ„‘0:¡ôdVkcì�/Ø³ÕÀ‚[Ë¡að!ÔZ,÷˜cÏ†]Å\€ëáÁ4@´XÜÝÑ"°.»ÃÈÎÁû–^CP	ªï‡µlÅ9çƒ£|KÄÛ1Œò7÷Ì£‡‹“¡•*7g.7™õÞEù–~¢uÕW…Ð›ZÎnëjó®ó1[-£22Í¹”þ"D©úV]èºËú@s-}¢ÌŠ—›B0ËÎËy‘’Š+5„Éçœg½wÆô‹Ø´UsýÛ‡ÓíùÛ�8ç®Hbú» Û³üññ¡}üüÝÕºÃ±63(ýP™->L�ÀwO+Ú)ö™mß�÷¶½|ú¸brCìú!ï[VçCg Dµ­i&Úõ¹–0öp Ôq8Å°mÏË¦.dú=@Ûùð¿àgÿÜõÃy×gÞ^ž/C,®2ýY´¶Ö8ÜÏÃv}¾´®ë½�–þ©m¿„»Ÿ}Ü?þT_>³Ii† ´eÇñþ®^ÏOÏ6'Üè ±iáððvÜ/¾ývº;À�ìj¹îÙßÑ˜ÔöyœCÞ/×mê­Zúˆ ¡úpÆvûtËã1z�–&4ì«üãý«ryy®ÃÝS“ÒoCr®Ýr	¯¿|(ïöÜ¿>ÆæÇÛ~Ëu#«§¥w�œkÛZÜ¯ï�Ÿ¿û�Ãh1¸ºÕmì¼‚·ô{0g(ººéÕ;l_û³óÓ1Ö¹#.×uñ~p³§Ö½ }ðÞÒ;´ºf7ô}Ý.Ëæ†±xÐÒ‘†\,v¯án//Ûp×5¥ïC"�/{ýê«ŸÃ7ÿè; _ôÚ(MP
(¹ðøÕ	åëÏÏgßm:tZŸóÍ�£Ó¨-s~<ª\>½ŒÝ±Ë2(½… Ú¶åþñ�«ÛÓóup�§×§»õù§ß—)žºCYóûVãÔ{”fHÎU;×é«¯¬}þîñíéÑ	fbúE€ê¹úé]ÏåÓÓŠCç†â¶�¯­ï"k ¥?tÆ4BQÖ¦w¯ÿ¾ýÙÏü€cïúià~{A�£ƒ«¢ˆíºl_}ï{øÉOÿñ?÷8OqÜÛy]Î±*AK3Ì™Ú5ûñ‹wýöþ»¢ÓÃ« ¥¿ÒÒòÃý;\.ß¼‡ëâøpÏr~z.®‡~Úú\nÝÐ9�–~	Ð®j÷Ç{œ?}X�©«Ù sKÙÇ·¯ýËÏ>~x=õ½£[ö¥´8z´õZ§Ž"Ó¥€\«»Ÿ{–çeÔ„Ó!"xùç¯ÆãÔ›¿Ü.9<tÎe1 ÐÚ¾qzuÏß|óaÂÍ™”f´¶7ß�žûv®~êAÐÒ["êsãÝûêpùúëËáð6pd>‡K‰ãW£Û¿ûnå«;ïŠJ$çjËu~xëo^žžîÊ4)M -Ê‡‡ÇÈÏß=mÓñ2MJ?É9‰0€ ²ì·v÷½wøüÿéŠ×£ÆS´Û·O˜Â$8ämåý÷»ëO¾þ®8öá0Ma9_ž·±ïÆÐkYÏ‡ÎÁ-Í�Ú¥êôÅC|zúx}8�Ýˆ1Äçë¹CŒFZzbË;^ÝmË§o¾»¾îÚ^L Û^Žóh/lé¦.È 4C [®å8•_>�×‡Ã±-´Fí[™¿<áéóÓ7ëÛ#`21ý& ­æãcÝ·ÏOÜÝt(Ûõå¥M1þ\¯;é‡c7„í¼^0ÆÎeGKÌ™Úµ´ãÛ·ýËË§¯·ùxò™&¥?¥€\·±wŠÏ?máø8ÕV)¥’sm[Þ½}•?}û³÷ïî�¡È 9•§ÇûÜž¯ûÝa*Îš”&ˆ J‘›O>?=ï¼;F5@ZÍÂ»;´ËÓsöwCïçÁçí¹ªïÛÐw±­õØìc[ÎKcâÜÅ²?·:N“3ÐÒ÷a®±•]_¾9}øøÍç§z7Q�k×rQBp�i†(WÊ²ºÃÛwxþøÍŠÇ‡©¸,@hëââÃ	ÏOŸ^†!K€¨m«ÝÃÃü1}þ˜:õ
kË…ŽŠóèörÞ»Qð´ôë€v+~xû–ëõ'Ûóñx´b€Ò°uõññÑßž¾ùÐÂèç01^Öu“sqè#Öm¯nŠÑR€¨rÃ8F»¼lyœæÐ‚olhWØxóörÝº82Ôº\�.`òsÍë¥!þÆ²®KŽSÍ™¥@Šê0±¯çÛ�>ŽdŠPË%êa n—}	Æx¼G[ŸÛúXÑ˜f´zƒîŽ3?/Ÿ?ôˆ‡Àô"ˆl{×ßuaÙÎÙ:/'“ƒrQ7?Æp=_Ê8ŽÝâ*Ó[ˆ ö¦pìByú¼£‹Sk¤¥7 m/­½ûÞ#.ßüãÜîOÇiº3ÿùzóî0"³1ý:ÐJÛñpº—ž>ìá8÷n££¥_€j¯6ÎãIçóÅöyèw×€
êÐÍ.ûg�¹óŽ�éD°!ãpšQž?\ÎwÓ�¼ÉÁÖªñþ¡ÏëçkèÆ¹Áå¼–æ]psçq^rõ¡³¸3ý æ‚ã»/ëíÃÇ×ab—óz)ˆÁ�Ü€Û²Õ~ì¼¯Lï ²•½éñô†Ÿ?½_k‡0~+ÏÙÇ!v-xKo!ÐJ)íøö‹aûôÍO¾ûytÃÀ¶¯¦ièOK?‚ Ø­ª{uº_^>\6Ü�Pª£¥ß„2†Ã+Ôëå}8½†òçç‹ÃØ»�ÞÒ;ÈU¥D»t¯æ|{ùd˜‡‘NÛmÝúxèCi{67ÅX£ 6UË]wyÉ·­2‡Ã¼/ËóYÇqÜœhi‚6Í‡è¯Oó~˜�œŸ®ˆÓÐ7ƒÈ‚ãáíÃ^ÞŸo!Þ…JQJ#D²7Æv[n;»Žh¤¥A¤iE��¯z÷éãyÇa3¦	"ˆÒ¶0=÷Ëí»'ôóÜïÎhéÏ@d+¶öÝ©ï—ÛåÌÐ�›-ýDš6+~Ž–åz�uw§‡ùüòùÊ~�ÍÓ +V}?Ï­]·½Sdõ´ô­][>¿˜Âõéýîïg³æDÖuË‡ã]_——�{›Æ)ÄˆlÏM~pý¤þ†k+è8NCàm{A�dõ´ôÍÖÊxš§°_ÖÏ]¼k¾ùPY}ì¼�¯7´CŒpFKDÐ˜Ñ§CY–O·µb ¼¥ïC¤µ-cšfÏóšw7tð–fˆ´¢âæÃ8Ô§ýú 'K_Â,Ëû‰®•s5ßwÞ¥DZ¶5L¯Æ¡\>\–61ûšfˆ”åJï&ÔÏ/0�ž”¥?„TªùñaF=?]#ûS´t‚Èºµ½§R¿½<ûáO®¯·²Z0†Ñu;Ö½¢s]£Oï ²•ªÈ×ÃÁž?]®}?øÐ<-}"UÝUC?ôÛõùRÃ8ºt‚HfçOóÌëùZ×S÷êié€H+vÓéá¸®Oç‚vÛêkúB•tƒÃvÙà‡aL¿sµäLžî†ËõV¦ã8„²,WØ8vò Ýn:Ü?÷íé²Ýæãxð.®¶ÔÜÃÇFŸ~ ´¶Vv‡ãöëåZ‡¡ó€Oˆhkiá~z˜Î_–:Â	Tš!U[}w¼;t·ÛùsÓ0MqöuY÷=ýŒÐ˜ŽPÛ3ºîþ`:º!ö‡Ð`L¿³�ì�Šî¶]âÈ V7oCôn³½¸NÁ;¥ Ûaèç	e[Jí†Ñ˜~Év0£³¼ïkF�ãÑ°�ó¥ý¡†B¡µ�qd¶eÛÂaìèeÝo¾Ã‰�rÙò
ŒÃèPóº*ô.ÄB ªÙäú	¥¬uÛÌ OKo ÒPÕ¦èÑnËž}Œ=(ßT´«›f‡óóós§Ø£ÀJ=ªæVãt7Žº]Ïç2÷³‚CÛ2pwºØžnOÈC×{SV®.G×‘^¢ÕGEåý–‰.Ä¹�{¹îF×õ‘rkÙ3B<DÜµn…±¼3@©‡ µñÔ¾]¯ë6Íý´;É ÔAX(ùnôkYrè]èkhÆt€Z±ÚbÜZ¾G²t‚wëÝØ·ÝÐÅàƒ1ýf9SÃÝ=ü¶¾¿Cw¦¬í2öcèó²nMì|tè¶þÿÁK¯mmZàû~ÞÃ8ÌÃ:ìoõ‡¤(¨2!€b0bDCCL$±	$šÚ�ìØR;þ»ão»þ+P§½÷ÚkÍ5çc¼‡çöºúq>O¸\¯ïšÇqˆî^›MylÜ÷ºƒæF Z�jõŽŽ1Õý¶UeLŠ2¡Ð[œb˜Öv½VÄiœ2òÕoêC1 âò¡^¡œæ(¯ë5"#G€Ëjµ`Œ³¡ã½7sËCm[[¡E‹FpùkÈÕ×¦8åSò×íº1�C Âr†«Æ2ä!FÕ½Ê€H.ß@¤@_¾�£oÞxš†ëm»õqÉš…åÿ@‚÷ÂÌ1±4/n9ÎÇXï·Rk˜âLÖî÷Ð™#úr† ªh)Ó÷~Û®+ÇœcÙ[µhÁE—-ª¡ÆF¡·wbð%CpsH°š‡ÀVÖkl9f�N@ˆz¢Í6Ä~_KIi’•¸ÛÖ†æ�1P5aÌ½úVîÉb‚ZàÖºï�á‚µ}mŒ‰Ñh�¹sÉp¢ÆÊ)æ„÷
Ï}îQÜÖ+Ss'—@ô¡C¦|r¹o»÷9S­ïÞ¬+º \~¢à„û8Ûk¹ïÝFNŠ¶ü_8 ^ESˆq/W…€I�—Gˆ’{¡bóèí~mQ£å@'i\~rBê­9Z+¥y˜ÆpØy¿÷Î`!*9hùHÙ{A´1«sÛ›!3!9	€¾|‚ ÁÛŽ€|@òrm%f%3p5få‚Wß€Àd‘‚D:Ø…–kFLˆ^K÷–ˆäF'Åå‚‹ðVWõ<ZÜë›o²ir6ï«ª1…!šzßºL`ìÖiË€ ¡¥š³…Îí®6h¶~o=xŒ&ÚiË¿‚Ôk±ž9Xß×"0‡€@ˆ¶ü): A^Èó\Ó¾Ý7Ø`çD–~W0&vH$—ÿ‰NB­6·�ƒT{rž3ì¶ï!00.¿
Áe€×½vÑzð ‘K„@‡¤^a-äÉú}ÛKô1Â(’—?…à„¼ïÑCÊê¾®œÃ9„¶î÷†˜­›ƒB\Å:°Ä1Æ‘h÷˜BP ¨e„ê­#„dÎ®ó(’ÓÀå¡KP¯¶ç4[ÄëzwO‡qNá®•;RÎ9I½´€(K œ.?†àNÀ½€S8Ç¼Õ×LáQJQ	H–˜ Q^íÎ<Ž³¡Þï[ËiJæªÅ«šbD´^£…Ñ‰¢@Êºu.'"ˆÞv˜�XÛµ ˆF�âò 	ä5õ²©µ= $÷ÀÉbëµWC¶,ãÁå×à€äJi}+-…ƒ¹¤–y+±NÉ†^úÍ•"3’Àå?Bè zmÈ!òzÛ{C
æ”9Ðò›:èÞvÃ8:ö«_"†€±™äò{¸»uzØ#fdô¶W³EwiË?ƒànÍÕCKm×ÍKˆ˜zèPï5Ñ‘lµš¢ƒH7_AŠÎ%A"€:\ ¬õ¢€9’·}¯eÆÄ½–ÚSd–RW#-Œ-•¶ÖªfÆä¢ä½5Ç`!Ô~k†4„¼­Þ�Â½7�!¨µ#,uÒI ’ ¡Q‰ ÞÊ
Ï-)-‘
]tÚò-jj9…i÷¾7ÂŒmù—pÑažJ�WÔ«¹å!Žh­{abB \ ¸<ÀI‡·Ö™“YstïCˆˆtï2\>À¡.ZŒÁw1aÀ•·.‹H&Ê€D·®ÊÈsV»»[dŠN©#¸ùòH.9lpï+,³¸Ýï•á0_ëº‘A:»m¡ñ¼Üû6Õ"w)Úò¿ð?ý€ÿ
ÿøï°=¹Sì$:		D .J€rP"D�p‚&AANs ú!@‚\rÀCÝ{ë5¹(A”K@ðèQA€j¬Á»;  %&s …››EMÕJhnÉ¢!°×VÍ{‡¬`�t‚ @¤–
;(‡»\A‘f4oueÉ
!0Ê{�Ì¢˜ÚªÀÌ`ÖÐwZ­’9‚›,#�ê­×è’uÓáŽ."!Ì‹íL€3pùcj½UÃ!¿w·8œÜªÖ‚)P¡/#$µdSH}¯{“�vˆ©Õ}/úl�0Só^c2o¥Ñ*bLÐò»Ôún&c+Û<+å^2ÓÌ7U¶dYZþ"¼WXO£¥­Ý·¨ÌÌÍ¤ÞöØÓ`(kë-rb°n}ùD¹ïV5}/+=ÄÈ`ËoBdïí6Ùá„½^·BL¶LáU=Æ‡Aåz)å0Œ±‡îË"Ð÷®8>$îûýZÒœ¬ÅîË °·½c8Ï¹ßÞömS‚u.! }k!ŽS|»loiˆÃÃGä—/_>áÃ|2ïZ>B ú^•ÓÓsj¯—_š�s¡ZŽè½ô2Ç^n_ÞÆm|zì·ëë[³}œ§ñCØ.Ÿ?·é4åâ2ÈTw„x°nw`Àä”-ÿ‚ÐzñÃã3âõómMãˆCz°òõÓ}ŸN3ä€–ï ÐêpÈS¿\®ÍÎ1¹ŒÞ·›æ��èŸ¿~6>„ðô8á—o¿,÷ù`áj�m7¤‡º¼ýâµ>Z¥;—o! ÚWŸ¾ùpÆë§·õ[¦tøðaüé§ÿ÷“ù6¤üüÝÃåíÓçÏ¿ú�âôÍd—O¿øúÝñùÔW Z~‰ìûùã7®o?ÿÉÈ‡§TU%Új�ç9oë—†aJÖ#}ù7psõ[±ÓÇï†õËÏ¯Ïç1áüôn¿ø»a}zJì[~]µôa>ÇËíË×0�çàhù€êæøøÌôùõå:´¡õç��xýÙO>m§Ñ¦ç�S¿ýò—?ýõÇÔšsù°×WO>ŒÃËÏ^¾|o§ùñØ·/_þ~�žÏ¡u—–ïA úuçüí÷qùú÷/¯Ãñp>|7Ýß_QÛ‡9¶éË-[iñÃÓcÿùÛ×—ˆ”ž¿Ý~ñéïp|þ�ji-¨¾ÃÃÛûåÒÎiÕèË@i�ço2^¾¼_ëøÀ¶‹¶ÌÀ†­OßZ¹|ùt=œglÖ¥åltK¡¶ûjCEÐ—DÀ·
{òýZ
‡˜œ�Ë?‚@Wñ2Î9­åë¾‚ažÂõíó×ö4ÂÍÜeÐ^Ûx<ØV¾´4Î1urù#`ß÷6Ì‡výt»�Ø¬KËì{éÃÃ³í¯/ï-�!ûýÀO?ýôy~œÆÇÇl_¿¼¾¦G4ÉÅå�½®Õæ(_k§Eúò=€—­Nß{ž·Ûç·­<?äÚ -Ï :èíRÃéû'ýéçË	™‡§gøË/Þ#|že¾¾üäg÷æêÔÚÓùÃÖ¯×m>ÏÜ+ åÏ!}s¤CòûZZˆ}ù+ˆ jí<|›ñúé‹Ç|)‡ º­-Ÿcìå¥zž²ÇÆå· k¯vzœËõýí�c^e€€æ%Ç\î—¾Ÿó`.h9ÂM½¿ßäÇ¶½|]Ó8Œ	TZÆqÖ¶Ý½Æ}æ�ï——4Ÿ§‡–?ƒ@×Þ}˜²ï·µ ‡‰ËoA ½ö=ŸÏúôþâéq„ºAË?‡4wS¨ûûŽ8Œ± QEÊ§1ÕÛ¾1¤Ïš_ß/éÐäÐòCˆ JÕp|8×··KÔyˆl¤/º—ªãñ©ù—÷÷ý˜§ÝZ~"ØØ-O	×µl°tx< ½Ü.´Ó�Z#}ùC`ãÖçó3o//_/ÓÃÙ¼}ù!DÐ)Í“mÛV†C0‘¾ÌA¿ãÃŒëåíÖ�iÜ«-êµÇxÈØÊqŒÑ:—ß‡øî>#k¹µ8…Nú2C û^ux:š^Þ_3C€CË	‚|íûÓáC-/_ÞSúæíáÎå�½@ã”P®û–ã Ñ¡ŽÈ×ýaŠ‘ /ßA|+!³o÷{‡0xh¡R4ŸòíëË…á0æƒ‹ì[/Óù¨ëë—µ†ãp9@ zíûtOííòÖñpt°sùˆto÷†¹ßê¾+„Ãa°ÝÞ[?çd…ôåO ÐûÚ8=œš¾^o1çê¾ Å÷a|ÊØîo—=è8>„ú~y-Ã4­Å%B•ŽqŠ½]«§Ãä&úr€ÈÞï1ä±Ýî;Æ”ÜD_þ"Ð|ÍáiÖ×Ûõµ¤ét°VÞ^/q8ŒE DîhñxœÒ~ëý!Œ54.ÿ’Q8$º9@‡;M ÌÃ½g~œú|y«œÏýþöõuc~<Cûô¥„pž†ó~{{» >NÑéË†¢4Ïéùd÷ÛÛeHÇTœôåªÔ4æ[¿Iã7Ô×ë——rN§ù¤õv+vœ“èëÎ|zŽéíåvÍ‡ÙC5@tu�C(o÷½çÄn.¨ôNÏ§r»]>MˆÇ|ö©]¿¾iˆç._þ"åµ—œŸãíþz±|ÈA¢/‘Þwgœ3¶}«8qêÙ—¯ìÃ4±_Ö¢4Æ;—Dz…b|½+1Â´D¨¢Œá)¢­oÍŽsFp ªqþpàv}):Œsus_è}ßS|x˜qûºµiŠ°¶Dôº!ˆVî›¥”¬/Gˆôª¦Çq*÷kÝÆãdmù"[Ý0fq¿·šSŠJZþ
"½øšŽÇ#·û[ÝâptÀ–ˆ^„<§ÐËµ­É²çÂåGé­(¦!êÖ¶ŽC7ì½´”ƒá~¯vŒ&_~"[}W¥þòmN)ÝÍ¨–rÆ½¿ˆs@c¯Ó!Nù¶¾_bž’±sù"½Ý ùÃü~¹(Œá¸ÛòW m¥„óùtçËû×”ŽcÞ(ÐÝw‡M9—}½÷I‰äN´,=<6¾_ÖWaš�SØî×Û%ÇaD¡´ ¢­kŒOÓÛíuCœžŸïï—/Í8Ï¸[[émë˜�øþEÎC†!øòO!éNÁˆ' ö¶V?ÎàíýòÉNÓø8É¿\oŽ||ø&÷ýåë×®s:í¸üM0Á\\Dôvu;ÎÏºÞ^ß¿ø<>?“ï×O{±x~<«´ûÛš†a‚«CèõÞSz²P¶uëá²Ì�††qx>Žëúz{‹ó+¹|‘jð’9é¾½xÇzÒò? ÞöÀy$Ëºµ�CTÐò#Ú!ãz»­Û�ùô|>^êûë=ÛiTh¤«`&Äë¾íäÀSÎiÛ®�˜GShË¼mÞ‡Sf¸Ý¶=Ãá\NÙŠ•aNVûVw„<Fßn·Š8ætiù!„¢®ñœ“o÷«+1:}ùK¨ß‡t:­^vWš’9\þÜwÛçœ¹¢Þ»²²çò«è}ë–€µ¯žC°€hË�¡^É1Ìh{mÝ£E’aùhñn>œêõ~/œ‡æ\NP/ÞyVÊû�ŒÃLŠË¿‡Dºu`‰" AjòžØË—^9Ää±†
[Fhqk§!ÙºßjKC
H”—°ÃÔÛÞ®Þ’#Ãòc¨!åc îûÆ8Ämù1Üw'bCÙ;MÉ|9@RÛ\81úm­m°IÐiËREèiôŽ¢5—dÉLàò»é^Â”Æ¡\/×VgL”_þ"z[¡<Q¥Ýz7³˜­Ó–\…	SBëµyÄhŒ�N.OyñÚÃœØ®ûÖ‚%ºA*DÎ#TÛmJÆ:Ø½!'Äâ·­—!çœQÖKñÃà„{ó8¦¸—µn}:œ§1ÕË­ìH‡ÀØi”‚ x…ûp²¹ÕÛZ{CˆJ\žáÖ�~³OqŒûúVK)0pù[4Riœ¨}ëï¡Ž6Õ¤åC½íæ!ÇÐ¹·bJ)Ñ õ^BÑ–AÞöÐBJ}¯µ85ÄAA‚ûš¥„ÒZ+Y!2P„ºï±g�¼©T7Cˆæ\~’¼DŽ#üÞn+1äcÎ¨kÝaÙ7D—?€ RÞv™fËÚ¶º�4py†$—
•Ó­_÷v§çùpl÷}#Ge¡Þ¶¨1£bk÷Žt˜fuÛÞ¯J‡ùêþ¾mˆ˜ŒŒ¤™Ñ tï¥Óâ!æ~¹¯èSLÁé€–A „^Ó&í·½öÄ	SB—-� ©�ó„xo{sCÄ(îË¿†w¯‰9Â µ9„èœ\!PåË"»+Ã8M×½ûÀC´ÜÞ×÷êHyŠ	ûVwšÑ’¢Æå8Õ[kCˆ[£’Ìh¸L�ËkôhÙPû�Ä,A€z�v�¼­7s!cèàò‡p@ò¾[Å	DÝ÷¢�,4RHp²·ºcš|í÷ÏŠAÁe\~rHÞöè9Øê]e`J†HhË#nÍ{]-äq«{%Ff³
\~ï¾™²M~×5ËC”(Ú’ ÁÕëží�¬·V:bä€Hkôå7áj±)‹ºU„°$ˆ\àÔ{A¶³�\ëÚ£…è¤“à!	®Æ 8‚e/¥#;£9Apù8àòzÈÉz«­&%fåÆ%‚Ë#ä�¼÷:„1D+µ4i¶¨Ön½GM´  Z"¸!9)õŠ†Ì�ëÍ=¤ˆÑ¸$ÈW³†8äŠ¶mŽ€ˆ˜º`\~B÷Þ8“ê»;3”@-�ÈkìŠCŒÞÊNEO=Ê‘Ë ¡»·nœÑ6ïV	‹$½·ZÆÇ=ì¾‚‘!É�Ë·po­3‡�®ÒeÍ#%@§-#w`�›ÙaŒx¯[—1ÐBŒË-ô}°c=ÜòÖ+˜Ì¢•!Úò .r¸ún•“m{)Âhº¨å/àpÁØ{ñÏ)·{yïˆ1¤nNô¶YsD_×*Æ¢r‡Óvv·./>Æ¹ÕvÙvÓ0°n—¢�0ZpJ5”ã«Ú†>ÈÂ FNžÂ½m{b°Ü‚$H\~‡Ðlgž‘¹·K	†h‚C4.©ÅÞCH­@N1€¢‰ôå� %ôÝ<ŒYîûÚ•{0s£D�Ë!‰3©;À :¼I"—åK„TÃ1ÒÖm[×xL§™¸­[³qx˜'«×uíqÀàœ&r9@öÞª§˜ƒcóâ`A ÀåÉ%õÖ0„Ô|ß�†˜‚èÖ—ÁáÖ‰öh9ÆÚKYCN{Û7Ñ¢¹…Þ}²)[×­æ4e©íêD#I è´å!š Hè2 ¹wóäô­(§cný¶îì‡XÊmë%NÃƒ¯½¬Ý†a<ø^oÅhf4 MËïÃ!HæÁ{ÙÜ[eŒƒBsIn�£$8M €D	 éª¡¦�r´ºß›â4¦Ð}o%L¹šL0Ö½È<L©×¾í­Æù8Dî—ýºÍyŠ9¬õR‹§áœcØêî=6¸›"�”w‡åìàî
�! N:mù[8Ù%gBì¾B)OÄ~o»²Ñz•ugõÿ£Pq±BASE      1è  xÁA  ƒ°YëñÀ þµ,9-P#*Øªlæ´\ÎµP�hŽpÆ’`k[1’Êq@M[‘¬ŠI¦¨m.a•RJA©ÛÜ’´SË`J[¥)	©ÀLe*n™d9Æ4•tÌ,ç¡Z#™I¦j�635"IET‹9%Wæšcº"sÂD…*uCGZ-[1e¤N7Í0Z’AÌØ!S�œdI67É((—:&•L`-¶d†¦[Y’–Œ˜sÓ©ÎÀ¦S%ÉÍM ÉÔå´†²`0ƒeÅ‚ÅT†67KgdÓQÊ¶dEÅ ·›¶M*±©c±6]MÖÓÆbmº6KÖÓ†aKm,M‘&ÌI$µÖl¡�À*1¶TÑYÖp¬J·`¹*MØÆ6‚NÏµBPOS      î  xÁÁ�A 1Ã‡õ´jÌAF|H‹Ð‘þþûóíõz}?}îÝóüþu¿Þ÷~êãv¿ŽæÙ=ÍzÊ®Ýgïú4hîYç\ò†­·Ônku(²Éu¤Þ).£l9qTw¥î
Ó)NÁ¸-Ó1ŽÐ4B[kZl[MHÇ²`CÆÓ@˜EÃd 0À †ÁÐlZ0²aË`¤iÀfÙ€ÖÐ˜``€eˆq @Â€ÖbiÔ‚-š FF€a@£¦…@XFÐ€Ö "Ñ .@’AIkÑh„@F»	2†ŒM'l¦ÑÐÖ™å‚q¬MÃ²f²0òÓ¬í?Êü/ñCNF4      #   xÁAJÃ@€á¿™¼$MSRJU‚¢(ºR·®½À;£Gqët]„RŒ†1és2~ßì¥}ž‘2ƒ8‹8H±Ÿ÷ØÇíÐÙyXÕŸð5\l¯Á¦ƒ	¬sÚF3ZÍiYÃ�¦môŽ¶Ñ”}ÃD#zCÀé)GpúDpàÅrœÎ	8­0�Ð—¢&ºÂ@ Cû¥ˆ!œf `€	‚�˜x£êk<‚¯}iˆ‰‰‰qp  ËÛKéD ?àJOm‚ø·11’iëê®Êv„+JK&8+ÇÝz`¹¯»UÊÞªù‘Pc>ÎÉºoø}óñ“"aJŠ‰ÑŸà1Ÿ.&ø[�­F4¢�hD#ÑˆF4¢}åS�³TEXT       Ïò   xÁMnƒ0Ðï(s °Æcl¬4á'ˆ�D]¡¤É²IUÏß÷0…1C˜¼Çi¿›[º¬mJ'Ù®q¶ÌÖÆ›§9´ÐN™ŠÐ…5áú|�0n/b]Û¢¶Ž„EÓï›®Ï	Óáö"65Wµx�å<uÍZX±¶…u”“°hÖÂŠWâÑ}¦}ÜŒ7¼ÍÇÙo±[ÿŒú~ß1†ö!îó¹Í5‹Ãxìo±ú¨î_?¸¤E£PŒKZ}$­øÔ:4tCLIP       	           C     C	®ZTR

SMP4      >j’e  xÁÙÏ®Y~äû^Ó3½ï7ì]{ïªžÜ®Œ·@‘­ØÄ€rV0!$Á¡ù–à 8‹q€�à	1(Š�ˆ„¢@Ûíî®®ª½÷7½ï3®µ~7×Å/þg ÿH>0v¾�i¦ñÜŸÏ÷÷¯^Ÿ>}óo>yõî‡¯¿sþô“·ŸöƒæwÞýèö›øöŸûÞóŸÃ…Ïþ~á/þ7 üÁßËoð:ÿ*þ^>ãŸÏ=þ!€øƒüÿöÿú�ÿÿÛßþ÷?ýø‡ðþÃÿßÿôü“?úâ�~üOòÿþÉŸ~ýó÷_øÉÃWï?<.Ï/óü²ìëu)¥™‘ø]ü/ð€îÏÿP›“Ê”@@0t"ÌŒr $Á@¢‰‚h„ ´$ˆNð A�Á$«Ñ¼3
¾Ñ9: ’¬Ah ehÑ‚$ ÎÓÓ“4HfªÑÌ$Á�9B„r á,˜YSó2“è�Ï!xVáÉŒ H€’ƒ@ ¢@€ Z‚� 
`„(Ð(Ñ @0‚“Ð¢& �rÎ;ï«l­™8Î’ ‘F(wPŽ Fd&�.¶ØàšŒ 	JP@ºç`v°Q”“¯ Ñ’ (PM¦¾²9ž;7/«|¬_Æ9¿‚±9µzÓF‹Í9ï 6¶â]ã�ÖL�Éù<A@ãN¹8u°u)+‚ûæ¼ò'ÌÔR2·ÙbE)øà¼ò÷!Z¨ÕûŽ†ukÑGy2÷¬ÂÌ¥±•e#Ù£ƒwÊo ¨µDŸ*�J„®ƒŽP*EóÌï Ê*C˜b¬mÙW¯.$G€–‚*�Bœ®k=šg¤—ËŒ€ƒiwa
}Û·u3ïƒ‚W~A­4ºÜ�}>¢ ²%‰ù!°úuïÎÜ×ç+Cìƒ™sÊ#ØqXo{ÔÇõ‚Ôõq£‡åïAl71Ýw�Ÿç£ëûp€€ò;@µjýé6Øóóe�Sìå_€r ” j1½#ž_Ðw½Ñ$�’ ˆ‚JÛàï^¥åúõG‡t+ßH€Ñ‚ótP�&‚¹ƒQæ<Tc‹ó‰"¡G×Þê~Q›|Gg�(h/Ïþôî3àáO¿¾qÓa3By€äP·­Ý¼ùžòøUÐ'·þ04˜$� Ì Ñ�Vówc¿ïëËâ£úiÚ6Ü£B?½>­Ï¿zÞÏSÏj€ò¯C Úa­¿;»Ëã×+†n2RþW!Âj%Oc_öýeáp‚Ay„(B ¬4º{7®åº€ÝP)ZNh$å	 ƒkQ  €æ$€ š]÷}ºÿôt|øðáãØßÍç@Y3 ÀV�£?¿ÅñøÕÃÏ1œ¦î´ïÛe.šBw¸\žæe˜¦V%‚åXŽÓ'¿€íç_­ÏxÝßô¾~}}ZlºC;db~�vHÃ ]ŸpœyX~sÖUÐ$(­ÔãxëÊË¼1žâÍÉ•í:ïô'sÅÁò�  Ú·=½úáé§ïçÓë›ˆb¢d\¼�˜×íýÉÁWZ$ ë:ß¼û.þë‡/¿>}åÛA@ù!Ð´«¸óäÂÇçùròÝ4ÞÍÇ‡Ë‚áäéš”æ ¶oÇÍ›{¼ÿòãæ¾uaÕ üŸ@ lkÖ½î|¹</ç8“AùS˜ƒÕ}ŽÃÛ×¸<ü$ðvµ <@€P–%NŸÞéå«¯?nátÛ�Ý2¿<ù®±Ì¡”ÃNßx…ç_= õ§û›½\?>_ÆÛ)º�0eÞpÿ�·¿²þìçÏg¼Ò$°lì†É»õy¦NÉÉ üˆû¾øWŸÜàåë/ýrw“lw&æ‚9Ô—Gw÷ÃàÇÿä|÷ÖC¢ò_ƒä`Ë¾ŽŸ|cÀû/~²ãõMœYå_… ¹3Ïßxë?ü/§O6”Hër=Þ|þàŸþÿøæ[ÓæÊ@K+áÕyØ_>\ë«›SiPþP[õÓé\öËó6}¨ÍÁòç€V«nN§ýyû@L±«Õ	PÛâíPË‡ùÚO¡+¾Iy‚(šíµ›nìXŸ.§äXþ›hVvo‡þx¸ÎúáHMÊ eè‡~¾^–åõ8´Ú,ÿ Uãíxƒõz)nœBqMÊŸClµrîÎaÞ/cH¢¨ü’ƒmÇ_}ñ'_|øêÏ¼ž¦² ü·¡P¶ân_�Ëúåójç[‡�Pþ=@«µŸŒáåéýR¦a2JTþ.D±± Þë1o‡÷ýxâ¼¿¬ÞŸ£k–Gˆ¢©*cjËòÜá+•Ohm£ëo:]Ö}fêûièŽýi«Þ�G(€¨bJÝ‰zÞ/µièoO¶Í/’;ß¤ü=´ZéN]¨ëe/1õ„‡åÿ"¬ÚÎxŽþºmÍ…OQùðP«çû“.ëSsSèK% Õï®ëcMCjs‚ÀR¯¾{uÃuþ¸…û4¦3ŽmyÞ‹sÓxBÙ¯3pêÃDåßƒ(šµ6õÁ¯Çv,žÓÐy\.kcÒÝp,×Ç£Äñd€¨ü¯CkÝëéÔÛñtÙÕ‡i÷’å	"¬ †xK]×}Er}
±ìÛQcßy9Zž €�èöþ¼¯Þ_—8Mç×õy1žeYëí›Oxýú'€7ã´:ÍmãÙÛ±¯h§eNùo@kÝ‘îûV_¶CƒOp•Êo¡p[¸»¿™ç¯žŠîïáwP-G˜Î}›×gC˜<i T+}wž×—>$óÎò÷!Ðê!ßŸ›×Ç‚>œE	"ŽëÝ·?¾ü£÷À›×Ðj€òw!Šµî­¿;ÕcžW—N]ñÆ–P›ÔßF³§¹.ÃàSs´ü7 Š:ö#¥{×ÖËsaçûÒ-¿…@•Vk¼¿íêË‡Å¹Û‘†Jå ¹–î|;m—�3un�jã¹·íXfœv8Zž J‡€SŒ¸nKébŠÍƒ0[·–nÏ	�×Çc:ßX• Ð´mÇp¾ÚÇç÷Oƒ°yX ‘¶¯—úú;oðßüôÇ_Â}çK5 *ÍûnŠ¶ÌKëb/'Zþ� Â´ƒqšz›/‹…>¥b¤åß…@ÓÞOç€çËc±©?õ®”uY|Ç‚Ž}íNw“–——Mç8àÀêwòÌP®ûÆè�r€µÅÐß{\—‡eLî4õa/órÔ–Â0k¹®¥s�´<B„é0¤qäQæeH$-ÿÇQ¥ê'ï·º,ÍRº�ÀºÏÛáR¸�(Ë:ï Î~b9æçûÑùJZþ¿ U]šˆ£^�Ö!ÆšµlË4¼qËüÕWY¦é5üqÝ.{qc_ Zþ=ˆ°Ztw7^ž®è¦©®ÞY BU†›>Çe=Ø‘r€jõv
CÝ�ëõ�Î}ÂV^fÀwÞ‚³<A„µ�èÓ c™wÅ˜‚Œù¯B„Õ¶Çîvðë|¹¼X?Ü�ÛpÙçÅ¡ïóß„ˆ‚ZÂØOmÞšC¿‡šo!Û�]Šeß¯«’ï�yŠªû\ü›ÏÎx÷õÏž~y¼é´�€öcÅði¿|x^_�vÑò[ˆ†Ö|¼e8–u1öpÊÍjé§àË¼¾ììý`ÁYž Âv-¡}3¬ËÓó†ó8à,OU«�n}Ò|}‘óCÚ“,Ÿ ÂÚrTwwÿ|}ÿÕû¦ûSÏgù× R7�¶})¥ITípqêhóe7„OgùªV4ôÑaYöÍù.„ê˜é |:;³²z$Òåß†T�œ"ÒQ¯ûîÐM~pîy>vt1‚Îò� ¢ÕmoÓí[Ï‡ËOg¸ó)øk!¢ímÓéõäñqù¸Ç~”jcþ>¤Ý·”úŽÇ±n×Ð…©s­Õ‹àºäé ¨ zwK×¶ýz„”¬/Ì¿«v„8%b?–µ¸±GhÌ?„µ!žO†m™vi€7æß‡Uµä&Ìë\À0D�µ-‡yÏ¡¦4·ÓùÁw‹­µ—’£Ë·P•±Oƒp=¶âxBòF˜J¡O]Š¥Ì35ø@zæ@°cßm_�u{zžÆÞ‡ÕVTÕÅ¨¶­­"Ì1ÿ{PE‘05,ó.�ÁóïÃÚaˆÛ²­Öq´R¨-Žq¬Ëþq^è¦Éue?Žµ8ôçxÚŽ²ì2ÄÎÉ;Ëï T5�¾'æc)•!2ŠùD´¶Ó¹‰ÎÍëÒØ)‰–GˆæSì‚s;®‡8ÉÉ¬¬rÞŸ"ýR¯›Q½wÞ˜{ˆ‚TêÃ0€m^WÔ¾‹Dªù·!;ÖÖ†óMjÛ¼¬B*¬UÐu½…¥,[cìo¼[¯Ï«�ºDGQù×ÑÜZÌõ·“ôq_Ì»Ô» æRs3Žá4Øò¸¶�Ò´{×òÁ¬C’³²¬>ïä˜Ï°Vh!ÞïG;L!†NŽùI;c7¶\gkCèè-T2ÿ‡�ÔZ…÷}lí¨«,0�à+–Öà�K¢c!¡¡Yò}HíØ–£øî4xìe_[>!Â�ù„oˆ}�‹–jBêC°c;VXç{‹-µv˜É§ÚŽegºv·µ²ƒ® º·�%(x:Çü4·]ßZ½ÇÉàò¯Cj�3N¥£•zuò§¦VŽÒ\èšgþ]ˆª’\7ì¥UÉ‡+`UtnR(:6.º¾z— ¡†�taJ}Y÷y£ë‡.Âpæ ô®ØZ�ú1eÙEç}d Eæ×�¡�fÑ�
[k»˜\)ÙnR?ÞQ—ù2·ÖOc_¹íkEó>z8ªµÝ:žCWt-Kó�=èI0¿†�µúO[]×«CìSrÚê¾úÚ!0
Ì†ªc[Øx£AžpX;ŸbmšËî�ú êŠŽb>õÑí¨û!Â3ˆ`î!ªoFjÝV÷jÍÕÉó;›?šcC8lY�šÜ©lõZŽ¨A©Å&¯ü´P]E—"±´c3…2ÀŠaiX/ÛsÝ¢OèL&çÉœ ©¸è"UŽ:Ó|ê,U20Ê¬¨97¹Ðj�w’]òðž•¿«™KÑ9›÷¥ Ÿ22¬-E×p)k‰u�Å
XåêÔ÷1Öm[¤A‰Îà¬kù/AƒPU 4#·ëñœÔÅRQñ¡óa¯{Ýàœ÷ðó/Ã ™í@=!øýX¯ð!zÑh¾�.…î0›·êÃàb;Úu<“Ò ÈDSs%ù®+¬ueELƒCi{Ecð±ATþ&g±øU¾ëN�Û|1K!y²‘ 'ƒÄ
"Ž>h³¹™"£ó�€¡Ñä»@X-¾N±Kí¨«Á¹!‰†£.Öúp²nm[Û#ƒ‹tt¤Q¢ò?	p„ÁÐ¸ÃÅn¨uÞ^.LC?9Õmß¶àRP\K�<LMMèÇ[¯²ÎkM]×¹`Îyf ˜#Ì	4ÊZeq¾“óK)G¡œ�ðpræ�EæïÂœ HªfÀèN�riæS`Z \ë”?‡LX¸GÄžlåº/±�†Ò–•�ïÌ{K˜ V­ÅÔwä¾ì.úäDdþ/ É(«Í·[YK�ÁÑQ ™¿IT+pnèC]�º8Ú H™¿A jŽqêâ¾Íëa�‹Ž„PXÈ.š­õ¨UÞ‰ó_‡L ­
žCï›{­)œýeÝK)„hŽ ó¿�ä„†”ú€½”UÑÅÈ A¤	Í'?¸®„½ìbˆrÁ’%‘ùˆ@2#©vT†!øvÌÇê"ƒ#Pþ 
lFRÅú!ù:okqêØ	N€ù_�ˆæj`Œ[iœóÌ?Âßðß¼ ‚(Š¢ Q„Q Q hy„(ˆ0B€£ä$A h€’Ø’E'ÒÓy8ÉÔˆæ`å”�4*ˆ!@ h¢ (GÐ(É¢g0çi°êjhž�ƒ
¢ š³d‘˜ (::z:‹-4x“"œÁ“Ö*x¸G/æ4PŒ0$�§ƒÌZk0P$(@!Z0Èyçƒ›op5´£(Gï¼'›¯ÎDB Zq[W½¼÷¢ ¶;�.!Ò©†áªƒ 
"D#Œ0@ù-$5kt�}A+¶G?Jk;ª/]ì°¯módDðù³B"ÅN,‡ÕÀé\>CR;(×%í~o‡CòÁ9GËo Y«¾KÚÝn­ ë†›m[ƒ“�¤Wþe(G åÌÉ‰0˜@@„©ñ€:×¹UëêÍRÞç’µªú Òö*Çä#è•¿Q¦ÒDŠ8Žy>À0tÞÕcÙ›DOçs€`¢r�“”ßA€HÉY ”	¢PUÍŸclÛq%|çÞÅe¹ì¡s½k–ÿ:D©5©?ß ^Ÿ(ut•ÿ$�"e‰ù5DµR‹¦›åñÃæÐc:a[Ÿ®êbWÌAùß‡Àê71Œ78æí"Ý8Eî—ÛÖ!Ýöðqž·!õq ò;@ÕÆñtÃãùá¥u¾×Ê$‡Ýöîö¦ÃÃüpøóä¬ÁÖÚ1œîy¹>>8ß�: ËŸC �ÍZ_¥ÑæëÝ˜èš #ó	"DËDQå¨n|ëºëúñ©ŽîÔß»\¿z¿½ÇÐ)O 
”ï ¢µµX?�ÂãrAŒ]Úƒ³ühûQp÷ºÇËÓã•ã4ìæay€(P�”"-DŠ%æw@‰’ò¯A¢H¤ÆÅÜôŠØö÷³ëBg�$ 	�'Ø\3’9@#,w gIfë¡áôºlëËuSÂíÉ ÷—gçN1Í‰�(@"HƒÊ·ÀV‹Ÿ¼º>¼¿À¥þtßÛÇËÇKŠwh¡<BT6àövÂËããüzi¡ü uE¸}ƒòòüaNçÛZshóªñ“OÂòág�s;uçó«ñryxÁ8Ž@q°<@ ›ö£»¿Ëöôa¦É�ò	’ƒ­Ëá¿q|ñþã‡t{�F(��jYÝônHëãWûqßùašX?~|výÍBÊŸB µµ¨¿ëjYæy§§OF??¼<Ïê†óýˆ§§¯¹MçÎ•°ü?B jkm¸¥ùúôâ‡›f�PþÀ–ÖÆ7¯ããõëùð÷ÂHy‚ä[¸úzs7ry¼¼¸i°Òå¿�juîæÆéòøˆ=¤p¾›ÜãÃ£^ÝöÞŒPž €[áéx¾<¬i=* üg! Z×6Þ¾Å²¾zZ‡~8Ÿ7¼ÿðn‰
‰rE×cz÷j8~úannPafk·ooëòðåõ¡Óx“úúôåzEô÷ãy_Ÿ¾šOçatÅPi%÷êãuIý¬Ê°ÔÃÅ;Ï}^)¸"*¢Øt¨omßžw¦SôÍÃòÐ:×ðî�«Ï_|õÅùîÌ31��j™uþôÄÇ‡‡ùq¸™Z!¤<@ +¶�nïÜ~y\5ö}…Ay‚ Ôz`¼Ööô¸Ã¥xzs·ïï¿~^Îïî¢?¾çõí0¾½kÇÓ‡�p§[a¥`¥¬Ö}ã­ž¿xÂx>�·..Ëýiô› Ø^ëts./ÏO÷	; åÊG9pw÷ñúasçb„Ý”N7®¬—ÚÝö••°üÐjmÓë›øñãå…§qj‰v¬Gÿíñ~ýðåå¯¦›é¶—Çë"ß�ÞÞ´§÷_?­è¦ó«¾<¼¿·}Ïj�à´•#�ß¤úøñËÇê§›SÛÃüñ˜º	5@ÊŸC�WøaHóòtmý0‰-:«eÁùÕ»²?|µ´ÛáÜ A4wa½Ÿî¶§ËK;Ã.ƒòo@ Õjá4MvÝ–%Å“#+•´¶Yo:«Ï—UÎ¥»stöŸ×}…‡å	M‡ùx:ÕcyÙ4¸®Ry„@³½ÀßŽuYžžj7&ß<,´c+ñ|ž¶—§ �ýtçíiyÜût.Î aC¸CY®—éãù®«ëåyÆµ8Xþ>DXÛÑNÝ€}¿V†zgùSˆR­ŠCŠmÛ/pCš£å¿Q,(˜8ºc]Ÿ’w€åD¡Zâm°–1œŠƒ³ü=ˆ¨\ÍŸR¬Û6ïat±9Z~Q4Û÷8ž//ó±Ž±º´ÍÏOýtsWû�/ºpÂX!€µµ:ÞÝû2=+Þô­JTþ× Š�qOÛú´Ô®ïº5ˆÊ#D±Ö-ÄWÁµåé9øSWB¡ò�juU¼=ß®×Ÿ?-<Ý‚,¿ƒ«­¦xÛ:o»¢•´<B„µ�èû1¬ó¾:öôFZþE´¶îoby~~®ãÍÙU9Y!ŠM»ù›�Ëv9*§Í"ZÙ¨»W–ÇÇ§‘’hù-Z-k—Þu<ÖãvH77öÇç�Ó©ëîï{·<<¼ÌèÓý8h½|uãIØ@µ~Lç²,aL­9Z~VmëÂy`½®;úB! ª´Æé.Ú¼<”’Bxurf�×ÕnÇDåÏ!Š‡ÛÂp×{¿,Îw©ÂÑòo@ *ö:œÎ7Ëú2—¾K©ÒòQ(uë»)Y»l›K!ŠÎò¯A ŽÃÜp¹<¼\Ã�¦¶{gy‚(¬v>�m¸>¦0žÔbƒ©µ‚p’®×‚Ðu¯³ùãÇÞ�Zó°<A «.t÷·#/–c˜N÷Ñ·ùùåÚ†¡„ÅCP[W×¿ºuíùáËÃx;Ü^ž/Å÷ñÕm‡ýùé°sßak åïB„Ù±+ž&Ör™±ôÆ€ëüð€.j…´ü ŠõPéÎ'·\_ž¦©Š¤å_…«­ºá¶óz~z)É�S?…²>Ï-u)’–ßB„¬î5…OBÙ®—�!vãÙ×ë~yFSsp–ßA„ÕÚZx�üÓõá#-Ý¦ûp]çù¥ý0y—ëcóCç]s´ü­Æ8¨´õ¢âyÃry¾ìš†×ñxZ®mH=Öh9 YOCÄ:/�SŽÎò7!µêc½Öc5¢÷ ¶êN·/×Øº“��åÏ!B¦tNQ—e]û$¸ükÑJiÖÒõËúñqA¼o’[Žy)1žœoŽ–ßA„•ºk¼´?_žú”*]~Vª»¹ñe}\,ô)nÞ «¡¿íx<?{?õôr–ßB„Ù‚�¯§ñ˜çC×±ŠùV[³xM�×kƒù~;lóS˜Æs§#@ÃêÛÍ4éx~^ë¹bi."Ú±7žû¤²ÌKc˜nÏþ˜÷§«sÝéÜEì—Ë|	Cw7µãúô|ÇJ µ½&œ{b¾Î†E:Hmo7ìöcY/(ý8Ýmu»Ì›þÜ;·í—e¡wÎ<óB5§ab\÷u…¥Ì3ÿ¢Úf§Ûô|]¶ÞOçnÛu~_¡ñ<Þíe™ŸC76€@C©±ïRw-/¥úé$Bt¯l×§g`Lñp•Ê#D˜v u7.íózm>ŽÃtS×ëË8ÄnsÊ¿Uðç“Ã¼¼,°aœîÊ:_æÍâ8žú°ïËËÚ0Œ·.-ËËºœ�n‡¯ã²¬ˆƒë× ¢íØúþ”â±Î‡¹>’p–OVG×Í¶Ô\ðt´»Spõåe[ëèèò-¤U]ßYµ¹  ��ù·aíhL£w¨{Ý‚>úFæ¬íb7ö°}�ëì9õSÀZž·âºî¦ïŠ®—}—i»­Í×Këbç\óÌÖÖŠñtFZ·kƒ‹C•€j©-Ý¤»—ú|¹&ßõž óMi8GÖë²2Œ)89	¶O=öýy•w£§\þ&dÇ!vCÄ¾Ík	‡¾omYæ?ødÞå3dÅèSÓ®ëR·0œÏóóËÓ‡øªëÊq™÷Zû.’rj¶!ñ&F»®—�QçÐù0×§+cˆ	tùÏ£¡ÕØ�‡¾.×ËÁø|UÞ¥[Ç:/[UŸÒ—OQÑûAÎ¶c•z×·àDC«É#ê²>ìb�Ð˜¿µ½‚ýàÓË6_vucD0æ¨ªÒÆèX�cõÍ÷ÖóÌvc��½Lá¦O8ö§u®~Çq×õ²‡Á%Áå4·ÅÒ÷æ6ÛëZÇnòuo—m�ý0<Ú1×ê“ëE¬Îº>æºÐ%7žù—`F?B¥®Û*�ÃØ©\öù�wc\X–½™KÑ3�ù¯@­Öh)zÔãØªw½órÌ'Èªµà&ùÆ}mUn8u±ûãQ|L.6OÙQ+ãC)×yi½¦¾sG[×£ÑwÞå¿
k‡!Q¼Ö²WX×‡ÉÊåe›Bì¶àóav>tcðÛ¾/Bò1VŸO�U·Åvm±C“³e™[I~¼Ç\¯[eˆ.È3¿ƒˆV+=O½¯ó¾ð)zo¡æ b´!œÚ¾{éºt7,¥ç£§wùV%º	Qu«‡‹1zxæ@­¨ZßûˆõXŠyŸÐÏ<A²¶	.�ã°]^ææB×+UŸ?ƒt Ö0ÆèÊ¶¯dß�›µEÕ§Þ'r_lCô�Q>ÿe˜÷¤Î'lš·¦8t©k<^JCP¢Èü¦y¥•v5úq~nûÖBbdj$óoBV\‰)ÆV2ºHÇ|†µ£Ð…a¬­ÌÇ±ûèz81ÿ>¬U±ãÙiÓ¢†„@OªÕÊà»žlóþR9Œ]ov]çFúèàÔªY±·c�Ø;GæÔŠ;\è…ÒŽ«,øàè˜Rs‡E7ÖÎp˜—èóoÂ`pL½G�q�°uõ»§KpŽù/Ãh^»3øqž·}}ðÁ!;Ì¡^{Ý*’šŠŠ±§•}¯Åcê´•ykp)„$
�•Qê¾; ¸ˆ@æïA0Y]LÉvºü?A0˜×…£”ÅÃG#(0F	h†Æ¬j¢NdGñ-#êuÝDŽ–à‘ù;0HªbŸz¬vm%¸�‰Î‰ ó¿	’*]ïéê^6çÓdT){YÀ¾8´ÙîÍRˆò`þ˜ 4?1lmß¥äCHr‚
›çÐ'WŽ­6„.y9 s€`P³=Xˆ‰u/Áu Z È|ƒ44¯xRØ�e¯,Ò�0 `" ÖÒ�8|YgÝ8¹h×¥V†™$
jÅ‚Ò$ß¶ã¨N)$x@$ó¿É³V<»ä$Û«==•ÿÈ ™*]ðZ-›Õ�Zh´”-¶èèL�k™�…!t>4§F92$³ƒò±ë1ÇÌEÁ[™‚Áípnð©Õºú#x�à¼„fMŒSí¸^uÃ�.¥ì‰}è[ "ó š§I…©w2]ëïB�Ô¸ëB¨{]g6* 8GÀÁò¿ÉLh FßEnöbÎÓwòl¾Thð.Ú±5Ô€D€9Â ©±8¤NÜŽV@KQž Eæß‚$˜3Wà˜âPÍGS×!ÔÙ)xFzP.ÿ&DQhÑÂáü)¢lûr@Á{: AYî!Â`bÅü9 ÔÅù.ø(#EæÂ e­"ø­mí¨¼Or„9ˆ$U(v±mk—V¼ïO]¶m¦)9m¶ ¢«Þ“€ƒ”’hÑ(úÎ9XC4Ì·hÁŒÎ£í^þ¤c¯…. M4'0†F˜wp(Gp¡Ã!•rù-àohÎœo¾9Èœ“%H¢(€‚Œ!-YÌD‘’ Z€@0H!A 4g	  C-$
 (P`‹h� „(2Z� Ì‰t9Pr-˜ÉD„ 
	'ZhÁ`ä�ƒ# 3Y2Š(��É˜#‰f5Â¼ED£µ"í©vÞ%óÞ¡9;\ó¢|%)
 ŒrE8zçäÔTCM2'@£cP iª®ÒL„s s€(�	9‰��ƒ Ð ŒPÖÔà¥ÀÎyÅj¨�Ñ¹@—ÿ9’HB&£˜_CÖ¬EÔ#Ðûà|NŒ"ÐÜaÞw#í¨tž!x�$Pþ„ÆÚBKÑ5^¶ÍÔ¹HŸA€K<U¿Õâ,À‡h^9A@‰”ÿe2@ù3ˆhù‚`RKqìUöyo1::£ H€#ÕöV|ºék›/;ÃØÀ+ÉAN |QíØ†ObwÌÏÏÇÞ< ¢QùØ`«º»É•ëÓõÀ�B�òÁ\NhZ­Gw¾‹óþõûzIwØ”ÿ2$„‰Êo B å›?ªºî>-óÓóÊSì°z'ƒò ¨&ýXÝËz…úA ò· ÐQ Á@‚¶·#¥óPæíeñiê**�!€–DÁY„å{´¶nmzs‡ùéãÒ†q2 RþDÑ´i˜^ÝÌÏ/[Ï,¾Š ”˜dŒ
f cþm`mGéÞÞíããWW?†&€LÌŸCå„–H–õãgï°ñÕCÕ�C8#µç¯¾þ¢‡¡®Ïó=›n¦äŸ¯�•]ÒÔ%–ëKá)$PTž €åPéïƒ¹¾li3B9B" 1'`9LçÛS]¯OÏ½	°ü‚ˆ½.¼ÿì•ùú'Íáþ¤
HùG�K¹ýg÷=~üå×À«{a!”?‡ 6[Š}‹²><oýÍèBÊ	¥QµìÓÍë�O»Ñ£yXþ»�HÛÊ2Ý}çõ{ý£¯ßóÍëÔ×¢èÊu9n¿û­ÿá§øÓü|ûÕÛÝv˜˜?‡ š=í|÷­{<üüç¿sÖCå	Ðª¹Ó©oûóËÄSˆ\ŸJ	SïÍÃò	PkÑ¹Žýy]Ò˜º]¢òAÄ±¬¼ùÆ�{ÿõ—úÛû®Õ
(DÛæÇoÞ¤‡?ûxÜŸƒY”¿l¼VÞžÓºÌ-…b?ð¸Î3z?–P¥|‚DÚ¶Íáí/Üàîgt {Ý`bî!ˆØŽÕî¿óæï>þü'�çþÓv•³èZÝÿÉ7Ç_úÓŸü´ß;ç;Ø¶^Z:øHe+õôî›ÿÝöåO�?:O¡�‰u»–cL]h ò°uCzuòóãÇe8#DóÌ#DQÇQq;öu}¼<ßq¬"”'@=*o^Åýúøb¸ïbÛ(ˆÒÅó-·ËóÞÎqjð°ü_B9 ÌõxýÙ›ñùg_/ñuÇZib Ð´æÞÜNóóÇË½O÷o:Ì_ýXÃýÉ¶nËR-%ï ËP�Ýn_}‚ãÃÃsíï‡fP  ÚgðÕÛa{úðEµñ”´’-2ÿ[ •uÆÍ·¾õßïü'ü÷_¿¹CYåÌ3Êu›�ñ›¿üñÿÿé«éœ†©mëË�ÔwE–ÿ3ˆ¢a/a8‡º>½ì7a”;(‘ÕJ÷§c½~ØÜtŽq3(ÿ&DÁöúÿ/;—mçY€ßï‡yZ‡ÿ¯ª]µí#o;¡; ÛABÁ²­4BˆŒ a�è€„„B‹“B!.€«àBD‚|ØUõÖZsÍ9NßËó„pŽÃV/W¯gÄ¦¥óFw<�Ì/_ßåÍLC(Ì¥ÉùÍÈÛç§]3Ãª°ô·@ˆÕÞ1�Æõ~{Îã28×!L?é=s|û8áóÓÓ>ŽaéA»Ýv¾ÔþçÿïÇð�ÓP4[7Ø=U,} évëñáááútù:È2ûŽN¦oƒBp7‰‡Ëóú*á}…é«}¦w\^žîátÙHaú6 ç,Ãß@¹üúv÷Ë K÷u¿Ü%Ã2H[ïkÆ!Ç&L3(j)ny|‡uýÚOË9’€¥oƒ³Ü‚?NÚêsi²ø`*–P(f{‡å�×Ë+—qˆM›0ý#P(]2pn¿½ÞÌa˜—I^?^¯ù¸L®y
Óhí†ñÃ—×�wûæùˆN¥¥w ÄPê®�Ë©|~¾Ž‡a5
ÓAˆÙVdz3ãöú|9†a¦ –&P(f÷OËóëåóÝN„£²öÃ;Œ·í¥é8ˆg¦ß…Â’·p|ëýëózuËq KßÆì¨ÇàKÉWÕ8Š‰Xú#P`%ï<?Æzûü¼iŒÃ2W.Oë§¥aò`íþÍÈívmûÁm"–¾…ÂR:¦óYnëó‡i2R,½“G)Ùß�ËóÓ§[>N3Š‰lµët\¶v¿n�â†å ùõéšqb£ˆ¥w Äl/ïŽs{yzÝp˜ ÝÁÒW Àlw2,�[»š™ºWKP`­WŽoc\ŸŸ·>Lƒjé¿ƒh­É2Àëmíã8ø"€¥4ŒÂ�oO[ÇqÖL,½V+ÊùxÄvù”¯î ED,ý”^àÎ£äËåµàÇ]D,} V+úržým]/Ë0Å°yµô�AACíqÂ¾n7«œâÃø|}Þ�#
ÅÒ{P`=øÓ<½®—kÇ!ÕT,-  gë²<·Ý®»Ewž|D.×„&é»  Ev?ž_.·û>NãØºsÔ®»!<Üv»ÜJ›§±ÅÒd-ŠaŠØï×Ž0Ì9šXú(`ï­ÌñÝiß_?­y9Ì®øšþ4ÔÇa¨}»_½÷“v'é¯‚Ba)]æÓ„òºnuFVhú; Õ*þèf½í/?:Š@z¨b:,QyÍ·"ÞBÓoƒÍrŽÇ©ìë¥ ŽQ›J:Ãšuq¥®f^ƒ£fÙµi ¬v�Éšþ3Ìvmþ8(Ö|Ûéƒ�CDn{‚‹j’~
Z)æ¦i‘z{½µ0ù±L¿²–†ùpÈýzY÷c%�`}‡÷ÇQ{Þ®VCÔ`^ ÖÞm<Ï#ï××=`ƒ¶Ö5³tÅ4qk]QÅE'éïƒ½6ºa	nË×1
€½qŒ¡´R
'	ÞTÒ ­ìã»aÂv»TŽÇ8 ‰%}6Ó,ç—µ!Ä¡RÒ‚h–½.ã;”ýë-‡áDì"`/;0GÔu{Ý5NQa*é`/…NÁÝËë
Ä1ºæ$ý°i¡s1”V{“œwNÒ{F«­ëx¶Û­·ƒŽN›Jú6ˆÙÞ›[üƒß^.—ýÁÍ“ª‰¤ß… K5Äá8·çkn£Îg®Kµ*a�¹“{nÎhú.ˆîšEŒè}Gwê‚RÒ7ÁFƒŒÃÜy¿å7§¹ç=¯&.¨S$-èšaqZ$®uÛ	ïC÷šþ¬÷^:­T8•ôÝrñãrte»=ýè\«Ö”çTÒƒhfˆq™µÜïkaœà©L?AkR,Æ9h©yï! ª9I3vË®øaTíu»Õ*qr£Ê}¿oÝBTO…¤?­7Õä^2í0„¡³l½k”èD5`ÒXêF¯Vö¦>¨ƒHú.Ì0¸vÝÙÄq^!é ºdÃ8NqÙ××­¨Ì‹RZ/;º8õÞA$ý	Hvë-™+dÏ5q‰êö¼­TL³÷Ü:!T§M€ØHÊì"ÚÖÖâ#ŠOG�l†â¤²ÉÚ[�è"T éwA6Í �GHÍûUûàœ£HZ`Ö¤E?9µŽb
xª“ôS�ìÖAƒ6Ë5Äs-íÚ›¸8¨ZkÜUêU…"iÍqa`“w:• …Öº37"Ð¶^�Þ+UA‘ôc˜ÄÚ$S¹ön¡«ó"i‚è®2z“^z�˜qBCƒXpôV·Ná�@Ò�„YTgîíR3œXCWÔ9ˆîš£Õu)4%½© éR`oÝ÷!8µr+ÕëTœHú
¤Y¯AÃÐ­�P8§JÀ,û:ŒÞïn³*ôðð@Ò·@‚ ›k!õ»±tpðÎ)�fU;ÂCÍuóý¨Æ¶÷BF/Ø5K“¡p"bšÞ€èAØ­˜÷£É®û†Ìƒš~]›ÂÅ1k¯U<ñ!éŸ� „ Áô kÝµ)ºÐx-Y\‡h�¹)=Ô;%I
£ôˆ^Xcœƒ·ûÞ÷ >(�šã`–û¶[öæ;L¨é„	h½w	¡õíAœ‡˜%�‘<!hZ “÷›îýŽ€Ñ&B‘t� XÌú0Í‘5_VÔq˜½öº×Í+œ
I�Hú�0À lf“D­uß:¢ÃØ R �h­˜¼¸{»Ô:À�-tRª–þÉSÀÞ³CœôÌ+:º§ LïAÒ 4:N‚½ÝÙ¢N©BZßƒùIôÞÖ=Ç8±sg1m1ÀiòTŠ¤o‚;*MìfÛŽîÄ‹Jò&À&Å$Ä è[Ý©N‡. D˜þH�ìÖ{�9Œ½Ô[iÄÄÄ©(ÌI¿	‚@šf‹„º•½a.ÔZÑ}4oBšHú!AkÖÆ ¼å\UÔEÂÄ‰@H¦ß)¡‘lbèqaåŠŒ�w8…À(L¿LÔ¬�~pQ6ÞÙ�:	½7�¨JA€"4C÷ÝÐuÉu»g‡8Z­[íu.D(Ó¿A[Ö‘"  ‚ …`Š£€ÉC@B*�BI¤�ÉÃ R-’*&B¡	„@(J@L,„	A˜ "º£uªˆ7%º³N3( aJEH¤�J !¦‚"h�j�4˜Šº §B«®jïì¦tpÞ;¢KÕæÛ@Qˆ(„ÄDŒBIÀ â©¡ƒ½ÁU5�Ž"BPP¡F �‚ ¡GP…B€£v „€&¤€RP„ ihŽF§Qze‡3Q!R 3¯æLÄŒ"Ðô-P(  éÁ 9È0¿Û¥+'	JuL(TŠL¿’½9s.B{«¤çÒPL¬Âù8ˆ_÷V©Î»Ha:€`ÓbÁÏ‚b[C—ÑÍ0fì½©GòÎ¤AB°–3à•N˜¾‚� Ü¨®X¾m¨ÑM“�¥n{Þï¼Â©±‰A§ÑY-¹;:çÍ‰2„dÏ‚0Ä�uÛKmâÝqÐ×\{�ž4«&QÝJÝœ©æD™&PhÖ|i_¼þâsÓaœ’ ÈZEÆc9_ŠMÄ„é(´V»ÌÇQÛþr•8Ž€0A!­ìÁì÷—|Aâx^†õþºîá0:I]îÎÆÓŒ|ªu†@@˜Ž ¤â.1œ‡Zögô1D8‚é
Y[CXí–K…z}X|½¬Ÿ�L‹oðÙwióñêõö´…9:¡(ÓÐÙªÄ7påúº�ª®�-?Úçq>¢u%Èfãñˆýúº®S�@À´€B4T™ß/×[óSP#@éº#¸Óˆ}]KÆÁ[è–þ¥Y®úðî[ŠÿÏ�ù‘ÖÕ()‚ E(HIßƒ�PéÎºR$=€TØvßãñKW^>}z�z?¼=¶ËÓÇ×ýËÑÛx~‡O¿úõçüám„u‚é=HçÞýùËÇ|ÿÅÓs~œöáô�÷íë_ýŸkÿÖc¨½ÐD€Î®aÒòeß§0BT,Í PZ»À=žçíöñ²Ô¿Xö_ÿâYâ›£o&FI
Œ{oóñÝ^×>NKó¤0ýŠaÓpzl¸\?·ù0¡V…¥÷  �{÷�ååùÓíò…/zzs¯ñë_œÝ"Ãã7%?}üõMÞQ³€é÷Aˆµl8=Œ²¾\6ïç³@L@¦B{ÉÃéÍéùúéã®§“Ê&`ú!H•Öw~ã4Þ>~ýê†·`30}¤emýá›‡íWþÿ¶�“Þ~1o_ÿò—s8žµ7é�Î]ôáqÞ/Ÿ_ót:h�é;  µW?žƒåûKåLaé»  Ûî6¼=ŒÏ—O¯îíyÑ. Óè­õãù,ùéSÆøz10} …Â’³›—Çr»\Ö1NR<Èô3�f{Ÿ�ëó¯_àOçÖÌ<Ó?…`î=çé¾­7çç ÝÁÒXÏ°yŒ\·ÒdŽ–¾Øyüâ¯Ÿ¯+–ChæÍIú) U‰ÃÉÕrÙ,¸¹`é=€5ïÃé^ž_>Æ/â›˜QÒ`Î-œÏùÓÓ§'=žÌ­b”ôŸ@@jÞëôîóóó5#NóqˆýãåëûtXœ	ŒJ´Òür~ÓÖÛç‹JÇÇ3ò/¿~µã2Yõ ÓÏ@*j»s~ûxËO¿Bûò4iKß!V;qš‚½]úGGÀÒO@ªÔ¼ÉøÅ‡^>>?ÉxÌ ¦¯@@ºÝút<?^ž>ãrTdšA@:wøùÅýé¢á¸Àdú
`ÛÖoÏ¸¾üòkÄÓš l+ˆo–°~¾½z>ö°	A ·n‡ÇØùùºÇyv~0} …ÒZÕñà{ÛóÄ»‡¥ÿ
RûîÇ7“ûtyY!Ñ/oÔn¿zåô0…M@¦‚BÔ*ar>ïûÎ! ˆ¥ ¨{–7.×�ÙFï³ÛÚõ©–yµ;Xú„˜mÅ†·óøt}Ùjn<¿qõþiëxˆ±7�¥„÷Îð0Ê}»”¦‹×î`éû ÀZm~|tV®×ìæ´*,}u7L�ƒ\¯O¯ÇÃ;,ýJç½�ÇóT·———iš¬@ÖFœ¢ò¶ÞÖàqM˜¾!f[îáñ\ÊëËfÓx„�ÂôsÂf÷2¾=»õùåõÆp�s´ö|}–%FìŽ °ßÇãùVn·›SO‡‡V¾þòx‚®dú{ „ÃÃ"ýóË¥Ç%„Í©¥ïƒc)ežßFÛ/OÙ�“t!-ýOP`­‰ÇcÇËå^&™Æ7ãtÛ>ÝòÃ²He¦÷ ÄZÍ�·§×+æÃ€»SK?…Rt³Óq²ýéyÃ<0;Xú À°—6._P®/OO{õðp°ûúéuôÓ±U’–fb–wÁÛ3êþúš‡ñh­«Xú(°fUçIe//E|P…Zú 
Ìvóî<úõþ|ëã8…ˆ¥/@�±æ¦qÄ¾nØ�1PM,½V-ûÃù$ÛúrŸ†á ZE,ýX/ÅÏ!–~Ý%zZú°I	á8kÏ—}íAãù¡¿^^_z‡Ðºcúo Àj¥N�CØÖë3pÆ¦´ô°ÉÝÉù8¶ü¼¿ª?Œ½ˆ °RÈãäí¾]x–˜� `eñóä­ì÷]Ââ-šXú(¨Rœ[¢ëû}­t®Ðt­›�ÓAôu»^=;q–q
šm½‹´+öÜ\˜ÊÛ5ç!ºe]¤£5LçYî×õƒoJKßlÌ†SÚí~ën¢é¯�Z)MOq¹oŸïëýR {®ðÇ3ô¾Ýë4DˆX"Ò€Òe‡,§€m]×Ì³5ý/­¢úÓìåþ\B<¬”ôW`Ì^Ü_,g�
'é¿€(jaæÆ{/‘PVkÎ-3âž_v ŒŽð :†iô…Ûmo¢Ñôû°ÖLãy}½ß®Á‚Óê€î{ób`ÙKé>zDhúW`¯êO‡n×mí.^¥)ˆ&ÍÅiRË»]½Ž!4‘®ÕÔÏŒ­—Ú�ù â$ýK°¢Ô8ÍGlûËzËÁ�'jÙîkëƒ�•ôOAìºLÇ¥ÚõZzƒsI?‚Y)q8�÷[¹©†@ÑD¤w Ìvß‡x°±Øµì¦a<zâe¿o9ÀGÀ©¥ïÂØºR�ãP·m+ÅO!€ª–þ	Vtå0Yëõ^âß…é=h•Ytqã^ÖûŒ^=’þ5Zkã\Û÷µÝ¼]zÙ·²KôÑÃ@+]Â8_jÞ­£;oy½‹óqÔáÞ^KõCˆHúß �Øª\/µÙÄ�J¦¿`/½…°Œàu¿Y÷œ„DeSGdÛJ¿ŒÎ»�×Zš§ >×l½A¨
…Hú› ŒMªÃ8FØý¾uŒT  Hú» ÁÞ÷Ðâ¢j¹¯½‰b0çT˜¾ÂÐAQ7jë÷ýÞ¤Í>ˆséG ÍŠ!ÆC•Òòªªƒ"%½ƒ	�®ÅÔ¢Xs)®à©„¤ß­71‰Qµ5d%àÔAÒÿ aBC‰mÒè„Åe¨Sçœ �ô ¤»·PYòVé‡É;ä²oÝ|\âPjÙ)ôœ9P¬iöô“ªÕ­–dò"²÷MšST¨éoƒFÀØ £—bùÎ>"2P)’ÞÀ@ŠYaÑ1(ki7Ö ¯É!é+ÐzƒCôÎu–¯�ÂzÕarýÞ÷ÞÔEªHú· ‰¦Õõè©ÖÊÕ]¤ª¡£Å‡Éå²Þ+ƒS*Õ´Š0Fõ[ÎA‚s�€Hú=Èi.Ž=ï­8xç½
A‘ôÛ0	1k]¼<
×¾¡M|wbÒ}	æc”l¥tFªHzšX0iŒ~,[½Rl>Æ`¹ÖRá�*EÒ_Ië�ŽîÀÈ’³U§nŽ¾m½Ýªbœ‡Þënf�^¼€ìÎ ƒ7�R	&éG Ö›˜Æ‰~kåÞ5Žn°Þ×½‰Z´ M@£5taè{_»´Aý@UI'Ðz§Ç e%ŠSˆ `ƒ¡Gï�¹îÖÇá`Ãn›ÕÔ#ˆ0Vt‰ÑiËVÃà<¶ºg
-0@DÒ{°÷j^â¢¾çvo,T`¨qqZ.EÕ«š«Aº+¡ÇÑ…,µfˆ›5²ì�mz…BÓÁFÃ„ÎµìÝ	‚Â	€$LÄJ‡�at¶·û�ÑRú~_Ñæ¸LQò¶—êÂ—Þ^ë­Ò©spÉ$}&Õ¼,ˆRó}‡a�Hi¾¸6EÒöÍ(ÞGÑ|np¡r×ÝGõTIïAÙ¬J˜tî}¿ß¡ntÞœ@,ý%P`èRÙà–8Ôm»ï=!@œš0EP@ë¥#¸ETÊ½dÇyŠ®çZïÕ&?/Ú¶¼oœS'ª±4€ì ½œ°ì¥ªó!˜HzšUSNq–˜ÛíÞ1úyFÝKÍÊù8Å¶æÒÁÉûÁT(æŒT«¨ªtË*ÞÏ
+½äà$J0� �îj«QN6×=ßŠ7¸äÅÒ 
!]+$º£„½ou‡t0é®tÅàê}/]‡	^÷RK÷ÑGtBéÖZsaq±õmÛáÆãäJÉ%‹‰wNMÐ IßS€uPœX5…´ÞBôCFo»	tl*40=€$èz/¹Š›&	ë~Y›…%ª+¥¬Ú|ƒoe»'„`C…Ñ&„ª°±z›¯Zöµ4§Ñ×µ¬-K8â8Ö{½×Lcè­•�êÄ¨ÝŸÿ?AÊeBASE      2è  xÁA  ƒ°YãxÔ þµ,9�Ú˜sÌl3æ¥…J8\h£h‚EZ4Zh£hÆŠ´h´T†áf…Ö’’m4©¦°4d˜‚eèšÚh£Á`H×ÖFÓáXh’ŠL¶Y–L¦šâ7L5mÌÌÆš LJÑµY“1 m6�ÙRIØ`È,k2GÈL†*²9­acC&1¢¥©¬iƒ� eéJØÔÙf¶&ƒ´e$B2Íªs*“1TÄP6TE&6YÛÕ±È±¥LE[K�‰”C¦6Û¦2`“)
Ó6µa(“ËJ…¦0Ú$+ØfŠÌÐdlË9E`²µ1i˜cc›:"s	šmTkÀ¨a[”F«™VáŒÖF8›4­6’fÔ,uÑf%U>Ï5óBPOS      î  xÁÁ�D±…ÓN?×	Ò"tìÿûç�ŸŸŸ??ß×ï¹ïïïçúÛ_=¦ïú¼šß�wûîmæöÎã¾¯½ó±jgg×»×Ë÷–÷ÅÉŽãìÄë F*KÕÓ½êÜïE¼›ÕéI°"OŠEÂM½š–gMRÞMMM<£‰£LÆfhlah��e–¦€146!60f€¬Å²ÁC`˜™‘E0€  ŒH`LÓCÓÔÀh@Ò11c€0�¤Á„&h`  fHZÔBB@(Q�ÈÐ
�Z25ÐnMk!»e‹±{Ä4ó¹±Ð»5°5FÿË†/ûCNF4      0²  xÁQNÛ@€á?^O»ÀJa¥È!U<r‡ª˜3ö(œ‚çHð`Q,\7é*f2Þ~ßêWý¹¢¯Kµ¬/+‚¯�¥9ß—°ü;^ÛÊwU5Ÿnç��$9�	.|@—7K5Ò’ÁÒð LZ3ÂÕ§‡~·¡§<ø):ÁpØ™Ü©à1rÔ†žüëOf{§5=mô€¦8EýAO§-hƒ‰6˜¢[^žÀ	˜µÚ`¢Wb‚�¨`€`€`‚Ó52D1Ál3‚}ná¼‡÷tY>º×Ûe^¸3ÁªÓ€$­Ù°ˆaïÐ’N{k�ùÍoþ~Û’°Öýî!rs–G‘ãoqöb-ãë&©åpoíøy¼´ -hAZÐ‚´ -è3ÿàLš¡TEXT       Îò   xÁMnƒ0Ðï(s °fÆØ.H,l@iÂO¡‰ºBI“e“.ªž¿ïaŠcqêàNûÝ„Xûà²¦.g»ºŸ­µ{ó8Í±�xÃJhãÚáò¸“2®Ob©\Q9OÊ*ôû¢ËãNÊt¸>‰mÅe¥�”U°|L-”UX”‹+œ§œ”UX”[.5 ýìfôi³Áò6ç°¥vý³æûuÃ›wÄ´Ïç&V�ñØ°Á2RôÉÜ¾~pîAaçnQô‰Ä(ðÇ¤4dCLIP       	           …<AlignableSequences trimStringency="Medium"><Sequence name="25_CMV-F_TSS20210119-027-7854_A07" ID="0" isTrace="1" sortOrder="0" trimmedRange="14..998"/><Sequence name="25_WPRE-R_TSS20210119-027-7854_B09" ID="1" isTrace="1" sortOrder="1" trimmedRange="0..980"/><Sequence name="26_CMV-F_TSS20210119-027-7854_D07" ID="2" isTrace="1" sortOrder="2" trimmedRange="17..998"/></AlignableSequences>  }‹     ÿ BC N srôe”```pðpáó³2Ô3ãö·²*Í+Î/*IMábÊqqQjZjQj^r*Ã:q p0op6   ‹     ÿ BC í—O
%5ÆÛÇA°Š,Ê�UdQàF=ÁT‘EÜy`j‘ãÌ•ÁcŒßÓ*‚;‡þý’¦ëOÒ�ï×¡O®ßôÃ‹ëzñþ;~…ñ//¯¿èëëg\ß¾¾®Ÿ¾ÂSãÎ§×¥Q³©4�Ü•+SM&›pôe%«”�Ø‘¨ß§ÞžÓm�WWÊ³ìL=:F5*=e4mi¸‘ïe39$…Vtž£¢,z[¶ÅT³ß?f[ûæÁÛÜª¹{Ì$kÊtŒ{åI)i$#…Ñ‚h‹ÆáÙº` aÆ-Ó‹«…¦4µcè¶¬héB¾Ý�)µ´,,º4Äj¯Í´›í"³L�@oÎ:ø‘R=[eCÛ{“ú´fjU'ËF-+SEêf¬tšU ¤x!ßàã¨‹†�R©RüÐÈ�(¢Gì4fïÆÔt†©H	ïm¯@Þ@áPQv²”äÌ 8ác_¼êäö³ºËÂYH_v*¶ä:y¬/ìà–óöý­[·>t}ñ„Â«'^_Ÿÿ
ß\ïpå:>ûßã©þÑu�vêTÂÊà:#`_0ª=Iyw3)Î‡�5z­>GŒ½ÖºQò?DI�$a=øËÿú_{ëÖ­]ô„Ã�ÿpbøöj€À›?�Þ<NtFÓÓ:\uxƒÇ(]Ü˜=Ž$ùÚ¾JžÓ5ŸSƒ�ƒÍ{mÙmÀÉ)$å¤¶íÜx{6;Á�e …ÚìÈ¨ûá #�ïŸtã©x°íÀÎ®Êh’ÊV›Ã��XA5üQ-l`ÂK3–ænoÝð©°Â¾Ýt¦ÃH…X§ÍôëX±Ïl´}º(4A8y7@©øáÏ œ˜Kç s,¦¸2×F¿ìs*ªèéÜÌq£ö…†‚–$+}0aõ€E¶ ŒPwÀãaô2tŸÀa<HÐÅ2Ì7@„µ¢³o¦xÇôÖÐ­ˆw ˆ€¢8Lt
X¶kÊ>„sB¹�Ã¹ªçðWÒÏ-—òmS†=ç†Â­[¾~­àöG  ‹     ÿ BC             !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  (4<?xml version="1.0"?><Features nextValidID="20"><Feature recentID="0" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="819" maxFusedRunOn="819" detectionMode="exactProteinMatch"><Segment range="652-678" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="YPYDVPDYA"/></Q></Feature><Feature recentID="1" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="819" maxFusedRunOn="819" detectionMode="exactProteinMatch"><Segment range="682-708" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="YPYDVPDYA"/></Q></Feature><Feature recentID="2" name="HA" directionality="1" translationMW="1102.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="819" maxFusedRunOn="819" detectionMode="exactProteinMatch"><Segment range="712-738" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;HA (human influenza hemagglutinin) epitope tag&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="YPYDVPDYA"/></Q></Feature><Feature recentID="3" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="5672" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="4881-5672" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="5673-5741" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="MSIQHFRVALIPFFAAFCLPVFA,HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW*"/></Q></Feature><Feature recentID="4" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2580-3374" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="MIEQDGLHAGSPAAWVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVADRYQDIALATRDIAEELGGEWADRFLVLYGIAAPDSQRIAFYRLLDEFF*"/></Q></Feature><Feature recentID="5" name="WPRE" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="838-1426" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;woodchuck hepatitis virus&amp;nbsp;posttranscriptional regulatory element&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4122-4710" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1742-2170" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="50-429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2184-2513" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="430-633" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2364-2499" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3550-3671" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5742-5846" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1492-1540" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="3768-3774" color="#ffffff" type="standard"/><Segment range="3775-3792" color="#ffffff" type="standard"/><Segment name="-35" range="3793-3798" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3813-3834" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="17" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3720-3736" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="18" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3744-3760" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="19" name="Factor Xa site" directionality="2" translationMW="473.54" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="1308" readingFrame="-1" consecutiveTranslationNumbering="1" maxRunOn="925" maxFusedRunOn="925" detectionMode="exactProteinMatch"><Segment range="1309-1320" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Factor Xa recognition and cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="IEGR"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ˜<Notes>
<UUID>6e5ccd0d-3758-45d8-9251-2b7f2d7e072a</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEnCMV-3Ã—HA-N</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created UTC="5:0:4">2019.1.23</Created>
<LastModified UTC="2:59:57">2025.8.28</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  Y      K         
?????                                                                                                       ÿ d      DO  d              E              ÿÿÿÿYô? P                                                                                                                                                             <StrandColors><TopStrand><ColorRange range="421..641" colors="black"/><ColorRange range="738..955" colors="black"/></TopStrand><BottomStrand><ColorRange range="421..641" colors="black"/><ColorRange range="738..955" colors="black"/></BottomStrand></StrandColors>   3<?xml version="1.0"?><EnzymeVisibilities vals=""/>
   )<?xml version="1.0"?><CustomEnzymeSets/>
